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The last two decades, natural product discovery and investigation increased tremendously 
due to the advances in molecular and analytical tools as well as the constant demand for developing 
new drugs, especially antibiotics and antitumorals. Polyketides are one of the most diverse 
compounds in nature, and their biological activity is of extreme interest for the pharmaceutical 
industry. This work studies the biosynthesis of polyketide labrenzin, produced by the marine 
alphaproteobacterium Labrenzia sp. PHM005 isolated from the marine sediments collected at the 
depth of 18 m near the coast of Kenya. This compound is a new analog of pederin, one of the most 
toxic molecules in nature, and has raised interest for the development of new antitumor agents. 
Today, more than 30 different molecules constitute the pederin-like family of polyketides, 
containing almost an identical core region and variable polyketide or amino acid termini. 
Nonetheless, the gene clusters associated to their biosynthesis have mostly been identified in 
symbiont metagenomes, as in the case of the polyketides pederin, onnamide, psymberin, diaphorin, 
and nosperin, thus, making their study difficult or impossible. However, Labrenzia sp. PHM005 is a 
free-living producer of labrenzin and can be easily cultivated in the laboratory, allowing for the first 
time the in-depth characterization of a pederin-biosynthesis gene cluster. 
For that purpose, the complete genome of Labrenzia sp. PHM005 has been sequenced and 
the 79 kb trans-AT PKS gene cluster responsible for the synthesis of labrenzin has been identified. 
The bioinformatic analyses allowed for the in silico characterization of lab genes, identification of 
the PKS/NRPS domains, delimitation of gene cluster and assembly insights through comparative 
analyses with other homolog clusters. Genetic engineering tools have been developed to facilitate a 
functional gene analysis, to decipher the function of most of the genes involved in the polyketide 
biosynthesis, to develop an elicitors screening method via translational fusions, and to generate 10 
new labrenzin intermediates and 10 more hybrid analogs, including pederin. 
The inactivation of lab3, lab4, lab11 and lab13 genes encoding HMGS, PKS, ECH and 
PKS/NRPS proteins, respectively, caused the absence of labrenzin and its intermediates in the 
PHM005 culture extracts demonstrating that these genes are essential for the biosynthesis of 
labrenzin polyketide backbone. To understand the role of the complete polyketide backbone in the 





was performed. Since labrenzin production drastically decreased in this mutant, it was concluded 
that the polyketide backbone has to be fully synthetized and released from the PKS/NRPS complex 
for its further hydrolytic processing into labrenzin. In addition, it was demonstrated that the 
polyketide cleavage happens inside the cells. 
Concerning labrenzin production, the knockout of trans-AT Lab9 significantly decreased 
the production of labrenzin and its intermediates supporting its role in proofreading. This mutation 
also demonstrated that the other trans-AT, Lab10, alone is sufficient for polyketide assembly. 
Polyketide tailoring reactions have shown to be a useful target for generating à-la-carte 
intermediates. Methyltransferases Lab6 and Lab16 are responsible for O-methylations of labrenzin 
core. Lab6 has a dual function and it sequentially methylates the C10-OH and C17-OH groups. 
Lab16 methylates the C6-OH and its knockout caused the quirality of the new generated 
intermediates. Both enzymes are substrate specific and their activity is not redundant. This work 
also revealed that oxidoreductase Lab5 is involved in the hydroxylation of C7 position, since its 
elimination caused the accumulation of the intermediates lacking one -OH group. On the other 
hand, a tandem deletion of cytochrome P450 Lab7 and oxidoreductase Lab8 demonstrated that both 
enzymes are necessary for the hydroxylation at C10 position. 
It was possible to heterologously express methyltransferase PedO, encoded in the Paederus 
fuscipes symbiont metagenome, and to produce for the first time pederin in a cultivable bacterium. 
It was demonstrated that PedO is less substrate specific, since it catalysed more than one 
methylation. 
Finally, the genomic and transcriptomic analyses carried out with this cultivable bacterium 
revealed new insights into the biosynthesis of pederin family compounds and set the foundations for 
the future studies destined to better understanding of the biosynthetic mechanisms of the complex 








1. Natural products in drug discovery 
Nature has always been a great provider of resources for humankind to produce food and 
materials, build communities and make their overall life easier. Historically, natural plant products 
were the first to be medically used in treatments of different kinds of diseases, since the ancient 
civilizations of Mesopotamia, Egypt, China or India (Cragg and Newman, 2013). One of the biggest 
historical outbreaks in fighting against bacterial infections and malaria were some well-known 
natural products such as penicillin isolated from Penicillium, quinine isolated from the bark of 
Cinchona species or artemisinin isolated from wormwood Artemisia afra. Other plants used for the 
isolation of anticancer compounds were alkaloids paclitaxel (Taxol®) from Taxus brevifolia and 
vinblastine from Catharanthus roseus. Whereas in the traditional medicine the total plant extract 
would be applied for a certain remedy, the modern medicine aims to the application of standardized 
protocols, safety, controlled dosage and precise molecular targeting in disease treatments. That 
inevitably requires isolation of the active compound and subsequent pharmacokinetic, 
pharmacodynamic and other analyses for a proper drug development. 
Although natural sources have been widely used in drug discovery throughout the years, 
there are still some important challenges to overcome. Often, chemical mixtures from the total 
extracts have synergetic effect. It is not uncommon a single molecule isolated from the natural 
active extract turns out to be biologically inactive. On the other hand, the exact mechanism of 
biological activity in some natural drugs often remains unknown. Discovery of natural products 
may be also impaired as some biodiversity protection laws try to protect species from extinction and 
environments from human alterations. Another challenge is to improve the screening methods to 
avoid the rediscovery of previously identified natural compounds, known as dereplication, which is 
both money and time consuming. In line with that, the advances in computational and analytical 
methods are extremely important in the determination of new bioactive molecules (Halton and 
Clark, 2019; Thomford et al., 2018). 
Despite the difficulties in the isolation of natural compounds, elucidation of molecular 
mechanisms, challenges in production and standardization procedures, about 42% of all the FDA 
approved drugs from 1981 to 2019 were natural-derived (Newman and Cragg, 2020). That 
including biological drugs: peptides isolated from an organism or biotechnological products; 




modification. Figure 1 shows a graphical distribution of FDA drugs from some of the categories. 
Most of the natural products and their derivatives are antibacterial and antiparasitic drugs, followed 
by anticancer drugs. 
 
Figure 1. Pie charts representing the number of FDA approved drugs by their source from January 1981 to 
September 2019 (modified from Newman and Cragg, 2020). 
After the Golden Age of antibiotics in the 1950‟s and 1960‟s, a peak of the natural drug 
production was reached in the short period from 1985 to 1988 and since then the discovery of new 
products has been declining (Newman and Cragg, 2020). Nevertheless, the emergence of new and 
rapid evolution of existing diseases, as well as the apparition of pathogens multi-resistant to 
antibiotics, have made both industry and academia to turn back to the natural product discovery 
considering the advantages that offer natural chemicals like high diversity, biochemical specificity 






1.1. Marine-derived compounds 
Oceans and seas occupy around 71% of the planet, so it is not surprising that the discovery 
of bioactive compounds from the invertebrates and microorganisms present in marine ecosystems 
have become extremely popular over last five decades. Particularly knowing that the average ocean 
depth is 3800 m and only less than 5% and 0.01% of deep sea and deep sea floor has been explored, 
respectively (Ramirez-Llodra et al., 2010). The inspection of marine environments has excelled in 
1970‟s with the introduction of modern snorkeling and scuba diving and in 1990‟s with the 
implementation of remotely operated vehicles (ROVs) that allowed the exploration of larger depths 
(Dias et al., 2012). Marine invertebrate organisms like sponges, corals, bryozoans and tunicates 
were the first sources of marine natural products (MNPs). 
Green, brown and red marine algae have been broadly studied for their antibacterial and 
antifungal properties. The dominant compounds isolated from these algae are terpenoids with wide 
range of biological activities: antimicrobial (e.g., crenuladial, a diterpenoid isolated from the brown 
alga Dilophus ligatus); anticancer (e.g., diterpenoids from Dictyota dichotoma) and even pesticide 
(e.g., halogenated terpenes from the red alga Plocamium cartilagineum) (Dias et al., 2012). 
Sponges (phylum Porifera) are one of the most primitive animals completely lacking 
nervous, circulatory and digestive system. They obtain food and other resources by filtering the 
whole marine environment, so it is not surprising that numerous natural products have been isolated 
from sponge biomass. Moreover, as sessile organisms, they have developed multiple chemical 
defense mechanisms against predators. Historically, several products isolated from sponges have 
generated potent pharmaceutical compounds such as, the antiviral nucleoside Ara-A, the anticancer 
agent Ara-C, and the macrolide eribulin mesylate approved for the treatment of metastatic breast 
cancer (Dias et al., 2012; Dyshlovoy and Honecker, 2019). Marine sponges have been the primary 
source of the MNPs until the last decade. The number of newly isolated compounds started slightly 
declining, assumingly due to the research shift towards marine microorganisms, often demonstrated 






Species of marine fungi Aspergillus, Penicillium, Talaromyces and Trichoderma are also 
known to produce a wide spectrum of biologically active molecules as radical-scavengers, 
inhibitors of isocitrate dehydrogenase, anticancer agents and antibiotics against methicillin-resistant 
strains of Staphylococcus aureus, vancomycin-resistant strains of Enterococcus faecalis, or Vibrio 
sp. (Nicoletti and Vinale, 2018). Apart from fungi, numerous free-living bacteria and symbionts 
associated with sponges and other marine invertebrates produce remarkably versatile natural 
products. Since 2014, the microorganisms are dominating the MNPs discovery whencompared with 
higher organisms. The biggest producer of natural products among the marine bacteria is 
actinomycete genus Streptomyces, occupying more than 50% of bacterial MNPs followed by 
Pseudoalteromonas, Nocardiopsis and Bacillus (Carroll et al., 2019). In addition, since 2016, the 
number of MNPs identified from cyanobacteria increased by more than 70%. 
1.1.1. Marine anticancer drugs 
It has been 50 years since the first antitumor drug of marine origin, cytarabine (Ara-C, 
Cytosar-U®), was FDA approved for leukemia treatment and introduced on the markets 
(Dyshlovoy and Honecker, 2019). The original prototype molecules spongothymidine and 
spongouridine were isolated 18 years earlier from sponge Cryptotethia crypta collected by the cost 
of Florida (Bergmann and Feeney, 1951). Marine-derived compounds are known to possess 
extremely cytotoxic activity. The most potent antitumor compound ever known, spongistatin, 
originated from a sponge, has an IC50 of 10
-12
 М in breast cancer cells (Stonik, 2009). Although the 
MNPs exhibit very strong cytotoxic properties, they are not necessarily the best option for 
anticancer treatments in humans or animals and often are excluded from further clinical trials due to 
their adverse side effects. This is mainly the reason why marine anticancer drugs, that managed to 
get to the clinic, are very limited. Approved marine-derived compounds used in cancer treatment as 










Table 1. Anticancer marine-derived drugs approved by the responsible institutions until 2020. 
Compound Type Trademark Marine organism Disease Company 
Lurbinectedin Alkaloid Zepzelca TM 
(2020)* 


























































Sponge Leukemia Pfizer 
*FDA Years Approved ** Australia Dec 2018 Approved. 
According to global marine pharmaceutical clinical pipeline updated by Mayer (2020), there 
are currently 21 other potential anticancer candidates undergoing phase I, II or III of clinical trials. 
Besides, more than 10000 marine originated compounds have reported in vitro activities and about 
2000 showed in vivo biological activities (Dyshlovoy and Honecker, 2019). The dynamic field of 
marine drugs discovery and production is rapidly growing. During the last 10 years, the number of 
newly discovered MNPs reached more than 1000 per year and the advances in synthesis methods 
allowed the mass production of active substances necessary for the clinical trials. Currently, there 
are 4 promising drug candidates undergoing phase III clinical trials in the US: Tetrodotoxin 
(Halneuron
TM
, Wex Pharmaceutical Inc.) developed as a painkiller for chronic cancer-related pain; 
fungal diketopiperazine Plinabulin (NPI-2358, BeyondSpring Pharmaceuticals Inc.) tested in non-
small cell lung cancer and brain tumor; Lurbinectedin (PM01183, Zepsyre®, PharmaMar) tested 
against small cell lung cancer, ovarian and breast cancer; and β-lactone-γ-lactam Marizomib (NPI-




1.2. Prospects in biotechnology 
Despite the isolation of more than 11000 new drug compounds from 1990 (Martins et al., 
2014), there have been significant challenges in drug production until the date. One of the most 
important is the difficulty to harvest the compounds from the often rare and dispersed marine 
producers. Also, the concentrations of the active compounds in marine organisms are extremely 
low, whereas to obtain the amount necessary for the chemical elucidation of MNPs it is necessary to 
collect immense quantities of the marine biomass. For example, initially three tons of sponges were 
required for the isolation of 0.8 mg of spongistatin and another 400 kg of sponges from different 
locations was used further to obtain 10 mg of spongistatin. Also, for the isolation of 18 g of 
bryostatin-1, from the bryozoan Bugula neritina that grows in colonies on the ship docks and piers, 
10000 gallons of bryozoans were needed (Stonik, 2009). In some cases, the strategy used to produce 
enough amounts of marine active compounds for the preclinical and clinical studies, was to culture 
the marine invertebrates in marine farms. This strategy was used by the US National Cancer 
Institute for the isolation of halichondrin B and for the isolation of trabectedin by PharmaMar. 
Nowadays, the active compounds are produced mainly by chemical synthesis or semi-synthesis 
through a mixture of chemical and biotechnological processes using natural or genetically modified 
microorganisms. 
More recently, the production of antibody-drug conjugates (ADCs) has become very popular 
since it increases the target specificity of the drugs, for instance in cancer therapies. ADCs are 
composed of the naturally derived cytotoxic compound, a lead molecule with the attached antibody 
designed to target specific proteins on the cancer cell membranes. By the end of 2019, 83% of the 
marine anticancer drugs undergoing clinical trials were antibody-drug conjugates (Dyshlovoy and 
Honecker, 2019). 
In the last decade, the advances in DNA sequencing have led to the identification of 
genomes of new bacteria and opened a new window to inspect their secondary metabolites 
biosynthesis potential. Nonetheless, only about 30% of known bacterial phyla had cultivable 
representatives which significantly limited the industrial potential for the production of active 
compounds based on bacterial fermentations (Achtman and Wagner, 2008). However, thanks to 
advances in next generation sequencing (NGS) technologies, rapidly growing metagenomics 





(Wilson and Piel, 2013). Identification of novel biosynthetic gene clusters alone is not enough, 
since many of them are downregulated or „silenced‟ even in the cultivable microorganisms due to 
the lack of the relevant activators or inadequate culture conditions. To overcome these challenges, 
several approaches have been applied during the recent years such as varying the culture conditions 
by OSMAC (One Strain Many Compounds) approach, co-culturing, addition of chemical elicitors, 
improving the translation rates by ribosome engineering, manipulation of specific and global 
regulators, quorum sensing and heterologous expression among others (Zarins-Tutt et al., 2016). 
Another important challenge in MNPs identification is to reduce the high rediscovery rate of 
natural active products. To avoid time consuming and costly re-isolation of already known 
products, chemical dereplication plays a crucial role (Dinan, 2006). Technological advances in the 
recent years have made high-throughput screening (HTS) largely implemented in the industry and 
analytical methods such as high-performance liquid chromatography (HPLC), nuclear magnetic 
resonance spectroscopy (NMR) or mass spectrometry (MS) are constantly improving (Kind and 
Fiehn, 2017; Pérez-Victoria et al., 2016). Particularly, the combined robust chromatographic 
strategies employed since the last 20 years have brought revolution to chemistry of MNPs, 
alongside with the rapid growth of spectra databases (Pérez-Victoria et al., 2016). 
Together with computational biology and analytical chemistry advances, genome mining 
coupled with genetic engineering, systems biology and synthetic biology techniques will be the key 
approaches to optimize the production of valuable natural products in industrial microorganisms. In 
order to achive that it is essential to understand the molecular basis of biosynthetic mechanisms and 





2. Polyketides and non-ribosomal peptides 
Secondary metabolism compounds produced by symbionts microorganisms are known to 
give the host certain competitive advantages like defense from predators, competition for resources 
or interaction with the same or different species. They are not considered essential for the survival 
of the host since they are not directly associated with growth or reproduction processes. As 
described in the previous chapter, natural products are secondary metabolites of great industrial 
interest due to the wide range of useful products derived from them, such as pharmaceutical drugs, 
enzyme inhibitors, immuno-suppressants, growth promoters, pigments, toxins, pheromones, 
pesticides, plastics, etc. Secondary metabolites comprise molecules like alkaloids, terpenes, 
glycosides, aromatic compounds, and different kinds of polymers, among other, but also 
polyketides and non-ribosomal peptides, which are the subjects of this doctoral thesis. 
Polyketides are remarkably diverse and complex natural products distributed across the wide 
spectrum of ecological niches including water and soil environments, fungi, plants and animals. 
Their synthesis has been extensively studied, but still leaves a great number of unresolved questions 
and mechanisms around this field. In line with the work developed in this doctoral thesis, the next 
paragraphs will introduce the main issues concerning the polyketide and non-ribosomal peptide 
synthesis. 
2.1. Polyketide synthases 
Polyketide synthases (PKSs) are multi-enzymatic megasynthases up to 10 mDa MW 
responsible for the synthesis of numerous polyketides (Lowry et al., 2016). PKSs share high 
similarity in biosynthetic precursors, architecture and chemistry with animal saturated fatty acid 
synthases (FAS). Both are giant enzymes consisting of covalently bonded catalytic domains 
performing similar chemical reactions. Whereas FAS comes and acts as a single copy and 
iteratively synthetizes long fatty acid molecules of primary metabolism with unique function, many 
PKSs combines several covalently connected FAS-like units, called modules, in a sequential 
manner to generate a structurally and functionally diverse group of secondary metabolic products 
known as polyketides. Recent advances in genome sequencing and genome mining have led to the 
identification of different types of PKS systems in a wide range of bacterial, fungal, plant or lichens 





2.1.1. Modular organization of PKS 
Modules define minimal biosynthetic units of PKS allowing the selection, processing and 
assembly of the polyketide precursors. Modular PKSs use small acyl-CoA molecules, mostly 
malonyl-CoA and methylmalonyl-CoA, as building blocks for polyketide assembly. Each acyl-
precursor is being incorporated in the growing polyketide backbone resulting in elongation by two 
carbon atoms. Depending on the type of PKS, modules can be sequentially bound in the large 
polypeptide or exist separately. One module consists of characteristic biosynthetic domains 
necessary for the assembly. There are several types of basic modules or domains: 
Ketosynthase (KS) is a key enzyme in polyketide biosynthesis because it catalyzes C-C 
bond between the growing polyketide chain and the incoming acyl building unit. The mechanism of 
synthesis is a decarboxylative Claisen condensation. Because it is highly specific for the incoming 
substrates, this fact is exploited for the bioinformatic predictions of the nascent polyketide 
intermediates (Helfrich et al., 2019). 
Acyl carrier protein (ACP) is a non-catalytic domain that acts as a carrier of the growing 
polyketide chain and the extender unit. It exists in two forms, i.e., an inactive apo form and an 
active holo form. It requires a prosthetic 4‟-phosphopantetheinyl group for its activity, which is 
transferred by a 4‟-phosphopantetheinyl transferase (PPT). 
Acyl-transferase (AT) is in charge of selection of specific acyl units and their covalent 
binding to 4‟-phosphopantetheinyl group of the ACP prior to polyketide extension. It has been 
reported recently that some AT variants can also have proofreading role by hydrolyzing the 
thioesters with incorrectly inserted extender unit or stalled intermediates (Jensen et al., 2012). 
Apart from the basic domains, several optional domains responsible for changing the 
oxidation state of the β-keto group or additional processing can be present in PKSs. They can be 
included in the module or acting in trans as separated enzymes. Some examples are: 
Ketoreductase (KR) stereo-selectively reduces keto-group of the keto-acyl-ACP 
intermediate resulting in hydroxyl-group. It belongs to a family of short-chain 




Dehydratase (DH) catalyzes the reaction of water removal in the β-hydroxy-acyl-ACP 
intermediate, previously generated by KR, and results in α-β double bond formation in cis or trans 
configuration. 
Enoyl-reductase (ER) subsequently hydrates the double bond formed by DH and generates 
the enoyl-ACP intermediate from the acyl-ACP. 
Methyltransferase (MT) catalyzes the reaction of the addition of a methyl-group to carbon, 
nitrogen or oxygen atoms of the polyketide residue, differentiating C-MT, N-MT and O-MT, 
respectively. In general, they possess two subdomains, one for accepting the methyl donor S-
adenosylmethionine (SAM) and the other for the methyl acceptor, which is a nascent polyketide. 
Thioesterase (TE) is involved in the releasing of the assembled polyketide from the multi-
enzyme complex. This step is catalyzed by cyclization of the final product or hydrolysis of the 
thioester bond between the ACP and the product. There are two types of TE, i.e., type I acts in cis 
and is positioned at the end of the last PKS module, and type II TE is separated trans acting enzyme 
which can act to release the final product, but also to remove unusual or stalled residues during the 
assembly (Kotowska and Pawlik, 2014). 
2.1.2. PKS assembly mechanism 
Based on the polyketide synthesis model best studied, i.e., the 6-deoxyerythronolide B 
synthase (DEBS), which produces macrocyclic core of the antibiotic erythromycin, modular type I 
PKSs are the reference for the PKS assembly mechanism. A peculiar property of PKSs is the 
linearity between their modular architecture and the nascent polyketide chain that they synthesize, 
whereas the polyketide chemical structure reflects the order of the enzymatic domains in the PKS. 
This is known as the colinearity principle and allows to predict the molecular structures of 
polyketides as well as to directed useful genetic modifications for the production of new desired 
products (Hertweck, 2009). 
As previously mentioned, the minimal biosynthetic unit of a PKS is composed of essential 
catalytic domains forming a single module. Therefore, selection of the extended unit and elongation 
of the growing polyketide chain is performed in cycles by each module. The modular polyketide 
synthesis cycle includes four steps and is known as turnstile mechanism (Lowry et al., 2016). The 





which allow to pass only one person at a time, because two persons do not fit in one entry. 
Following the same analogy, each PKS module can receive the incoming intermediate from the 
upstream module only after passing the current intermediate to the downstream module. The four 
transformations of this mechanism include entry translocation (I), transacylation (II), elongation 
(III) and exit translocation (IV) (Figure 2). 
 
Figure 2. Scheme representing a turnstile mechanism for the PKS assembly. (I) Translocation of the 
intermediate from the previous module (blue) to the KS domain of the following module (orange); (II) AT-
catalyzed transacylation of the extender unit from the methylmalonyl-CoA donor to ACP; (III) Elongation by 
decarboxylative Claisen condensation; (IV) Translocation of the synthetized intermediate to the ACP of the 
downstream module (purple) (Lowry et al., 2016). 
Entry translocation involves the covalent binding of the polyketide chain from the upstream 
module to the entry site, whereas the thiol-group of the active cysteine residue of the KS domain. In 
transacylation step, AT catalyzes the selection and transfer of the acyl-unit from the acyl-CoA 
donor to the ACP phosphopanteteinyl arm. In the subsequent elongation step, the polyketide 
intermediate is being elongated via decarboxylative Claisen condensation between the thioester 
tethered on KS domain and acyl-ACP. Importantly, although the KS domain becomes vacant after 
the elongation step, it cannot bind new intermediates before the release of the ACP-tethered 
thioester. Finally, in the last exit translocation step the growing polyketide chain is being 




ready to receive another intermediate. This way the iterative KS synthesis is prevented and orderly 
assembly of the polyketide is assured. 
Interestingly, although more enzymatic reactions are necessary by FAS to get a full product, 
as compared to PKSs, when product rates were measured in vitro, PKS was more than 100 fold 
slower than FAS (Smith and Tsai, 2007). It supports the argument that PKS synthesis is highly 
beneficial for the host. 
2.1.3. Classification of PKSs 
Polyketide synthases are divided in three canonical groups, depending on the modular 
organization and their mechanism of biosynthesis, although there are many combinations of basic 
types known to date. The overview of biosynthesis principles of each PKS type will provide the 
understanding of the molecular basis for the remarkable diversity of polyketides in the nature. 
Modular type I PKSs can be divided in non-iterative multi-catalytic enzymes (see chapter 
2.1.2.) and iterative synthases that reuse one module in a cyclic manner, resulting in homogeneous 
polyketide product composed of the same monomers. Non-iterative PKSs are mainly found in 
bacteria, like DEBS for the antibiotic erythromycin production (Figure 3A). On the other hand, 
iterative PKSs are mainly extended in fungi, like producers of lovastatin implied in lowering the 
blood cholesterol. Depending on the reduction of β-keto-groups, iterative PKSs are further 
subdivided in non-reducing (NR), partially reducing (PR), or highly reducing (HR) PKSs. 
Additionally, type I modular systems are separated in two distinctive groups; cis-AT PKSs 
and trans-AT PKSs. The main difference between them is the localization of ATs. In the cis-PKS 
systems AT domains are integrated in the modules of a polyketide synthase (see Figure 3A), 
whereas in trans-AT PKSs ATs are separated enzymes that associate with the PKS in trans forming 
a complex. Another difference is a much higher diversity of trans-AT PKS products because their 
molecular structure usually does not reflect the modular architecture. Trans-AT PKSs could have 
unusual starter units and may including modules with special domains, non-elongating KS
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domains, modules split on two proteins or possessing additional tailoring enzymes acting in trans, 
apart from the ATs (Helfrich and Piel, 2016). 
Type II PKSs are common in prokaryotes, mainly actinomycetes and, unlike type I PKSs, 





and ACP. The example of this type of synthases is an aromatic polyketide tetracenomycin C (Figure 
3B), acting as anthracycline antibiotic. 
Type III PKS are the simplest PKSs comprising only iterative ketosynthases and do not use 
ACPs but instead use directly acyl extender units as substrates. The total size of produced 
polyketide is defined by the spatial architecture of the catalytic site. The best known type III 
synthases are plant chalcone and stilbene synthases, although there are examples found in bacteria 
and fungi. The mechanism of type III PKS is schemed in Figure 3C. 
 
Figure 3. Scheme representing three types of PKS and their corresponding mechanisms of biosynthesis. The 
final product of each biosynthesis type is shown. A) Mechanism of type I PKS. B) Mechanism of type II 
PKS. C) Mechanism of type III PKS (modified from Shen, 2003). 
2.2. Non-ribosomal peptide synthetases 
Ribosomes are main organelles responsible for protein synthesis in all living organisms. 
Nonetheless, alternatives to produce non-ribosomal peptides with wide varieties of biological 
activities have important role in the nature. Those molecules are synthetized by non-ribosomal 




and plants. Likewise, PKSs synthetize compounds by generating C-C bonds in an assembly-like 
fashion, the NRPSs catalyze peptide synthesis by amide bond formation between mostly natural 
protein-derived amino acids and sometimes acyl units. The integration of different non-protein 
amino acids, such as halogenated amino acids, aminobenzoic acids, methyl and hydroxy amino 
acids, phenylglycines and cyclopropyl amino acids (Süssmuth and Mainz, 2017), contributes to the 
complexity of the chemical structures of NRPs and extends the range of their biological activity. 
2.2.1. Modular organization of NRPS 
Similar to previously described PKS domain architecture, NRPSs are organized in modules 
comprising core catalytic domains essential for the peptide bond formation and peptide chain 
elongation. Although additional modifying domains might be a part of the module, such as 
methyltransferase (MT) (Jirakkakul et al., 2008), epimerization (E) or cyclization (Cy) domain 
(Keating et al., 2002), a minimal biosynthetic unit is composed of adenylation domain (A), 
thiolation domain (T) or otherwise called peptidyl carrier protein (PCP) and condensation domain 
(C). The last module contains the thioesterase domain (TE) at the C-terminal end which is 
responsible of releasing the final product by hydrolysis, oligomerization or cyclization (Mootz et 
al., 2002). 
2.2.2. NRPS elongation mechanism 
The scheme of biosynthesis mechanism is shown in a Figure 4 (Weber and Marahiel, 2001). 
The first step is activation of the corresponding amino acid by adenylation domain generating 
aminoacyl-AMP. Then the substrate is loaded to a thiol group of 4-phosphopanteteyl cofactor of 
peptidyl carrier protein, using the chemical energy from the phosphoester bond to form a thioester. 
In the next step the upstream C domain catalyzes the formation of peptide bond between the 
preceding amino acid bound to a donor position and an activated amino acid delivered to an 
acceptor position of C domain by PCP. The resulting growing peptide is now loaded to PCP, which 
allows regenerating of the thiol group of the upstream PCP and translocation to donor position of 
the downstream C domain to continue the assembly line. The cofactor covalently bound to PCP has 
a role of swinging arm transferring the intermediates between the domains. This movement is 
largely random which affects the synthesis speed. The importance of NRPs for the microorganism 









Figure 4. Scheme representing mechanism of peptide bond formation in a modular NRPS biosynthesis: 1) 
Substrate adenylation by A domain; 2) Loading of PCP-thioester formation; 3) Peptide bond formation by 
upstream C domain; 4) Peptide bond formation by downstream C domain (modified from Weber et al., 
2001). 
2.2.3. Types of the NRPSs 
Depending on the modular iteration and linearity of biosynthesis, there are three canonical 
types of NRPSs that synthesize different NRPs (Figure 5). 
In linear type A NRPS, each module is responsible for the integration of one amino acid. 
The same messenger RNA encodes the sequence of the nascent peptide chain on the ribosome 
during translation, so the resulting chemical structure in NRP assembly can be predicted by the 
NRPS modular sequence. The number of modules varies, resulting in different NRP length. Some 
examples of products of linear type A NRPSs are precursors of β-lactam antibiotics like penicillins 
and cephalosporins (Felnagle et al., 2008), as well as lipopeptide antibiotics like daptomycin 
(Robbel and Marahiel, 2010) and surfactin (Kraas et al., 2010). 
Type B NRPSs are iterative, i.e., all the modules are repeatedly used generating NRPs with 
repeated moieties, like fungal bassianolide and beauvericin or bacterial gramicidin S and 




Type C NRPSs are responsible for a non-linear NRP biosynthesis employing certain 
domains inside the module more than once or skipping certain modules. Some modules even miss 
entire A domains and likely use A domains from neighboring modules (Zhang et al., 2020). 
Examples of non-linear type C NRPSs products are syringomycin, bleomycin or vibriobactin 
(Mootz et al., 2002). 
 
Figure 5. Examples of NRP products produced by type A, B and C NRPSs. 
 
2.3. Hybrid PKS/NRPS  
Beside the canonical classification of the NRPSs and PKSs, also there are mixed-type 
PKSs/NRPSs, both linear and non-linear, which in combination with the possibility of the iteration 
largely expand the combinatorial power of these multimodular enzyme complexes. In these hybrid 
systems, PKSs and NRPSs can be tethered in the same multienzymatic molecule or separated in 
different enzymatic polypeptides. Some examples of hybrid type PKS/NRPS synthetized products 
are the siderophore yersiniabactin, the tumor promoter microcystin-LR or the immunosuppressant 
rapamycin (Miyanaga et al., 2018). In marine bacteria Tistrella and Thalassospira there have been 
isolated 14 new analogs of immunosuppressant thalassospiramides that differed in structure and 





The knowledge gathered through years about the great diversity in modular structure as well 
as the elucidated mechanisms of PKSs and NRPSs, provided new insights into the impressive 
biosynthetic versatility of polyketides and an opportunity for the combinatorial biosynthesis in the 
future. Yet, there are still many functions unknown and questions unanswered. In 2014 was 
performed a very detailed and extensive comparative analysis between PKS systems obtained from 
various databases. The survey generated 885 non-redundant PKSs catalog (O‟Brien et al., 2014). 
Among them, only about 14% of the PKS clusters had their natural products identified. The 
sequencing technology has advanced significantly in recent years, but there are still numerous 
orphan PKS gene clusters awaiting to be deciphered. Surprisingly, almost 25% of the catalogued 
gene clusters belonged to trans-AT PKS systems, out of which one-half were hybrids of 
PKS/NRPS. They are most commonly found in microbes who are yet understudied or impossible to 
cultivate in laboratory conditions. One of the first identified trans-AT PKS/NRPS gene clusters was 
the pederin gene cluster (Piel, 2002). This work provides continuity of Piel‟s work and broadens the 
knowledge on pederin-family biosynthetic clusters. 
3. Pederin family compounds 
Pederin is a potent polyketide toxin known to cause severe dermatitis in humans followed by 
blisters, skin lesions and necrosis after contact with small rove insects of genus Paederus, family 
Staphylinidae, order Coleoptera (Figure 6). A collection of 25 million of Paederus fuscipes beetles 
was needed to isolate the crystalized chemical compound for the first time in 1953 (Pavan and Bo, 
1953). The exact chemical structure was elucidated later (Quilico et al., 1961). There are more than 
600 known species of Paederus genus but less than 4% are reported to cause skin lesions. These 
rove beetles are widespread around the globe, inhabit mostly wet places like riversides and lake 
banks or irrigated fields. They used to bring the attention after localized epidemic dermatitis 
outbreaks, which are also common nowadays, usually in subtropical and tropical climates, caused 
by light attraction of the insects by night, like in the dormitories, hospitals, on riverboats, oil camps 
or military units (Frank and Kanamitsu, 1987; Heo et al., 2013; Ngatu, 2018; Suwannahitatorn et 
al., 2014). The insects do not harm by stinging or biting, but only cause the blisters after 
accidentally, or intentionally, crushing them against the skin. Hours after the contact, the reaction 
progressively causes rash and itching, blisters and severe skin damage, which depends on the 
amount of the chemical in contact (Figure 6). It also causes strong ocular reactions like increasing 




but washing affected skin surface with soup and water prevents infections and reduces the risks 
formation of lesions. 
 
Figure 6. Images of beetle P. fuscipes and the dermatitis skin symptoms it causes (modified from Ngatu 
(2018)). 
Today, there are more than 30 molecules identified that belong to the group of pederin-like 
molecules that have been isolated from different micro or macro-organisms. Decades after the first 
pederin isolation, studies have revealed the potent anticancer activities of pederin family 
compounds and raised the interest of pharmaceutical industry in anticancer drug production. The 
biosynthesis of the closest pederin analog, labrenzin, is studied and described in this doctoral thesis. 
3.1. Pederin characteristics 
3.1.1. Toxicity 
The review made by Frank and Kanamitsu (1987) describes detailed toxic effects of pederin 
collected from Japanese literature. Pederin is reported to be at least 15 times more potent than cobra 
venom, which makes it as one of the most potent animal toxins known. The toxicity was tested on a 
wide range of vertebrates, however, the evidence that pederin is used as defense against predators 
remained inconclusive. The pederin effects presented variations in dosage needed to provoke the 
reaction as well as in responses in different sites of injection in each tested animal. For example, for 
an ocular reaction, a much higher concentration was needed in chickens than in laboratory mice, 
rabbits and rats, while frogs and hedgehogs showed no reaction at all. Considering the animals who 
directly feed on the insects and the lack of the toxin effect, it did not produce expected avoidance of 





was completely destroyed upon treatment with 0.4% HCl (pH 1.8). However, ingestion of pederin 
could poison horses and cows, and intravenous injections killed rabbits, guinea pigs and mice. 
Additionally, it was assayed as a possible antibiotic, but had none or very few effects on 
bacteria like Bacillus subtilis and Escherichia coli, whereas in yeast Saccharomyces cerevisiae and 
protozoa Trichomonas columbae exhibited strong growth inhibition. In vitro studies showed that 
pederin was active against eukaryotic organisms with 80S ribosomal unit, but not against 
prokaryotes with 70S ribosome that placed pederin as a ribosome-specific toxin (Tiboni et al., 
1968). It was shown that pederin inhibits protein synthesis and mitosis, but the exact molecular 
target and mode of action was unknown. In an assay with known antibiotics, it was demonstrated 
that pederin interferes with the steps following the ternary complex formation between mRNA, 
ribosome and aminoacyl-tRNA (Tiboni et al., 1968). 
Pederin was shown to be especially powerful against tumor cell lines in vitro. The first 
reported anticancer activity of pederin inhibited sarcoma 180 tumors in mice (Pavan, 1958). The 
severe cytological alterations and the blockage of mitosis in normal and HeLa cells were caused by 
as little as 1 ng/µL of pederin in less than 2 h (Soldati et al., 1966). It was also showed to be very 
efficient against murine P388 leukemia cells (Narquizian and Kocienski, 2000). These initial studies 
raised interest of pharmaceutical industry for the further exploration of pederin-family compounds 
as potent anticancer agents and potential drugs. 
3.1.2.  First studies on pederin biosynthesis 
Pederin was quantified in both male and female Paederus species and unexpectedly, female 
insects contained 10 times more pederin than males (Kellner and Dettner, 1995). Although pederin 
was present in all parts of an adult beetle, except for the wings, the highest pederin concentration 
was accumulated in eggs laid by Paederus females. However, there were 10% of females unable to 
biosynthesize pederin, therefore they could not pass it on the eggs. This, what appeared to be female 
polymorphism phenomena, allowed Kellner and Dettner (1995) to conduct the first study on 
functional importance of pederin for the species of Paederus. It was noticed previously that some 
species of wolf-spiders pray on Paederus offspring (Kurosa, 1958). Therefore, different insect and 
spider species were collected from the Paederus habitat and fed on pederin positive (+) and 
negative (-) larvae. Insects showed no selection for (+) or (-) larvae, while the wolf-spiders clearly 




supported the role of pederin as a larval chemical defense from specific predators they cannot easily 
run away from. 
The subsequent study wanted to tackle the heredity of the pederin toxin, since its 
biosynthesis was shown to be matrilineal trait. Nonetheless, the offspring of (+) mothers did not 
show the expected Mendelian proportions in laboratory grown new generations of Paederus 
riparius (Kellner, 2000). It was the first time Kellner suggested that pederin producer might be a 
microorganism horizontally transmitted among the beetles. Furthermore, to prove that the real 
producer was an endosymbiotic bacterium, an antibiotic susceptibility study was performed. Due to 
the fact that Paederus beetles also feed on conspecifics, (-) female offspring was fed with (+) eggs 
previously treated with antibiotics benzylpenicillin, erythromycin, oxytetracycline or streptomycin 
(Kellner, 2001). The treatment with antibiotics resulted in loss of pederin content. Although the 
antibiotic efficacy depended on their spectrum, dosage and duration of exposure, the greater 
effectiveness of oxytetracycline and streptomycin indicated that the pederin producer was likely a 
gram-negative bacterium. Next, total DNA was extracted from Paederus females to run the 16S 
rDNA studies for the molecular identification of the symbiont. A phylogenetic three showed close 
relationships with the genera Pseudomonas (Kellner, 2002). 
3.2. Pederin-family gene clusters identified from the metagenomes 
Symbiotic bacteria have been long known to play an important role in exchanging nutrients 
with their host and providing defense against predators. However, majority of those symbionts are 
impossible to grow in laboratory conditions. The rapid development of DNA sequencing 
technologies and the eagerness to know the real producer of pederin and molecules alike led to 
several metagenome sequencing projects. It allows obtaining the genetic material of the bacterial 
symbionts directly from complex samples like soil or higher eukaryote organisms from marine 
environments to mine for the biosynthetic gene clusters responsible for the production of bioactive 
molecules (Figure 7). After sample collection and DNA isolation, there are two common natural 
product identification approaches: 1) creation of a metagenomic library followed by screening by 
biological activity or PCR; 2) high-throughput sequencing to discover bioactive small molecules 
and characterize their biosynthetic genes for future applications. Metagenomics opened the door to 
the identification of numerous secondary metabolites gene clusters of industrial interest, among 






Figure 7. Graphical diagram showing steps of the metagenomic workflow (Wilson and Piel, 2013). 
 
3.2.1. Pederin gene cluster from Paederus fuscipes 
The first insights into the true producers of pederin were obtained by cloning a fraction of 
the pederin biosynthesis genes (ped cluster) from genomic DNA obtained from P. fuscipes beetles 
(Piel, 2002). The partial ped cluster that was initially located on a 54-kb region bordered by 
transposase pseudogenes encoded a mixed modular PKS/NRPS. The ped cluster was distributed 
among two distinct regions (pedIJK and pedABCDEF) of the genome from an uncultured bacterial 
symbiont of the insect that exhibited a similarity to genera Pseudomonas (Piel, 2002; Piel et al., 
2004a, 2004d). This finding supported the closest relationship to P. aeruginosa previously detected 




carry additional ped genes (pedLMNOPQR) speculated to be involved in the early stages of pederin 
biosynthesis (Piel et al., 2004c, 2005). Transposase genes, indicating the unusual fragmentation of 
the secondary metabolites gene cluster, delimited all three ped regions. 
3.2.2. Pederin-family gene clusters from sponge symbionts 
Marine sponges have long been known as a rich source of natural bioactive compounds and 
a home to innumerous symbiotic organisms. They are one of the oldest multicellular eukaryote 
organisms and first metazoans inhabiting marine environment (Zumberge et al., 2018). Highly 
diverse sponge-associated microbes can build up to 40% of their biomass. Moreover, densities of 
microbial cells can exceed 10
9
 per mL of sponge tissue. It is not surprising since 1 kg of sponge 
approximately can filter up to 24000 L of sea water per day (Taylor et al., 2007). The symbionts 
mainly contribute to denitrification and anaerobic ammonium oxidation processes, cell signaling, 
adhesion-related proteins production, removal of toxins from the sponge and transport of nutrients 
(Webster and Taylor, 2012).  
Metagenomic mining projects from marine sponges revealed a great pool of bacterial genes 
encoding PKSs and NRPSs. Surprisingly, cytotoxic polyketides closely related to pederin have been 
isolated from several genera of marine sponges distributed all around the planet. To emphasize the 
patience and scientific dedication invested in isolation of these compounds, in one example 600 
fractions combined over 11-year time were needed to chemically elucidate psymberin from 
Psammocinia sp. collected from the coast of Papua New Guinea (Cichewicz et al., 2004). Other 
pederin-related molecules were: theopederins A-E from Theonella sp. collected from Hachijo-jima 
Island near Tokyo (Fusetani et al., 1992) as well as onnamides A-D from Theonella genus 
(Matsunaga et al., 1992; Sakemi et al., 1988), theopederins K-L isolated from Discodermia sp. 
collected from Honduras (Paul et al., 2002) and mycalamide A from genus Mycale obtained from 
New Zeland (Perry et al., 1988) (Figure 8). All the mentioned compounds, except onnamides, are 
patented which indicates the importance they have in the pharmaceutical industry regarding their 






Figure 8. Structurally similar polyketides isolated from P. fuscipes beetles and different marine sponges 
(images taken from Kampa et al., 2013). Molecular core of pederin is colored in red (modified from 
Newman and Giddings, 2014). 
The efforts to identify the gene clusters responsible for the biosynthesis of pederin-family 
compounds were priority in the following years. Partial onnamide cluster has been identified from 
the metagenomics library screening from Theonella sp. Related genes covering a 36.5 kb region 
named onnABCDEFGHI were highly homologous to ped genes identified from P. fuscipes 
metagenome (Piel et al., 2004c). However, one region of the second hybrid PKS/NRPS was missing 
along with other related tailoring genes. Five years later a complete psymberin gene cluster 
comprising genes psyA-N was found in another metagenomics project using the sponge specimen 
Psammocinia aff. bulbosa (Fisch et al., 2009). Since then, there have been numerous unsuccessfully 
attempts afterwards to synthetize psymberin chemically (Bielitza and Pietruszka, 2013). Although 
the complete set of genes necessary for the biosynthesis of this extensively studied antitumor agent 
was fully available, the heterologous production has not been achieved yet. More recently, using 
genomic DNA obtained from the sponge Mycale hentscheli, a producer of mycalamide A and a 
great variety of other polyketides, the complete mycalamide gene cluster was revealed (Rust et al., 
2020). Whole genome sequencing of sponge microbiome allowed identification of 14 genomes 




producer of mycalamide. Four DNA fragments were connected by PCR to generate a myc 
biosynthetic cluster highly similar to previously reported ped, onn and psy gene clusters. 
3.2.3. Pederin-family gene clusters from other symbionts 
The diverse distribution of pederin-gene clusters across different ecological niches identified 
from host species divergent one from another have raised great interest in evolutionary relationships 
of these clusters and deeper understanding of their functional role, along with the defense 
mechanism. Apart from terrestrial beetles and marine sponges, which had strikingly little specimen 
and environmental connection, two more pederin members have been discovered from unusual 
hosts at about the same time. One of them is produced by the lichen-associated symbiont that 
produces a new pederin analog called nosperin (Kampa et al., 2013). Terrestrial lichen Peltigera 
membranacea was collected in Iceland and whole genome sequencing revealed trans-AT PKS gene 
cluster distributed along 59-kb region that highly resembled pederin type PKS clusters. The core 
pederin structure is partially shared in nosperin (Figure 9). Phylogenetic analysis of the symbiont 
producer pointed towards a Nostoc sp. cyanobacterium. PCR-based screening also confirmed the 
presence of nsp cluster in other P. membranacea collected in Vancouver Island and the mainland. 
The gene mining showed the presence in several Nostoc species isolated from Peltigera spp. On the 
other hand, lichen-no associated cyanobacteria were not positive for nsp genes. 
Another host-symbiont relationship was described in the case of an Asian citrus pest 
Diaphorina citri. The sequencing of the microbiome of the insect allowed for the assembly of the 
complete genome of the symbiont bacterium named Candidatus Profftella armatura which 
uncovered the newly identified PKS gene cluster, responsible for the biosynthesis of pederin-family 
polyketide, diaphorin (Nakabachi et al., 2013). It was the first time the ped-like gene cluster was 
integrated in the whole genome context. Interestingly, the genome size was significantly reduced, 
since the circular chromosome was only 459,399 bp long, which was considered a trait of a 
symbiont bacterium in an obligate host-symbiont dependence. The dip cluster expanded through 
two different loci in the genome and was highly similar to ped cluster. Even the molecular structure 





3.3. Pederin-family gene clusters identified in the genomes of free-living 
microorganisms  
The previous studies argued that the ped-like gene clusters found in symbiont genomes 
could provide competitive advantage to their hosts by the means of chemical defense against the 
predators. It was assumed that the pederin-family compounds were exclusive to symbiont 
producers. However, a free-living cyanobacterium Cuspidothrix issatschenkoi was isolated from 
moss Blasia as a producer of a another pederin-like polyketide cusperin (Kust et al., 2018). The 
identified cus biosynthetic cluster is almost identical to nsp cluster, therefore nosperin and cusperin 
possess very little structural differences (Figure 9). Interestingly, cusperin showed no cytotoxic 
activity, as opposed to the rest of the pederin-type compounds. Moreover, its producer is a 
freshwater planktonic cyanobacterium causing toxic water blooms that raised questions about 
possible roles of pederin-family compounds in the ecological context, other than just defense 
agents. 
 
Figure 9. Pederin-family compounds isolated from lichen and insect bacteriome. Image of lichen P. 
membranacea hosting Nostoc sp. cyanobacterium, a producer of nosperin (up left, taken from Kampa et al., 
2013). Ventral view of a fifth-instar nymph of D. citri. The arrow indicates the yellow bacteriome in the 
abdomen. The scale bar represents 500 µm. (down left, taken from Nakabachi et al., 2013). Respective 





In 2017, an 18-O-demethyl pederin (compound 1) has been isolated from the free-living 
marine alphaproteobacterium Labrenzia sp. PHM005. The marine sediment samples were collected 
back in 2005 at the depth of 18 m near the coast of Kenya. In this doctoral thesis, the compound 1, 
was renamed as labrenzin. Previous studies on ped-like gene clusters did not carried out any 
functional gene analysis so far, due to inability to either cultivate or genetically modify the producer 
microorganism. This thesis constitutes one-step forward in understanding the biosynthesis of 
pederin-type polyketides and opens the door to modify and overproduce these anticancer drugs for 





The foundation for this doctoral thesis is the recent isolation of labrenzin from the culture of 
a marine heterotrophic α-Proteobacterium, Labrenzia sp. strain PHM005 isolated from marine 
sediment. This was the first report of the production of this family of natural polyketides by a free-
living marine bacterium that could be cultured in the laboratory. Therefore, the focus of this thesis 
is to characterize for the first time the gene cluster involved in the biosynthesis of the highly 
cytotoxic polyketide labrenzin. To address properly this aim, the gene characterization is performed 
through in silico analysis and experimental functional studies. Thus, the two main objectives of the 
thesis and the corresponding specific subobjectives are: 
1) In silico identification and characterization of labrenzin biosynthetic cluster: 
The aim of this objective will be to localize and annotate the genes for labrenzin 
biosynthesis in the genome. The specific subobjectives are: 
- Sequencing and analysis of Labrenzia sp. PHM005 genome; 
- Delimitation of the labrenzin gene cluster and gene organization; 
- Comparative analysis with homologous gene clusters; 
  
2) Functional analysis of the genes involved in labrenzin biosynthesis:  
The aim of this objective will be to assign specific in vivo roles and the activities to the 
genes responsible for labrenzin biosynthesis. The specific subobjectives are: 
- Exploring transcriptional activity of the genes; 
- Developing genetic engineering tools; 
- Identification of genes that are essential for the polyketide backbone assembly;  
- Identification of tailoring modifications of the core molecule and their 
assignation to the genes involved; 
- Identification of labrenzin intermediates and generation of new analogs by 
genetic engineering; 
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1. Bacterial strains, plasmids, media and growth conditions
1.1.  Microorganisms
Table 2 shows the bacterial strains, their genotype or NCBI accession number and the 
application in different processes throughout this work. 
Table 2 Microorganisms used in this work 
Microorganism Strain/Reference Genotype/NCBI accession Application 
Escherichia coli DH10B (Invitrogen) F
–. mcrA, Δ(mrr-hsdRMS-mcrBC), 
φ80lacZΔM15ΔlacX74, recA1, endA1, 
araD139, Δ(ara-leu)769, galU, galK, λ–, 
rpsL (StrR), nupG 
Cloning procedures 
Escherichia coli cc118λpir (de 
Lorenzo and Timmis, 
1994) 
Δ(ara-leu), araD, ΔlacX74, galE, galK, 
phoA, thi1, rpsE, rpoB, argE (Am), recA1, 
lysogenic (λpir), RifR 
Cloning procedures for 
R6K replication ori 
plasmids; donor in 
triparental conjugation 




pir) ΔrecA, ApraR, ZeoR, ErmR 
Biparental conjugation 
Escherichia coli HB101 (Promega) F
–, thi-1, hsdS20 (rB-, mB-), supE44, 
recA13, ara-14, leuB6, proA2, lacY1, 
galK2, rpsL20 (StrR), xyl-5, mtl-1 
Helper strain in 
triparental conjugation 
Labrenzia sp. PHM005 (provided 
by PharmaMar) 
CP041191 and CP041190 labrenzin producer 
Stappia indica PHM037 (provided 
by PharmaMar) 
CP046908 sesbanimide producer 




1.2.  Culture media 
Standard overnight E. coli cultures were grown aerobically in Luria-Bertani (LB) broth or 
LB agar at 37 ºC (ref). The medium was supplemented with diamine-pymelic acid (DAP) (1 mM) 
and antibiotic, when appropriate (see chapter 2 for the concentrations details). Marine bacteria were 
grown in Marine Broth (MB) Difco 2216 (Sigma-Aldrich) at 30 ºC with shaking at 220 rpm or 
Marine Agar (MA) Difco 2216 (Sigma-Aldrich), supplemented with antibiotic, when appropriate. 
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Unless stated otherwise, all the strains were cultured in falcon tubes or flasks with the medium:air 
ratio 1:5 (vol:vol). 
All the media and the solutions were prepared using MilliQ water followed by the 
sterilization during 15 min at 121 ºC and 1 atm pressure or by the filtration. The media are 
described in liquid version; agar plates were obtained by adding 1.5% of bacterial agar, except the 
already mixed commercial powders, and appropriate concentration of antibiotic, when needed. In 
addition, DAP (1 mM) was spread on the surface of an agar plate, when required. 
Culture medium used to study gene transcription, growth and labrenzin production in 
Labrenzia sp. PHM005 was prepared as follows: 1) modified marine basal media (MBM) 
(Baumann and Baumann, 1981) with NaCl (20 g/L) and 0.2% glucose as carbon source; 2) 
modified MBM supplemented with vitamins (MBM + vit) [B12 (50 µg/L), panthotenic acid (50 
µg/L), riboflavin (50 µg/L), pyridoxamine (10 µg/L), biotin (20 µg/L), folic acid (20 µg/L), 
nicotinic acid (50 µg/L), p-aminobenzoic acid (50 µg/L), thyamine (50 µg/L)]; (3) MBM 
supplemented with biotin (20 µg/L) (MBM + B); (4) MBM supplemented with thyamine (50 µg/L) 
(MBM + T); (5) MBM supplemented with biotin (20 µg/L) and thyamine (50 µg/L) (MBM + B + 
T). For the growth experiments in other carbon sources, MBM+vit was supplemented with 0.2% 
citrate, glutarate, benzoate and cyclohexanoate. 
Previously described medium MBM+vit containing 2.0% of glucose (M2 medium) was used 
for enhanced production of labrenzin and other analogs for better peak detection by HPLC/MS.  
1.3. Growth conditions for labrenzin production 
Labrenzia sp. PHM005 was grown overnight in 50 mL falcon tubes in the MB at 30 ºC with 
shaking at 200 rpm in the New Brunswick Innova® 44/44R Incubator if not stated differently. The 
overnight culture was washed in 0.85% NaCl solution and diluted to an optical density (OD600) ≈ 
0.1 in 20 ml of fresh medium. For growth monitoring, the OD600 was measured by UV-mini 1240 
spectrophotometer (Shimadzu) every 3 h during the cultivation period. At the laboratory scale, for 
the HPLC/MS analysis of the production of labrenzin and other intermediates in wild type (wt) and 
mutants, the culture was monitorized for 72 h. When necessary, the culture media was 
Material and Methods 
39 
 
supplemented with appropriate antibiotic (for concentrations see chapter 2) or inducer 3-methyl-
benzoate (0.2 mM), when the plasmid expression system required so. 
2. Vectors and antibiotics 
The cloning vectors and antibiotics used in this work are shown in Table 3. The specific 
recombinant plasmids constructed in this Thesis are described and named in the corresponding 
chapters. 










3.5 Kanamycin E. coli pUC derived/high Invitrogen 
pSEVA338 4.9 Chloramphenicol Broad- host pBBR1/medium (http://seva.cnb.csic.es) 
(Silva-Rocha et al., 
2013) 
pSEVA238 5.1 Kanamycin Broad- host pBBR1 /medium (http://seva.cnb.csic.es) 
pSEVA312S 2.2 Chloramphenicol E. coli “pir” 
strains 
R6K /low (http://seva.cnb.csic.es) 
(Martínez-García and 
de Lorenzo, 2011) 
pSEVA428S 6.5 Streptomycin Broad- host RK2/low (http://seva.cnb.csic.es) 
pSEVA331 2.9 Chloramphenicol Broad- host pBBR1/medium (http://seva.cnb.csic.es) 
pSEVA227M_p14g 4.6 Kanamycin Broad- host RK2/low provided by Gonzalo 
Durante 
pSEVA237_p14g 3.9 Kanamycin Broad- host RK2/low provided by Gonzalo 
Durante 
In order to select the clones of interest, in both E. coli and Labrenzia sp. PHM005, a few 
antibiotics were employed: chloramphenicol at 34 µg/mL or 5 µg/mL, respectively (Sigma-
Aldrich); kanamycin at 50 µg/mL (Roche); and streptomycin at 50 µg/mL (Sigma-Aldrich). 
3. DNA isolation 
Genomic DNA of Labrenzia sp. PHM005 for the routine PCR amplifications and generation 
of fragments for cloning was isolated with the following procedure: The cell biomass was collected 
from the agar plate or by centrifuging 10 mL of an overnight culture and harvesting cell pellet. The 
cells were resuspended in 400 µL of 10 mM Tris-EDTA (pH 8.0) (TE) and incubated at 80 ºC 
during 20 min. After cooling down at room temperature, 50 µL of lysozyme (10 mg/mL) was 
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added, mixed gently and incubated 1-12 h at 37 ºC. Afterwards, 75 µL of SDS containing 10% of 
proteinase K (10 mg/mL) was added and incubated at 65 ºC for 10 min. Subsequently, the 100 µL 
of 5 M NaCl and 100 µL of CTAB/NaCl, previously warmed up at 65 ºC, was added and incubated 
at 65 ºC for another 10 min. The addition of 750 µL of chloroform/isoamyl alcohol (24:1) was 
followed by vortex mixing and centrifuging for 5 min at 14000 x g. The aqueous phase was 
transferred by pipette to an Eppendorf tube and the equal volume of phenol/chloroform/isoamyl 
alcohol (25:24:1) was added, mixed by vortex and centrifuged for 5 min at 14000 x g. The aqueous 
phase was transferred to a new Eppendorf tube and precipitated by isopropanol. It was further 
maintained at room temperature minimally for 30 min. Finally, the DNA was centrifuged for 15 
min at 14000 x g at 4 ºC, washed with 200 µL of 70 % ethanol and centrifuged again for 2 min at 
14000 x g at 4 ºC. The ethanol was removed carefully by pipetting and the remains were air dried. 
The precipitated DNA was dissolved in 40-100 µL of TE.  
Genomic DNA extractions for genome sequencing purposes of Labrenzia sp. PHM005, 
Stappia indica PHM037 and Labrenzia aggregata PHM038 were performed using the Blood & Cell 
Culture DNA Mini Kit (Qiagen) to obtain the DNA with higher purity from 2 mL of an overnight 
bacterial culture.  
Mini-preparation of plasmid DNA was done using the High Pure Plasmid Isolation Kit 
(Roche Diagnostics) for overnight culture volumes from 2-4 mL. 
DNA concentration was measured using NanoPhotometer (Implen). 
3.1.  Whole genome sequencing  
The genome of Labrenzia sp. PHM005 was sequenced by a PacBio RSII sequencer and was 
assembled de novo in a single contig. Samples were prepared at PharmaMar and library 
construction, sequencing, data processing and assembly were provided by Macrogen. The depth of 
the sequencing was 131. 
The genome of strain PHM005 was re-sequenced using an Illumina MiSeq system with a 
300 nt pair-end library to determine the presence of plasmids in the strain PHM005 that cannot be 
detected by the PacBio sequencing method as well as to correct other putative PacBio sequencing 
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errors. The library was constructed following the manufacturer‟s recommendations (Nextera DNA 
Flex, Illumina). The reads were trimmed and assembled into contigs using CLC Genomics 
Workbench software package (Quiagen). The service of the genome sequencing and assembly was 
provided at the Complutense University of Madrid, Department of Genomics. 
Library construction, sequencing, data processing and assembly of genomes of strains 
PHM037 and PHM038 were provided by MicrobesNG (https://microbesng.com): genomic DNA 
libraries were prepared using Nextera XT Library Prep Kit (Illumina, San Diego, USA) following 
the manufacturer‟s protocol with the following modifications: 2 ng of DNA instead of 1 ng were 
used as input, and PCR elongation time was increased to 1 min from 30 s. DNA quantification and 
library preparation were carried out on a Hamilton Microlab STAR automated liquid handling 
system. Pooled libraries were quantified using the Kapa Biosystems Library Quantification Kit for 
Illumina on a Roche light cycler 96 qPCR machine. The genomes were sequenced by Illumina 
HiSeq technology using a 250 bp paired end protocol (https://microbesng.com). The depth of the 
sequencing was 30x.  
3.2.  Sequencing of PCR fragments and plasmid constructions 
All cloned DNA fragments were confirmed by Sanger sequencing provided by Secugen S.L. 
DNA sequencing was done with fluorescently labeled dideoxynucleotide terminators and AmpliTaq 
FS DNA polymerase (Applied Biosystems Inc., USA) in an ABI Prism 377 automated DNA 
sequencer (Applied Biosystems Inc., USA). 
4. Bioinformatics analysis 
Sequence searches by homology was routinely performed using BLAST algorithms (all the 
variants) in the different databases of the National Center for Biotechnology Information (NCBI), 
(http://www.ncbi.nlm.nih.gov) and HMMER (http://www.ebi.ac.uk/Tools/hmmer) (Potter et al., 
2018). Genome mining for secondary metabolites gene clusters and analysis was performed using 
online platform antiSMASH 4.0 and updated version antiSMASH 5.0 (Blin et al., 2019). Fully 
automated Rapid Annotation Subsystem Technology (RAST) Server was used for the genome 
annotation and gene categorization for sequence analysis before publishing the genome (Aziz et al., 
2008). SWISS-MODEL Server (https://swissmodel.expasy.org/) was used for modelling and the 
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analysis of the thioesterase aa sequence. The sequence alignments, genome and plasmid maps 
visualizations and cloning simulations were performed using software Geneious versions 10.0.2 and 
Prime 2020.0.4. 
4.1. Genome assembly and annotation of Labrenzia sp. PHM005 
The genome of strain PHM005 was assembled in one contig by Macrogen. Nevertheless, the 
PacBio technology had some sequencing errors resulting in incorrect ORFs recognition. Trans-AT 
PKS/NRPS cluster, producer of labrenzin, was manually curated for the mistakes of the structural 
and functional annotations. The errors were corrected by Sanger sequencing of specific PCR 
amplicons surrounding the sequencing errors. Additionally, to obtain a high quality genome 
sequence, the more precise Illumina sequencing technology was applied. The obtained reads were 
mapped to a PacBio generated contig by Geneious v.10.0.2 and the errors were manually curated.  
Illumina sequencing determined the presence of a plasmid, which was assembled in one 
contig and circularized by overlapping the contig extremities. The estimation of the plasmid copy 
number per cell was done by dividing the total chromosome and plasmid size by the number of 
Illumina reads covering them, and by the difference between the resulting numbers. The circular 
chromosome of strain PHM005 and the plasmid p1BIR were annotated using the NCBI Prokaryotic 
Genome Annotation Pipeline (PGAP) and deposited in the NCBI database with the accession 
numbers CP041191 and CP041190, respectively. 
4.2. Whole genome comparison 
Whole genome alignment of Labrenzia sp. PHM005, L. alexandrii DFL-11, L. aggregata 
RMAR6-6, Labrenzia sp. CP4 and Labrenzia sp. VG12 was performed using the progressive 
Mauve algorithm with default settings from the Geneious v.10.0.2. In addition, each strain was 
aligned separately to Labrenzia sp. PHM005 to calculate the minimum weight for Locally Collinear 
Blocks (LCB). Average nucleotide identity (ANI) was calculated using reciprocal best hits (two-
way ANI) between two genomic datasets in an online tool developed at Kostas lab (Rodriguez-R 
and Konstantinidis, 2016). 
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4.3.  PKS/NRPS domain analysis 
AntiSMASH v.4.0 and 5.0 was used for a rough secondary metabolites cluster mining and 
the identification of the individual PKS/NRPS domains. The specificity of NRPS adenylation 
domains and trans-ATs was predicted based on a combination of tools implemented in antiSMASH 
(Stachelhaus code, NRPS Predictor3, pHMM, SANDPUMA and Minowa). The domains were 
manually revised for conserved motifs. PKSs and NRPSs domains and their substrate specificities 
were also analyzed by an online tool TransATor (https://transator.ethz.ch/) that predicts the core 
structure of a trans-AT PKS derived polyketide (Helfrich et al., 2019). 
4.4. Delimiting the labrenzin gene cluster 
To establish gene cluster boundaries, SEED Viewer read-only browser on the RAST server 
was used for rapid gene comparison and screening for the common genes between strains. 
Additionally, the proximal DNA regions from each strain were aligned using MAFFT package in 
Geneious v.10.0.2 setting the parameters for the scoring matrix BLOSUM62 and the gap open 
penalty to 1. 
4.5. Phylogenetic analysis of the PKS/NRPSs Lab13 and homologs  
The phylogenetic analysis of the third PKS/NRPS in the lab cluster was performed using a 
Geneious Tree Builder. The Lab13 closest homologues were collected from the NCBI database by 
BLASTp search. Only the whole protein sequences were included in the analysis. The sequences 
were previously aligned by Clustal Omega build in Geneious. The Jukes-Cantor model was used as 
a genetic distance model, tree building method was Neighbour-Joining. For tree resampling a 
bootstrap of 1000 replicates was used. Subtrees were separately aligned and the trees were 
constructed using Neighbour-Joining method in MEGA 7 (Kumar et al., 2016). 
5. PCR amplification and purification of DNA fragments 
5.1. Design of the oligonucleotides 
To design oligonucleotides for different applications (Tables 4-10), the Labrenzia sp. 
PHM005 genome was used as DNA template. For optimal primer design several parameters were 
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considered like CG content, annealing temperature, the formation of hairpins or dimers and it was 
done using Primer 3 tool build in Geneious. 
Table 4. Oligonucleotides for the PacBio sequencing error correction 
Name Sequence (5’→ 3’) Application and specifications 
A F CTTCCGGATACCGGCCAATC 
PCR amplification of ORF4  
A R AAGGTGTCTGGGAGTCCAGT 
B F AATCTTGGGTCTGATCGCGG 
B R GCGCACATCGGAAAAGAACA 
C F AGAGTGATTTCCAACCGCCC 
PCR amplification of ORF15 
C R ATTGGACGAGTCTGGGCAAC 
D F AATTTCATCCAGGGTGCCGT 
D R ATGCAGTAAACCCCGCCATT 
E F TTTCCGGGCGAAACTGTCTA 
E R GTGATCTGGCTTTGGAGGGT 
F F GCGGTTCCTGCAACAGAATG 
F R TATGCAGTGATCCGCCAGAC 
Table 5. Oligonucleotides for the RT-PCR 
Name Sequence (5’→ 3’) Application and specifications 
4 F CGGAAGCGCCTGTAATCATG 
RT-PCR of lab4  
4 R GGGGTTCGGCTGACTATCAT 
5 F GACGGGTGGATCTTGGCTTT 
RT-PCR of lab5 
5 R TTATCAGCAACCAGACCGCC 
6 F CGATCTGGGCCGATATGCTT 
RT-PCR of lab6 
6 R CCTGGAGCGTTTTGAGAGGT 
7 F ATCAGATTAACCGGGCGTCC 
RT-PCR of lab7 
7 R GAGGCGATGCGAAATAAGGC 
8 F CAAAACTGTGCTGAGCCTGC 
RT-PCR of lab8 
8 R CGGGTGTTTGCCAAAGTGTC 
9 F GAGCACCATCAACATAGCGC 
RT-PCR of lab9 
9 R GGCTGAAACTCTGATTGCCG 
10 F TCTGAAATGACTGAGGCCGC 
RT-PCR of lab10 
10 R GGCATTGTATTCGCCCACAC 
HK F CACCACGACAAAAGAACCCG RT-PCR of housekeeping gene 
rpoD HK R GAGAACCTGGGCTTCGTTGA 
Table 6. Oligonucleotides for the gene replacement constructions 
Name Sequence (5’→ 3’) Application and specifications 
3 UP F CTGCAGCTTCCATCGACAGGGTGATGACATC  Δlab3; PstI underlined 
3 UP R ATCCCGAGCTCGCCTGTTTGATTTCAAAGAGCCGG  Δlab3; SacI underlined 
3 DOWN F ATCCCGAGCTCCTGTTCTGTTGTCACTGACAGGAG Δlab3; SacI underlined 
3 DOWN R ACTAGTACCTCAGAGCTTCGGTAGGATTTG  Δlab3; SpeI underlined 
PKS4 UP F  ACTAGTCTAGACGCAGTCGTCCTGATGAGAT  Δlab4; XbaI underlined 
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Name Sequence (5’→ 3’) Application and specifications 
PKS4 UP R ATCCCGAGCTCATGGGAACGTCCAGTATCGC  Δlab4; SacI underlined 
PKS4 DOWN F  ATCCCGAGCTCGGTCGTATTCAACACCCGGT  Δlab4; SacI underlined 
PKS4 DOWN R TACCCAAGCTTAGGATCCTGCAAGAAGCCAC Δlab4; HindIII underlined 
5-6 UP F  CTGCAGGACCACAATACGCCGTTACAGAAC  Δlab5; Δlab5-6; PstI underlined 
5-6 UP R ATCCCGAGCTCCATTCCACAATCTCCGCTGGATG  Δlab5;Δlab5-6; SacI underlined 
5 DOWN F GAGCTCCAGTACATCCAAAGCAGCCTGAAC  Δlab5; SacI underlined 
5 DOWN R ACTAGTTTCAAGTCCTCCGGGGCTTTATAG  Δlab5; SpeI underlined 
6 UP F CTGCAGCAGTACATCCAAAGCAGCCTGAAC  Δlab6; PstI underlined 
6 UP R GAGCTCTTCAAGTCCTCCGGGGCTTTATAG Δlab6; SacI underlined 
5-6 DOWN F  ATCCCGAGCTCAGTACTTCGGATGCCTATCGCTAG  Δlab6;Δlab5-6; SacI underlined 
5-6 DOWN R ACTAGTGGATCGGGCTAAAGTTACTGTTGG  Δlab6;Δlab5-6; SpeI underlined 
P450-OX UP F ACTAGTCTAGAACCTCTCAAAACGCTCCAGG  Δlab7-8; XbaI underlined 
P450-OX UP R  ATCCCGAGCTCCCTGCTTTCTGCCTTTGCTG  Δlab7-8; SacI underlined 
P450-OX DOWN F ATCCCGAGCTCATCCCCTTTACCATGGCACC Δlab7-8; SacI underlined 
P450-OX DOWN R  TACCCAAGCTTGGCCTGGACAATTCAGTCGA  Δlab7-8; HindIII underlined 
PKS13 UP2 F  ACTAGTCTAGAGATCCAGCCGGTTCATTTCCAGACC  Δlab13; XbaI underlined 
PKS13 UP2 R ATCCCGAGCTCGCAGGCCTATGTCACAGTATCGGAC  Δlab13; SacI underlined 
PKS13 DOWN F  ATCCCGAGCTCCGCCGCCATATTTGACCTTG  Δlab13; SacI underlined 
PKS13 DOWN R TACCCAAGCTTCTTCCGACCGTTTTGACACG  Δlab13; HindIII underlined 
Table 7. Oligonucleotides for the screening of Labrenzia sp. PHM005 mutants 
Name Sequence (5’→ 3’) Mutant 
M1 F TCTTGGTGGACGAGACCAGT Δlab4 
M1 R GGCTTCGTGTGGTGAAATGC 
M2 F ATACTGAATCTCTGGATCAGGCCG  
Δlab7-8 
M2 R CATGTTGGGGACACATTCGATCAG  
M5 F GTCAGTGAGGCCAATTCGC  
Δlab13 
M5 R TGAACGCCGGATCGAAGC  
M13 intern F CTGGTCTGTAAACGTGTTGGGATC 
Δlab13 
M13 intern R CGAGGAGTTGGCACGGTATTTAC  
M6 F GAGACATGATTGTGCATATCCGGC 
Δlab16 
M6 R GGCATGATCCGGATAGACGATACTC  
M7 F CCAGTGCGATGGCAAGAAAGTATC 
Δlab11-12 
M7 R TTGATCGATTCTTATCCCCCTGCG 
M8a F CTTCAGTGATGAGACCTTGGGACAG  
Δlab9 
M8a R CAAACCGTCTTCGAAGTTGACCAC 
M9 F CCACTGAAGTAGTTCCTCCCGAAG  
Δlab5-6; Δlab5; Δlab6 
M9 R GGACGAAGAGGAGACACTGACAAA  
5 DOWN R ACTAGTTTCAAGTCCTCCGGGGCTTTATAG  Δlab5 
6 UP F CTGCAGCAGTACATCCAAAGCAGCCTGAAC  Δlab6 
ACP-HMGS F ACTAGTCTAGACTGCTGTTCTCACCACTCGT  
Δlab3 
ACP-HMGS R TACCCAAGCTTAAGCCTATCGGAGCAGAGGA  
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Table 8. Oligonucleotide for the overexpression or complementation of genes from Labrenzia sp. PHM005, a 
producer of labrenzin 
Name Sequence (5’→ 3’) Application and specifications 
P1 F ACCATGCCTAGGCCTTATAAGTGACTGGCTG
CCAGAGCAAAAGAGC  
Amplification of lab4-lab5-lab6 operon region 




Amplification of lab4-lab5-lab6 operon region 
by Gibson assembly; PmeI in bold, overlapping 
region underlined 
VP F GTTTAAACATCCTCTAGAGTCGACCTGCAGG  Amplification of plasmid pSEVA238 by 
Gibson assembly; PmeI in bold, overlapping 
region underlined 
VP R TTATAAGGCCTAGGCATGGTCATGACTC  Amplification of plasmid pSEVA238 by 
Gibson assembly; PsiI in bold, overlapping 
region underlined 
PnPKS4 F ACTTACCATGCCGCAATACG  Amplification of Pn4 for cloning into 
pSEVA238_PsiI_ lab4-lab5-lab6_PmeI 
PnPKS4 R AGCAACACCTCAGAGCTTCG  Amplification of Pn4 for cloning to 
pSEVA238_PsiI_ lab4-lab5-lab6_PmeI 
MTs F TGGCTATCTCTAGTAAGGCCTACCC Verification of cloned methyltransferases by 
PCR amplification and sequencing 
MTs R CGTAATATCCAGCTGAACGGTCTGG Verification of cloned methyltransferases by 
PCR amplification and sequencing 
ACP F ACTAGTCAACGATTAGACTTTGGATGCTGCC  
 
Amplification of gene lab2 (acyl carrier 
protein); SpeI underlined 
ACP R GAGCTCCCGCTGATTTCAATTGCGCC  
 
Amplification of gene lab2 (acyl carrier 
protein); SacI underlined 
HMGS F CGGAATTCCGGATGCAGGGAGAGTGTCACG  Amplification of gene lab3 
(hydroxymethylglutaryl-CoA synthase); EcoRI 
underlined 
HMGS R CGGGATCCCGAAGCCTATCGGAGCAGAGGA  
 
Amplification of gene lab3 
(hydroxymethylglutaryl-CoA synthase); BamHI 
underlined 
OR5 F GAGCTCACGGGAAGCGGCATGAGC  
 
Amplification of gene lab5 (oxidoreductase); 
SacI underlined 
OR5 R ACTAGTGAAAGAAAAATGTGTGCTCGGCCG  
 
Amplification of gene lab5 (oxidoreductase); 
SpeI underlined 
OR5-6 R ACTAGTCCTACCTAGCGATAGGCATCC  
 
Amplification of genes lab5 and lab6 
(oxidoreductase and methyltransferase); SpeI 
underlined 
FMN-OR F ACTAGTCCACCAGTCCGTATCTGTTTCCTCC  
 
Amplification of gene lab8 (oxidoreductase); 
SpeI underlined 
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Name Sequence (5’→ 3’) Application and specifications 
FMN-OR R GAGCTCGGGGCTGATACGCAAAACCTGAG  
 
Amplification of gene lab8 (oxidoreductase); 
SacI underlined 
P450-OR F ACTAGTGATCCTGGGCGCATCTAAACCTC  
 
Amplification of gene lab7 (cytochrome P450); 
SpeI underlined 
P450-OR R GAGCTCTCAAACGGCTTCTTATCTGGGAGC  
 
Amplification of gene lab7 (cytochrome P450); 
SacI underlined 
AT F ACTAGTTCACCCCATAGTCATCCCGAAAAG 
 
Amplification of gene lab9 (acyltransferase); 
SpeI underlined 
AT R GAGCTCAAGTCATTCAACGGACTCGCC  
 
Amplification of gene lab9 (acyltransferase); 
SacI underlined 
AT9 F GAGCTCTCACCCCATAGTCATCCCGAAAAG  
 
Amplification of genes lab9 and lab10 
(acyltransferase); SacI underlined 
AT10 R GAGCTCATTCCCTTGGGAACTCTAGAGCCAG  
 
Amplification of genes lab9 and lab10 
(acyltransferase); SacI underlined 
ECH R GAGCTCGACTAGGGAATAGGGATGTTGTCG  
 
Amplification of gene lab11 (enoyl-CoA-
hydratase); SacI underlined 
KS F ACTAGTCCCTAGTCAGAACTCAAAACCGTGG  
 
Amplification of gene lab12 (ketosynthase); 
SpeI underlined 
KS R GAGCTCGGTTTCTGGCAAATCTCCTGAACG  
 
Amplification of gene lab12 (ketosynthase); 
SacI underlined 
11-12 F ACTAGTCTGGCTCTAGAGTTCCCAAGGGAAT  Amplification of genes lab11 and lab12 (enoyl-
CoA-hydratase and ketosynthase); SpeI 
underlined 
Pn PacI F TTAATTAAACTTACCATGCCGCAATACG  Amplification of Pn4 for cloning to 
pSEVA227M_p14g; PacI underlined 
Pn AvrII R CCTAGGAGCAACACCTCAGAGCTTCG  Amplification of Pn4 for cloning to 
pSEVA227M_p14g; PacI underlined 
 
Table 9. Oligonucleotides used for sequencing the lab4-lab5-lab6 operon 
Name Sequence (5’→ 3’) 
16kb R1 GTCCATTCGGGTCGATTGC  
16kb R2 CCGCATTATGCCAGGCTGC 
16kb R3 CAGGTCTGCCCGTGAAGAGAC 
0seq1 F ACAGTGGCAGACCCGGTACTGC 
seq2 F GCCTATGGTGGCTTCTTGC 
seq3 F CAAGAGTGGTTGAAGAAGCAGC 
seq4 F CACGTTCTCTGGAGCAGTGC 
seq5 F ACCCCGACGCCCTTGAAAGG 
seq6 F GGAAATCGAGCGGCACGGAC 
Material and Methods 
48 
 
Name Sequence (5’→ 3’) 
seq7 F TTGCCCCAAGTGCACCCTTCC 
seq8 F AATCCGCAAGCTGCGGCTGC 
seq9 F AGATGAACTGGCACGGAGTG 
seq10 F GCTATCTTGAGGCGCATGGC 
seq11 F CGTGTCCGATAAGGCTCAGG 
seq13 F GCCCGCTTTACCGATGAGC 
seq14 F GGCACCAGTACGATCCGC 
seq15 F AATCCATGTCGCGATGAGC 
seq16 F TGGTCCGGACGCTCCACAG 
seq17 F GTCTGACGATCCGAAGTGG 
seq18 F CCGCTCTGACTGAAGTGAG 
seq19 F CATGCCTGCGTCAGCGATGC 
seq20 F GAGGCCTTGGACATGAATACCC 
seq21 F GTCACCATCCCGCTACACC 
4F CGGAAGCGCCTGTAATCATG 
Table 10. Other oligonucleotides employed in this work 
Name Sequence (5’→ 3’) Application and specifications 
F24 CGCCAGGGTTTTCCCAGTCACGAC  Universal oligonucleotides for sequencing 
inserts in pSEVA plasmids  R24 AGCGGATAACAATTTCACACAGGA 
M13 F GTAAAACGACGGCCAG Universal oligonucleotides for sequencing 
inserts in pCR™Blunt II-TOPO®  M13 R CAGGAAACAGCTATGAC 
5.2. PCR conditions 
5.2.1. PCR amplification of DNA fragments for cloning 
In order to obtain blunt end DNA fragments for cloning purposes, the Phusion® High-
Fidelity DNA Polymerase (New England Biolabs) was used. The rest of the PCR reaction mix 
components were added at the concentrations according to the manufacturer protocol (genomic 
DNA, oligonucleotides, DMSO, dNTPs and water). The final volume of the PCR reaction was 50 
µL. The PCR reaction performed in the thermocycler Mastercycler Gradient (Eppendorf) had the 
following program: initial denaturalization for 2 min at 98 ºC; 30 cycles comprising 
denaturalization of 10 s at 98 ºC, primer annealing for 15 s at 57-60 ºC (depending on the primer 
Tm) and extension for 15 s per kb of DNA at 72 ºC; the final extension for 2 min at 72 ºC; and the 
cooling at 4 ºC. 
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5.2.2. Long fragment PCR amplification 
The high fidelity PrimeSTAR® GXL DNA Polymerase (TaKaRa) was used for a long DNA 
fragment amplification. Other PCR reaction mix components were added at the concentrations 
according to the manufacturer protocol (genomic DNA, oligonucleotides, DMSO, dNTPs and 
water). The final volume of the PCR reaction was 50 µL. The PCR reaction had the following 
program: initial denaturalization for 5 min at 98 ºC; 30 cycles comprising denaturalization of 10 s at 
98 ºC, primer annealing for 15 s at 58 ºC and extension of DNA at 68 ºC (min/kb); the final 
extension for 15 min at 68 ºC; and the cooling at 4 ºC. 
5.2.3. Colony PCR for screening and verification of mutants 
NZYTaq II 2× Green Master Mix (NZYTech) was used to perform colony PCR for 
screening purposes. The oligonucleotides, water and DNA template (single colony picked from a 
plate) and a Master Mix were added to the PCR reaction tube according to the manufacturer 
protocol. The total volume was 15 µL. The program for the PCR amplification was: initial 
denaturalization for 10 min at 95 ºC; 30 cycles comprising denaturalization of 30 s at 94 ºC, primer 
annealing for 30 s at 55-60 ºC (depending on the primer Tm) and extension for 15 s per kb of DNA 
at 72 ºC; the final extension for 2 min at 72 ºC; and the cooling at 4 ºC. 
5.3. Purification of PCR fragments 
The DNA fragments obtained by PCR amplification were subsequently purified using 
QIAquick® PCR Purification Kit (Quiagen) or purified from the gel using QIAquick® Gel 
Extraction Kit (Quiagen) according to manufacturer instructions. 
6. DNA in vitro manipulations 
6.1. TOPO cloning 
One-step “TOPO® Cloning” strategy was used to clone blunt-end PCR amplification 
products, obtained previously using high fidelity polymerase, in a pCR™Blunt II-TOPO® vector 
provided by the Zero Blunt® TOPO® PCR Cloning Kit (Invitrogen). The vector had pUC origin of 
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replication, thus allowing high copies inside the cell which made it a great tool for storing DNA 
fragments for further restriction cloning and sequencing.  
6.2. Restriction cloning 
The enzymatic digestions of plasmid DNA were performed using restriction enzymes and 
buffers CutSmart or NEB 3.1. from New England BioLabs following the specific manufacturer 
instructions. When needed, the Shrimp Alkaline Phosphatase (rSAP) (New England BioLabs) was 
employed following the manufacturer recommendations. The phosphatase dephosphorylated the 5‟ 
ends of the DNA thus preventing the empty vector re-ligation. When non-phosphorylated PCR 
products were used as inserts, T4 Polynucleotide Kinase (New England BioLabs) was used for 5' 
phosphorylation of DNA for subsequent ligation.  
The DNA fragments were resolved by gel electrophoresis in TAE buffer (0.04 M Tris-
acetate, 1 mM EDTA, pH 8.0). Likewise, gels were prepared using TAE and 0.7% or 1.5% agarose 
(Condalab). The samples carried the loading dye (0.25% bromophenol blue, 0.25% xylene cyanol, 
15% Ficol type 400). Quick-Load
®
 DNA ladder (New England BioLabs) was used for the fragment 
size estimation. Electrophoresis was carried out at 100-135 V for 15-30 min in a Mupid®-One 
electrophoresis system (NIPPON Genetics). Afterwards, the gel was dyed by GelRed® Nucleic 
Acid Gel Stain (Biotium) for 3-5 min and observed under the UV light (285nm) supplied by the 
system GelDoc® (BioRad). Subsequent ligation steps required the purification using QIAquick® 
Gel Extraction Kit (Quiagen) or QIAquick® PCR Purification Kit (Quiagen). 
The purified vectors and their respective inserts, previously obtained by PCR or enzymatic 
digestion of pCR™Blunt II-TOPO® vector carrying the inserts, were ligated using the T4 DNA 
ligase (New England BioLabs) applying the buffer according to the recommendations of the 
manufacturer and employing vector:insert molar ratio 1:3. Prior to ligation, the concentration of the 
vector and the insert was measured spectroscopically by NanoPhotometer (Implen) and/or 
visualized by gel electrophoresis. The ligation was performed overnight at 16 ºC or 1 h at room 
temperature. The control mixtures contained water instead of the insert. 
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6.3. Gibson cloning 
Gibson Assembly® Cloning Kit (New England BioLabs) was used to clone long DNA 
fragments into a desired vector. The procedure was designed to join multiple overlapping DNA 
fragments, regardless of length, in a single-step reaction. Firstly, the both vector and the long DNA 
fragment DNA, were amplified by PCR. Following the manufacturer recommendations regarding 
volumes, the non-purified PCR blunt-end products were mixed together with Gibson Assembly 
Master Mix (2X) and water. The assembly mixture was incubated at 50 ºC in a Mastercycler 
Gradient (Eppendorf) for 1 hour. Thermo-competent cells were transformed directly with the 
assembly mixture upon the completion of the incubation.  
7. Plasmid constructions 
All the PCR fragments employed in this work were previously cloned in the pCR™Blunt II-
TOPO® vector and verified by Sanger sequencing. The plasmid constructions created throughout 
the course of these studies were analyzed via enzyme digestions or sequencing. Design and 
visualization of each construction was supported by Geneious software versions. 
7.1. Constructions for the genetic replacements 
All the plasmids used for here described constructions of site-directed mutations, gene 
expressions and promotor fusions, as well as specificities of each plasmid are listed in Table 3. 
7.1.1. Gene knock-out constructions 
Figure 10 shows the scheme for the suicide plasmid constructions necessary for the 
generation of gene knockout mutants. The upstream and downstream fragments flanking a desired 
deletion site in a gene of interest were amplified by a PCR (Table 6), purified and ligated using 
Instant Sticky-end Ligase Master Mix (New England BioLabs) and equal volumes of each fragment 
following the manufacturer instructions. After incubation at room temperature for 5 min, 1 µL of 
the ligation mixture was used as a template for the PCR amplification to generate a single UP-
DOWN DNA fragment comprising upstream and downstream region connected by the bridging 
restriction site. The PCR product was purified and cloned in the TOPO vector. The restriction 
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cloning method was employed to clone the generated UP-DOWN fragment into the suicide vector 
pSEVA312S. 
 
Figure 10. Scheme for the suicide plasmid pSEVA312S construction directed to gene knockouts. 
Table 11 shows the upstream and downstream fragment sizes, regions deleted and the 
restriction enzymes used for each mutant. An exception is a double mutant Δlab6Δlab16 generated 
by repeating the described gene-knockout protocol for the lab16 deletion over already created 
Δlab6 mutant. Constructions for mutant Δlab2, Δlab9, Δlab16 and Δlab11-12 were designed in 
Geneious and synthetized by GenScript. 
Table 11. Mutant strains generated and their genotipic specifications 
Mutant Upstream (bp) Downstream (bp) Deletion (bp) Enzymes 
Δlab3 580 527 563 PstI-SacI-SpeI 
Δlab4 763 552 763 PstI-SacI-SpeI 
Δlab5 502 559 481 PstI-SacI-SpeI 
Δlab6 559 527 787 PstI-SacI-SpeI 
Δlab5-6 502 527 1826 PstI-SacI-SpeI 
Δlab7-8 672 692 2477 PstI-SacI-SpeI 
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Mutant Upstream (bp) Downstream (bp) Deletion (bp) Enzymes 
Δlab9 541 512 539 PstI-SacI-SpeI 
Δlab11-12 556 653 1410 PstI-SpeI 
Δlab13 578 603 15850 PstI-SacI-SpeI 
Δlab16 539 559 631 SacII-SacI-SpeI 
 
7.1.2. Amino acid serine replacement with an alanine in a conserved thioesterase 
(TE) motif 
In order to make a single point-mutation in a conserved catalytic site in a thioesterase 
domain at the end of the final PKS/NRPS module in Lab13, a serine from His-Ser-Asn triad was 
changed to alanine. Region of 819 bp in a thioesterase domain containing an active serine67 in a 
conserved motif GWSSG was modified by changing the nucleotides from the Ser codon in a way it 
created Ala codon and at the same time generated a NheI restriction site to facilitate the easy 
screening for mutants by PCR amplification and enzyme digestion. To do so, a 5‟- GCTTGA -3‟ 
motif (Ser codon underlined) was changed to a 5‟- GCTAGC -3‟ motif (NheI restriction site; Ala 
codon underlined). Digestion with NheI enzyme would cut the PCR fragment (819 bp) into two 
pieces (≈400 bp). The design for a modified DNA region flanked by PstI and SpeI restriction sites 
was done using Geneious and synthesized by GenScript.  
7.2. Constructions for gene complementation and overexpression 
7.2.1. Gibson assembly of lab4-lab5-lab6 operon 
 The 15751 bp long region comprising an operon lab4-lab5-lab6 was cloned in plasmid 
pSEVA238 under a 3-methyl benzoate inducible promotor Pm, as the promotor is active in both 
exponential and stationary growth phase. The plasmid is comprised of a medium-copy BBR1 origin 
of replication, MCS, Pm expression system and kanamycin resistance. Both the long DNA fragment 
and the plasmid were amplified by PrimeSTAR® GXL DNA Polymerase (TaKaRa) followed by a 
Gibson cloning without the previous DNA purification steps. The oligonucleotides were designed 
following the instructions for the Gibson assembly protocol, but also introducing the new enzyme 
restriction sites for PsiI and PmeI that do not cut neither the plasmid nor the insert, allowing the use 
of those sites for additional cloning like changing the promoter or RBS. The resulting plasmid was 
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pSEVA238_PsiI_ lab4-lab5-lab6_PmeI (20776 bp) lacking the part of the MCS, including the 
restriction sites EcoRI, Eco53kI, SacI, Acc65I, KpnI, XmaI, TspMI, SmaI and BamHI. The sequence 
of the operon was verified by Sanger sequencing using oligonucleotides listed in Table 9.  
Additionally, the promoter Pm was swapped with the native promoter region of the operon 
lab4-lab5-lab6 Pn4 (350 bp) by restriction cloning using restriction sites SnaBI and newly created 
PsiI to generate a plasmid pSEVA238_Pn4_lab4-lab5-lab6_PmeI. 
7.2.2.  Methyltransferases overexpression and complementation system 
Plasmid pSEVA338 was used as an expression system for three methyltransferases MT6 
(Lab6), MT16 (Lab16) and PedO. The artificial operon was designed as indicated in Figure 11, 
where each gene with the corresponding RBS was flanked by specific restriction sites (blunt cut) in 
a way that individual genes or the combination of genes could be easily generated by digestion and 
re-ligation. The operon was synthetized and cloned using SacI and SpeI restriction sites by 
GenScript yielding plasmid pSEVA338_MTs (7699 bp). Other plasmids derived from 
pSEVA338_MTs were: pSEVA338_lab6 (5854 bp), pSEVA338_lab16 (5705 bp), 
pSEVA338_PedO (5880 bp), pSEVA338_lab6_lab16 (6691 bp), pSEVA338_PedO_lab6 (6856 bp) 
and pSEVA338_PedO_lab16 (6736 bp).  
 
Figure 11. Scheme representing the design of the artificial operon comprising PedO-Lab6-Lab16 
methyltransferases. 
7.2.3. Complementation and overexpression of other genes 
For the purpose of complementing the created mutations, the respective functional genes 
were cloned in previously described plasmid pSEVA338 and pSEVA227M_p14g (or 
pSEVA237_p14g) (Table 3). Plasmid pSEVA338_GFP was previously constructed by cloning a 
GFP, excised from the pSEVA637 (http://seva.cnb.csic.es) by HindIII and SpeI. Table 12 shows all 
gene inserts and sizes, plasmids, restriction enzymes used for cloning and the final constructs. 




Table 12. Gene expression constructs 
Gene Size (bp) Cloning plasmid Enzymes Construct 
HMGS; Lab3 1330 pSEVA338 EcoRI-BamHI pSEVA338_Lab3 
P450; Lab7 1440 pSEVA338 SacI-SpeI pSEVA237_p14g_Lab7 
OR; Lab8 1497 pSEVA338 SacI-SpeI pSEVA237_p14g_Lab8 
P450-OR; Lab7-8 2797 pSEVA338 SacI-SpeI pSEVA237_p14g_Lab7-8 
AT; Lab9 1089 pSEVA237_p14g SacI-SpeI pSEVA237_p14g_Lab9 
ATs; Lab9-10 2382 pSEVA331 SacI pSEVA331_Lab9-10 
ECH; Lab11 759 pSEVA338 BamHI-SpeI pSEVA237_p14g_Lab11 
KS; Lab12 1280 pSEVA338 BamHI-SpeI pSEVA237_p14g_Lab12 
ECH-KS; Lab11-12 2031 pSEVA338 BamHI-SpeI pSEVA237_p14g_Lab11-12 
7.3. Fusion of the Pn4 promoter to a GFP encoding gene in plasmid pSEVA227M_p14g 
For the purpose of transcription regulation assays using different elicitors, a strong promoter 
p14g in plasmid pSEVA227M_p14g was replaced by weak Pn4 promoter using restriction enzymes 
PacI and AvrII generating a new construct pSEVA227M_Pn4 (4930 bp).  
8. Plasmid DNA transformation and construction of mutants 
8.1. Preparation and transformation of chemically competent cells 
E. coli strains were regularly used for plasmid transformation. To prepare competent cells an 
overnight pre-inoculum in LB was diluted to approximately 0.05 OD600 in a fresh 100 mL LB. The 
culture was further incubated at 37 ºC and shaking at 220 rpm until it reached 0.48-0.60 OD600. 
Subsequently, the culture was cooled on ice and centrifuged at 4000 rpm and 4 ºC for 7 min using 
ultracentrifuge Sorvall Lynx 6000 (Thermo Scientific). The supernatant was discarded and the cells 
were resuspended carefully in 30 mL of a sterile TBFI solution (100 mM RbCl, 50 mM MnCl2, 30 
mM KOAc, 10 mM CaCl2, 15% glycerol, water; pH 5.8) by manually shaking the tubes on ice. The 
cells were incubated on ice for the next 2 h. Upon the completion of cell incubation, the 
centrifugation was repeated as before. The supernatant was discarded and the cells were 
resuspended carefully in 4 mL of a sterile TBFII solution (10 mM MOPS, 10 mM RbCl, 75 mM 
CaCl2, 15% glycerol, water; pH 6.8) and 200 µL was aliquoted to a sterile 1.5 mL Eppendorf tube 
on a dry ice and ethanol to allow the instant freezing of the competent cells. The competent cells 
were stored at -80 ºC. 
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For plasmid transformation the competent cells were thawed on ice for 10 min and the 
plasmid DNA or ligation mix and respective controls were added and shortly mixed by pipetting; 
the cells were incubated on ice for 15-30 min and transferred to a water-bath at 37 ºC for 3 min; 
afterwards cells were immediately switched to ice for 2 min and recovered in 800 µL of fresh LB. 
The tubes were incubated at 37 ºC and shaking at 220 rpm for 1 h. Finally, the desired dilutions of 
transformed cells were spread on Petri plates with LB agar and appropriate antibiotic. The plates 
were incubated in a stove at 37 ºC. 
8.2. Preparation and transformation of electro-competent cells  
When required, E. coli MFDpir strain was used as a donor strain for conjugations and thus 
was necessary to previously prepare electro-competent cells and transform them with the plasmid 
DNA. 10 mL of an overnight LB culture was centrifuged in Multispeed Centrifuge CL31R (Thermo 
Scientific) at 3800 rpm at 4 ºC for 15 min. The supernatant was discarded and the cells were 
resuspended in 10 mL of sterile water, previously cooled at 4 ºC. The centrifugation was repeated 
for 10 min. The cells were washed again in 10 mL of sterile water and centrifuged for 8 min. The 
cells were resuspended for the third time in 1 mL of sterile water and transferred to a sterile 1.5 mL 
Eppendorf tube. The cells were centrifuged in Multispeed Centrifuge CL31R (Thermo Scientific) at 
13000 rpm at 4 ºC for 3 min. Finally, the supernatant was discarded and the cells were resuspended 
in 100 µL. Then, 3 µL of plasmid was added in a tube with electro-competent cells and gently 
mixed by pipetting. The whole volume was transferred to a previously cooled 2 mm electroporation 
cuvette (Cell Projects) and treated by Gene Pulser (BioRad) under these conditions: 25 μF 
capacitance, 200 Ω resistance, 2.5 kV pulse. Upon the electroporation finalization, the cells were 
recovered immediately in a 900 µL of fresh LB supplemented with DAP and transferred to a sterile 
1.5 Eppendorf tube. Subsequently, the cells were incubated at 37 ºC and shaking at 220 rpm for 1 h. 
Finally, the desired dilutions of transformed cells were spread on Petri plates with LB agar, DAP 
and appropriate antibiotic. The plates were incubated at 37 ºC in a stove. 
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8.3. Gene knockout by homologous recombination in Labrenzia sp. PHM005 
8.3.1. Homologous recombination using I-SceI endonuclease system 
Throughout this work all the deletion mutants were developed based on the I-SceI 
endonuclease system that induces the DNA repair by homologous recombination (Martínez-García 
and de Lorenzo, 2011). Nevertheless, the original protocol was optimized to fit the specificities of 
the strains used.  
Figure 12 shows the simplified scheme of an endonuclease I-SceI directed system followed 
for gene deletion constructions. Gene knockout was performed using two-vector system; (1) the 
suicide plasmid pSEVA312S carrying chloramphenicol resistance and the upstream and 
downstream DNA fragments flanking the desired deletion region; (2) the pSEVA428S carrying the 
I-SceI endonuclease and the streptomycin resistance. The expression of I-SceI endonuclease is 
controlled by Pm promoter inducible by 3-methylbenzoate. Once it is expressed, I-SceI 
endonuclease digests the specific site in the suicide plasmid pSEVA312S integrated in the host 
genome causing double-strand brake and indirectly inducing the homologous recombination repair 
system. The survival cells manage to repair their genome, but loose the chloramphenicol resistance. 
The resulting mutant genotype was theoretically 50%. To generate the knockout of the desired gene 
the first conjugation was needed to integrate the suicide plasmid in the host genome by homologous 
recombination. During the second conjugation two things occur: the transformation of the plasmid 
carrying the I-SceI endonuclease; and the expression of the endonuclease independently of the 
inducer due to the leaky promotor and observed high endonuclease efficiency. The recombination 
occurs during the second conjugation so that the plated bacteria can be screened for a mutation 
directly. 




Figure 12. Scheme showing the endonuclease I-SceI induced homologous recombination repair for the 
creation of deletion mutants. 
8.3.2. Triparental conjugation 
Triparental conjugation was performed using E. coli cc118λpir carrying the suicide plasmid 
as a donor strain, E. coli HB101 harboring the plasmid pRK600 as a helper strain and Labrenzia sp. 
PHM005 as a receipt strain. 1 mL of overnight cultures was centrifuged at 13000 rpm for 1 min and 
the pellet was washed in a 500 µL of sterile 0.85% NaCl solution. The cells were centrifuged again 
and the pellet was resuspended to a final volume of 200 µL of NaCl solution. 50 µL of each strain 
were mixed and pipetted to a 0.22 µL filter disc placed on the MA plate. The plate was incubated 
overnight at 30 ºC. The next day the filter mating discs were collected in a 15 mL tube with 1 mL of 
a sterile 0.85 % NaCl solution and vortexed thoroughly to detach the cells from the filter. 
Afterwards, the 100 µL and the rest of the cells were plated on MA plates containing as selective 
antibiotics chloramphenicol (5 µg/mL) and kanamycin (10 µg/mL). The transconjugants T1 were 
selected after 5-7 days and verified by colony PCR. Subsequently, pSEVA428S was transformed to 
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PHM005 T1 by triparental conjugation and selected on the MA plates with selective antibiotics 
chloramphenicol (5 µg/mL), kanamycin (10 µg/mL) and streptomycin (50 µg/mL).  
8.3.3. Biparental conjugation 
In order to optimize the conjugation and selection procedure, the biparental conjugation was 
introduced using as a donor strain E. coli MFDpir, which is an auxotroph for diamine-salicylic acid 
(DAP). The conjugation procedure was as described previously, with the following exceptions: 
First transformation was selected on MA containing as selective antibiotic chloramphenicol 
(5 µg/mL) and second recombination was selected on the MA plates with selective antibiotic 
streptomycin (50 µg/mL). The transconjugants T1 were selected on MA containing as selective 
antibiotic chloramphenicol (5 µg/mL); then, pSEVA428S was transformed to PHM005 T1 by 
biparental conjugation during 6 h; the mutation candidates were selected on the MA plates with 
selective antibiotic streptomycin (50 µg/mL) and verified by colony PCR. 
9. RNA extraction and transcriptomics analyses 
9.1. RNA extraction and quantitative analysis by RT-PCR 
To isolate a total RNA from bacterial cells a High Pure RNA Isolation Kit (Roche) was used 
with a few modifications of the manufacturer protocol. A volume of 5 mL of a culture in an 
exponential growth phase was used for the extraction, centrifuged at 3800 rpm at 4 ºC for 10 min. 
The cell pellet was resuspended in 500 µL of TE buffer. To ensure improved cell lysis, 50 µL of 
lysozyme (50 mg/mL) (Sigma-Aldrich) was added to the cell suspension and incubated at 37 ºC for 
10 min. Additionally, the cell suspension was instantly deep frozen in a dry ice and ethanol 
followed by a defrost in a water bath at 37 ºC in three series for 1-2 min. The rest of the protocol 
was followed as instructed by the manufacturer. The purified RNA was further incubated with 
Ambion® TURBO DNA-free™ DNase Treatment and Removal Reagents (Life Technologies) kit 
to remove the contaminating DNA from the RNA samples. The RNA concentration was measured 
using a NanoPhotometer (Implen).  
Reverse transcription of 1 µg of DNA-free RNA per sample was done using the Transcriptor 
First Strand cDNA Synthesis Kit (Roche) to generate cDNA following the manufacturer protocol. 
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RT- PCR semi-quantitative analyses were carried out to check the mRNA levels. The rpoD gene 
was chosen as the housekeeping gene. Taq-polymerase and 10X Standard Reaction Buffer 
(Biotools) was used for the PCR amplification. Water, dNTPs and oligonucleotides were added as 
indicated in a manufacturer protocol. The PCR amplification was done using 1 µL of cDNA sample 
and program was: initial denaturalization for 5 min at 95 ºC; 25-30 cycles comprising 
denaturalization of 30 s at 95 ºC, primer annealing for 30 s at 57-60 ºC (depending on the primer 
Tm) and extension for 1 min per kb of DNA at 72 ºC; the final extension for 2 min at 72 ºC; and the 
cooling at 4 ºC. Relative mRNA expression was visualized in 1.5% agarose gel by gel 
electrophoresis. Negative controls contained RNA samples without the reverse transcriptase.  
9.2.  RNA-seq and 5‟Cap RNA-seq analysis 
The RNA extraction from Labrenzia sp. PHM005 for the transcriptomics analysis was 
performed at the early exponential phase (12 h) in a modified MBM+vit medium as described 
previously. Three sample replicates were used for the RNA-seq analysis. The construction of cDNA 
library, sequencing and bioinformatics analyses were carried out by Vertis Biotechnologie AG. The 
percentage of the mapped reads to all annotated genes was 78.4%, 80.8%, and 77.0% for each 
replicate sample.  
Cappable-seq is a method (Ettwiller et al., 2016) for the precise identification of bacterial 
transcription start sites (TSSs) used in this work for TSSs determination in the genome of Labrenzia 
sp. PHM005. The sequencing and the bioinformatics analysis was performed by Vertis 
Biotechnologie AG using the same RNA samples described above. 
10. Fluorescence measurement in GFP producing bacterial cultures 
To measure the GFP fluorescence and optical density (OD600), an automatic plate reader 
Varioskan Flash (Thermo Scientific) was used. The appropriate dilutions of the bacterial culture in 
MBM+vit were prepared in 0.85 % NaCl solution and 200 µL of each cell suspension was added in 
three technical replicates to a 96-well plate (Falcon). The excitation wavelength was 485 nm and the 
emission wavelength was 511 nm. The raw data was automatically collected in an excel sheet. The 
fluorescence was normalized manually by OD600 value. Data analysis and representation was done 
using Microsoft Excel.  
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11. SDS-PAGE and protein concentration determination
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used for 
qualitative analysis of the protein expression of cloned genes and verification of plasmid expression 
systems. 
11.1. Extraction of intracellular proteins 
10 mL of an overnight bacterial culture was centrifuged at 3800 rpm for 10 min at 4 ºC and 
the supernatant was discarded. The cell pellet was resuspended in 0.85 % NaCl solution and 
centrifuged in Multispeed Centrifuge CL31R (Thermo Scientific) at 3800 rpm for 10 min at 4 ºC 
and the supernatant was discarded. The washing procedure was repeated two times. Finally, the cell 
pellet was resuspended in 1 mL of buffer 20 mM Tris-HCl (pH 8.0) and transferred to a 2 mL 
Eppendorf tube. Next, the cells were lysed by sonication in a Ultrasons sonicator (Selecta) by 
applying 5-6 pulses at the maximum intensity for 30 s. The time between pulses, the samples were 
placed on ice. Finally, the lysed cells were centrifuged in MiniSpin centrifuge (Eppendorf) at 13000 
rpm for 1 min. The supernatant was transferred by pipetting to a clean Eppendorf tube and the pellet 
containing cell wall and insoluble proteins was resuspended in 1 mL of 20 mM Tris-HCl (pH 8.0) 
for further analysis. 
11.2. Determination of soluble protein concentration 
The concentration of soluble protein obtained from the intracellular extracts was determined 
by Bradford (Bradford, 1976) was used for the determination of soluble protein concentration. 
Bradford reagent at 5x (Bio-Rad) was diluted with water to make 1x Bradford reagent solution. The 
appropriate cell suspension dilutions were prepared and 20 µL of each sample was mixed with 1 
mL Bradford solution. The protein absorption was measured spectrophotometrically at 595 nm with 
UV-mini 1240 spectrophotometer (Shimadzu). To calculate the protein concentrations, a previously 
prepared standard curve with bovine seroalbumin was used: 
The optimal concentration to load the gel was 15-25 µg. 




To prepare the polyacrylamide gel for electrophoresis, a running gel (12.5%) and a stacking 
gel were prepared as indicated in a Table 13. First, the running gel was poured in the glass plates of 
Mini PROTEAN Tetra System (Bio-Rad) and let to polymerize. Then, the stacking gel was poured 
over the running gel and let to polymerize.  
Table 13. Polyacrylamide gel preparation: reagents and volumes 
Running gel (12.5%) Volume  Stacking gel Volume 
Acrylamide 40% 3.13 mL  Acrylamide 40% 0.250 mL 
1 M Tris-HCl (pH 8.0) 3.75 mL  1 M Tris-HCl (pH 8.0) 0.125 mL 
SDS 20% 50 µL  SDS 20% 12.5 µL 
Water 3.01 mL  Water 1.950 mL 
APS 10% 50 µL  APS 10% 12.5 µL 
TEMED 8 µL  TEMED 2.5 µL 
TOTAL 10 mL  TOTAL 2.35 mL 
The gel electrophoresis was conducted in a PowerPac Basic power supply (Bio-Rad) and the 
conditions were: initial 120 V for the stacking gel and 80 V for the running gel. Ladder used was 
BlueStar Prestained Protein Marker (Nippon Genetics). The gel was stained by Coomassie Brilliant 
Blue R 250 (Serva) while slowly agitating. 
12. Extraction, purification and identification of polyketide compounds 
12.1. Polyketide extraction procedure of culture supernatant 
Upon the fermentation completion in MBM media, the 20 mL culture was centrifuged in 
Multispeed Centrifuge CL31R (Thermo Scientific) at 3800 rpm for 15 min at 4 ºC, the supernatant 
was frozen at -80 ºC and subsequently freeze dried. The lyophilized product was then dissolved in 4 
mL of distilled water and equal volume of ethyl acetate. It was further thoroughly homogenized by 
vortex during 30 s and centrifuged at room temperature. The organic phase was separated by 
pipetting and the extraction was repeated. All the organic phase was dried by vacuum centrifugation 
to a solid extract which was further dissolved in 150 µL methanol and filtered for a HPLC/MS 
analysis. 
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12.2. Extraction procedure of the intracellular polyketide compounds 
An overnight culture of Labrenzia sp. PHM005, wt and respective mutants, was diluted to 
an OD600 of 0.1 in a fresh 200 mL of MB medium. For the purpose of an assay of the labrenzin 
transport inside and outside the cell, 50 ng of purified labrenzin dissolved in methanol was added to 
a culture medium of non-producing mutant of Labrenzia sp. PHM005. After 24-72 h of incubation 
at 30 ºC and shaking at 220 rpm in New Brunswick Innova® 44/44R Incubator, the cultures were 
centrifuged using an ultracentrifuge Sorvall Lynx 6000 (Thermo Scientific) (rotor F14-6x250y) at 
4000 rpm for 20-30 min at 4 ºC. Afterwards, the cells were washed and resuspended in a 10 mL of 
water followed by a centrifugation in a Multispeed Centrifuge CL31R (Thermo Scientific) at 3800 
rpm for 10 min at 4 ºC. The washing procedure was repeated. The cell pellet was finally 
resuspended in 10 mL of water and the cells were submitted to high-pressure cell rupture using 
French Pressure Cell Press (American Instruments Company) in order to break the cells. After 
centrifucation in Multispeed Centrifuge CL31R (Thermo Scientific) at 3800 rpm for 15 min at 4 ºC, 
the supernatant was separated for further extraction (see chapter 12.1) and HPLC/MS analysis. 
12.3. HPLC/MS chromatography 
HPLC-MS was carried out using a mass spectrometry system (Thermo Mod. FinniganTM 
LXQTM) with on line HPLC Surveyor comprising pump with four separate solvent feeds (Surveyor 
MS pump Plus), an auto-sampler for multi sample analysis (Surveyor AS Plus), a Photo Diode 
Array detector (Surveyor PDA Plus) and a mass spectrometer LXQ equipped with linear ion trap. 
Ionization source used was electrospray ionization (ESI). Separation was performed on a C18 
column (ZORBAX Eclipse plus C18, 5 µm, 4.6 × 250 mm, Agilent Technologies, Santa Clara, CA, 
United States). Two methods were developed throughout this thesis project. Short run method was 
following: solvent A was 100% water and solvent B was 100% acetonitrile. The flow rate was 1 ml 
min
−1
 and the gradient (per cent solvent A/B) was t = 2 min, 100% A; t = 5 min, 95% A; t = 25 min,
0% A; t = 27 min, 0% A; t = 30 min, 100% A; t = 35 min, 100% A. Long run method was adjusted 
for a 500µL min
−1 
flow rate with the following gradient: t = 2 min, 100% A; t = 8 min, 95% A; t =
40 min, 55% A; t = 53 min, 0% A; t = 55 min, 0% A; t = 57 min, 100% A; t = 65 min, 100% A. UV 







1. Genomic study of Labrenzia sp. PHM005 
Labrenzia sp. PHM005 was isolated from a marine sediment sample collected at 15 m of 
depth in the Indian Ocean by the coast of Kenya in 2004. PharmaMar collected the sample, isolated 
the strain, fermented the culture, identified and purified the novel pederin-family polyketide in the 
culture supernatant, later named labrenzin. The compound exhibited potent cytotoxic effect against 
four human cancer cell lines, and the GI50 (compound concentration that produces 50% cell growth 
inhibition, as compared to control cultures) was in the range (2.0−2.9) × 10
−9
 M (Schleissner et al., 
2017). This was the first example reported of a free-living bacterium, which can be cultured in the 
laboratory, as a producer of a pederin-like compound. This opened the door to the genomic study of 
the gene cluster responsible for the biosynthesis of labrenzin and better understanding of the 
molecular mechanisms involved. 
1.1. Genome sequencing  
To start, the genome of Labrenzia sp. PHM005 was sequenced de novo by PacBio system 
and assembled in a single contig (see Materials and Methods 3.1.). Nonetheless, several sequencing 
errors were detected in the trans-AT PKS sequences that resulted in frameshifts that rendered 
several unexpected stop codons. Sanger sequencing of specific PCR amplicons, surrounding the 
sequencing errors, as schemed in the Figure 13 corrected the errors. To determine the presence of 
plasmids in the strain PHM005 that cannot be detected by the PacBio sequencing method as well as 
to correct other putative sequencing errors, the genome of strain PHM005 was re-sequenced using 
an Illumina MiSeq system (see Material and Methods 3.1). 
 
 
Figure 13. Correction of lab gene cluster sequence by Sanger sequencing. PCR-amplified regions for the 




The genome sequence of Labrenzia sp. strain PHM005 revealed two replicons comprising a 
circular chromosome of 6,167,349 bp (accession CP041191) and a circular plasmid (named p1BIR) 
of 19,450 bp (accession CP041190) shown in Figure 14. The genome average G + C content is 
55%, contains 51 tRNAs, 3 copies of rRNA sequences (5S-23S-16S) and 5,988 coding sequences. 
Plasmid has a G + C content of 48.5% and contains 17 ORFs most of them coding for putative 
replication and conjugation related proteins (Table 14). The plasmid encodes two putative Abi 
family proteins involved in bacteriophage abortive infection resistance (BIR) systems (Garvey et 
al., 1995). A plasmid copy number of about 60 was calculated taking into account the genome and 
plasmid sizes and the number of Illumina reads covering both, i.e., 3,820,045 reads and 712,018 
reads, respectively (SRA accession SRS5035208). The whole genome of strain PHM005 was 
annotated using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) before the submission 
to the GenBank database. 
 
Figure 14. Circular maps of the genome of Labrenzia sp. PHM005 and plasmid p1BIR. (A) From outer to 
inner circles: The first four circles show the coding sequence (CDS), transfer ribonucleic acid (tRNA), 
ribosomal ribonucleic acid (rRNA), and open reading frame (ORF). The fifth circle represents the GC 
content (black). The sixth circle demonstrates the GC skew curve (positive GC skew, green; negative GC 
skew, violet). The genome position scaled in 500 kbp from base 1 is shown on the inner circle. (B) The 
circular map of plasmid p1BIR (Geneious version 10.0 created by Biomatters. Available from 
http://www.geneious.com). Dark green arrows represent genes coding for proteins with homology in other 




Table 14. Coding sequences of p1BIR and the closest homologs. 
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1.2. Comparative genomics analysis 
Functional comparison of genome sequences by Rapid Annotation Subsystem Technology 
(RAST) Server (Aziz et al., 2008) revealed Labrenzia alexandrii (strain DFL-11) (score 548) as the 
closest neighbor of strain PHM005, followed by L. aggregata (strain IAM 12614) (score 539), 
Roseibium sp. (strain TrichSKD4) (score 328), Agrobacterium tumefaciens (strain C58) (score 207) 
and Sinorhizobium meliloti (strain 5A14) (score 198). The genomes of five Labrenzia species, i.e., 
Labrenzia sp. (strain PHM005) (accession CP041191), L. alexandrii (strain DFL-11) (accession 
CM011002), L. aggregata (strain RMAR6-6) (accession CP019630), Labrenzia sp. (strain CP4) 
(accession CP011927) and Labrenzia sp. (strain VG12) (accession CP022529), were analyzed for 
average nucleotide identity (ANI) to provide intraspecies and interspecies relationships (Table 15). 
These four strains were chosen because their whole genomes were the only complete genomes of 
the closest strains uploaded to the NCBI database at the time. Strain PHM005 appears to be most 
similar to L. alexandrii (strain DFL-11) although both genomes do not seem to belong to the same 
species since the ANI value is below 95% (Goris et al., 2007). Nonetheless, only L. aggregata 
(strain RMAR6-6) and Labrenzia sp. (strain CP4) most likely belong to the same species showing 
an ANI value of 97.76%. 
 
Table 15. Average nucleotide identity (ANI) comparison of Labrenzia genomes. 
 
Using the five previously described Labrenzia species, a whole genome alignment using a 
progressive Mauve algorithm from the Geneious version 10.0.2 was performed. According to these 
algorithms, L. alexandrii (strain DFL-11) showed the highest local collinearity number, which 





Table 16. Four Labrenzia genomes aligned to Labrenzia sp. PHM005 using progressive Mauve algorithm 
individually. 
Labrenzia sp. PHM005 aligned to: minimum weight for Locally Collinear Blocks 
Labrenzia alexandrii DFL-11 164 
Labrenzia aggregata RMAR-6 42 
Labrenzia sp. CP4 92 
Labrenzia sp. VG12 72 
 
2. In silico analysis of the lab cluster 
The circular genome of Labrenzia sp. PHM005 was firstly set for a secondary metabolite 
gene cluster mining using an online platform antiSMASH 4.0. In total, 101 gene clusters have been 
identified: (i) one bacteriocin or other unspecified ribosomally synthesized and post-translationally 
modified peptide product (RiPP) cluster; (ii) 4 putative fatty acid clusters; (iii) 4 putative saccharide 
clusters; (iv) 89 putative clusters of unknown type; (v) one putative polyhydroxyalkanoate 
biosynthetic gene cluster; (vi) one putative mixed PKS/saccharide cluster; (vii) one trans-AT 
PKS/NRPS cluster. The later was studied in detail, as it showed high similarity with pederin gene 
cluster, as presented in the following sections. Additionally, the rest of the clusters were manually 
screened for similarity in other microorganisms and we have counted 17 clusters which lie within 
the order of Rhizobiales sharing from 10% to 32% of cluster genes (Table 17). 
 
Table 17. Homologous gene clusters in other microorganisms according to ClusterBlast by antiSMASH 4.0. 
cluster  genome location Cluster Blast hits NCBI sequence ID % 
t1pks-
saccharide 
480196 - 549637 Labrenzia alexandrii DFL-11 EQ973121 85 
Rhizobium sp. LC145 LBHV01000004 25 
putative 668100 - 685508 Pseudomonas sp. GM74 PMI34 AKJG01000048 17 
Rhizobium tropici CIAT 899 CP004015 15 
saccharide 686985 - 711837 Rhizobium etli bv. mimosae str. IE4771 CP006986 14 
Azorhizobium caulinodans ORS 571 AP009384 11 
putative 732631 - 741605 Kiloniella sp. P1-1 LANI01000017 27 
Rhizobium rhizogenes NBRC 13257 BAYX01000006 22 
fatty_acid 935479 - 956702 Rhodomicrobium vannielii ATCC 17100 CP002292 20 
Rhizobium sp. Leaf391 LMQG01000042 17 
putative 993628 - 1003997 Rhizobium sp. Leaf311 LMNZ01000009 12 
Rhizobium rubi NBRC 13261 BBJU01000029 10 




cluster  genome location Cluster Blast hits NCBI sequence ID % 
Bradyrhizobium valentinum strain LmjM3 LLXX01000143 20 
putative 2140378 - 2156286 Bradyrhizobium elkanii strain 
UASWS1015  
JXOF01000173 13 
Bradyrhizobium sp. YR681 PMI42  AKIY01000259 10 
putative 2225472 - 2235766 Mesorhizobium sp. LNJC405B00 AYWC01000002 15 
Mesorhizobium sp. Root554 LMGA01000001 12 
putative 2359048 - 2367711 Phaeobacter sp. CECT 5382 CYSG01000021 34 
Bradyrhizobium sp. DFCI-1 AMFB01000012 21 
putative 2379843 - 2396431 Rhizobium rubi NBRC 13261  BBJU01000023 17 
putative 3516897 - 3522239 Neorhizobium galegae bv. officinalis CCRH01000015 17 
fatty_acid 4522154 - 4543389 Sinorhizobium fredii HH103 HE616890 25 
putative 4543774 - 4553183  Bradyrhizobium sp. STM 3843  CAFK01000193  16 
putative 4658717 - 4682200 Mesorhizobium sp. Root695 LMHO01000015 20 
fatty_acid 4699018 - 4719995 Phaeospirillum fulvum MGU-K5 AQPH01000012 48 
Mesorhizobium sp. Root102 LMCP01000045 32 
putative 4825217 - 4843781 Haematobacter missouriensis strain CCUG 
52307 
JFGS01000018 25 
Bradyrhizobium sp. LTSP849 JYMR01000055 25 
 
2.1. Identification and delimitation of the cluster 
The genome of L. alexandrii (strain DFL-11) was used to estimate the size and the putative 
boundaries of the trans-AT PKS cluster in the genome of strain PHM005. The alignment of both 
genomes is shown in Figure 15A. This alignment revealed that the trans-AT PKS cluster has been 
probably inserted within two rDNA regions. The putative cluster limits were further compared with 
the whole genomes of other three previously mentioned species of Labrenzia, i.e., L. aggregata 
(strain RMAR6-6) (accession CP019630), Labrenzia sp. (strain CP4) (accession CP011927) and 
Labrenzia sp. (strain VG12) (accession CP022529). Interestingly, the genes located downstream 
from the gene cluster were found in the same orientation in all species. The similarity and the 
corresponding gene positions in each species are shown in Figure 15B. On the contrary, the genes 
located upstream the trans-AT PKS cluster were only found in L. alexandrii (strain DFL-11) (gene 
position at genome between 3,628,890 bp and 3,648,023 bp following the same order). 
Accordingly, to these comparisons, the homologous genes present in at least two genomes were 





Figure 15. Representation of the lab gene cluster and its bordering genes distributed among the selected 
Labrenzia species genomes. A) MAFFT alignment of L. alexandrii DFL-11 and Labrenzia sp. PHM005. 
Coding sequences are represented by arrows: gray, CDS; red, ribosomal DNA; green and orange, lab gene 
cluster; light blue; identical genes. B) MAFFT alignment and localization of downstream bordering genes in 
Labrenzia species. 
 
Finally, the trans-AT PKS/NRPS cluster, further named lab cluster, consists of a 79-kb 
region (776,792–855,905 bp) comprising 3 genes encoding multi-domain PKS/NRPS proteins 
(lab4, lab13, and lab15), 16 auxiliary enzymes with assigned functions and 6 uncharacterized ORFs 
annotated as hypothetical proteins. The results of the BLAST protein homology analysis indicate 





Table 18. BLAST homology of the Labrenzia sp. PHM005 trans-AT PKS gene cluster as of May 2017. ORFs are listed from left to right of the cluster 
(upstream to downstream). 
 
ORF Annotation (RAST) BLAST homolog Origin accession number cover/identity 
% 
HYP1 DUF3089 domain-containing protein 
 
DUF3089 domain-containing protein  Labrenzia sp. DG1229 WP_051644561.1 100/65 
HYP2 ParA family protein 
 
ParA family protein  Labrenzia marina WP_103225501.1 100/73 
HYP3 DUF697 domain-containing protein 
 
DUF697 domain-containing protein  Labrenzia sp. Alg231-36 WP_108873020.1 100/81 
HYP4 DUF697 domain-containing protein 
 
DUF697 domain-containing protein Labrenzia sp. Alg231-36 WP_108873020.1 100/81 
HYP5 prohibitin family protein 
 
prohibitin family protein  Stappia indica WP_067221789.1 98/62 
Lab1 ABC transporter substrate-binding 
protein 
 
ABC transporter substrate-binding 
protein  
Oceanibaculum indicum WP_008945422.1 91/37 
HYP6 hypothetical protein 
 
hypothetical protein  Oceanibaculum indicum WP_008945421.1 95/62 
Lab2 acyl carrier protein 
 
acyl carrier protein PedN Candidatus Profftella armatura WP_020915408.1 95/44 














PedP  Symbiont bacterium of 
Paederus fuscipes 
 AAW33975.1 99/61 
     
Lab4 trans-AT polyketide synthase type I 
 
OnnB  Symbiont bacterium of 
Theonella swinhoei 
AAV97870.1 79/40 
 putative type I polyketide synthase 
PedI 
Symbiont bacterium of 
Paederus fuscipes 
AAR19304.1 96/42 
Lab5 LLM class flavin-dependent 
oxidoreductase 
 
luciferase  Methylocucumis oryzae  WP_045777999.1 100/64 
 flavin-dependent oxygenase  Nostoc sp. 'Peltigera 
membranacea cyanobiont' 
ADA69238.1 100/60 
 putative oxygenase PedJ Symbiont bacterium of 
Paederus fuscipes 
AAR19305.1 100/61 
 OnnC  Symbiont bacterium of 
Theonella swinhoei 
AAV97871.1 100/63 
Lab6 methyltransferase domain-containing 
protein 
 
OnnG  Symbiont bacterium of 
Theonella swinhoei 
AAV97875.1 99/51 
 OnnD  symbiont bacterium of 
Theonella swinhoei 
AAV97872.1 97/46 
 hypothetical protein ETSY1_46125 
(plasmid)  
Candidatus Entotheonella sp. 
TSY1 
: ETX03779.1 99/51 
 PedO  Symbiont bacterium of 
Paederus fuscipes 
AAW33974.1 97/43 
 putative methyltransferase PedA Symbiont bacterium of 
Paederus fuscipes 
AAS47557.1 97/47 
 SAM-dependent methyltransferase, 
partial  
Methylocucumis oryzae WP_052700174.1 72/58 
Lab7 cytochrome P450 
 
cytochrome P450  Labrenzia alba WP_055112014.1 97/54 
 cytochrome P450  Oceanibaculum indicum WP_008944496.1 98/54 






ORF Annotation (RAST) BLAST homolog Origin accession number cover/identity 
% 
Lab8 FMN-dependent oxidoreductase 
 
FMN-dependent oxidoreductase PedB Symbiont bacterium of 
Paederus fuscipes 
AAS47558.1 98/56 
Lab8 putative FMN-dependent 
oxidoreductase, PedB-like protein  
Candidatus Profftella armatura WP_020915402.1 98/52 





Methylobacter tundripaludum WP_104425066.1 98/41 
 polyketide biosynthesis acyltransferase  Candidatus Profftella armatura WP_020915461.1 92/34 
 putative acyltransferase PedC Symbiont bacterium of 
Paederus fuscipes 
AAS47559.1 98/35 
Lab10 ACP S-malonyltransferase 
 
malonyl CoA-acyl carrier protein 
transacylase  
Burkholderia gladioli WP_036053944.1 98/51 
 malonyl CoA-acyl carrier protein 
transacylase  
Methylocucumis oryzae WP_045778127.1 98/50 
 malonyl CoA-acyl carrier protein 
transacylase  
Candidatus Entotheonella sp. 
(ex. Theonella swinhoei) 
AKQ22695.1 98/52 
 putative acyltransferase PedD Symbiont bacterium of 
Paederus fuscipes 
AAS47563.1 95/51 
Lab11 enoyl-CoA hydratase/isomerase 
 
enoyl-CoA hydratase  Oceanibaculum indicum WP_008944492.1 94/50 
 enoyl-CoA hydratase  Labrenzia sp. DG1229 WP_029061353.1 97/43 
 PedL  Symbiont bacterium of 
Paederus fuscipes 
 AAW33971.1 91/43 
Lab12 polyketide beta-ketoacyl:ACP 
synthase 
 
polyketide beta-ketoacyl:ACP synthase  Oceanibaculum indicum WP_008944493.1 98/44 
 
 Polyketide biosynthesis malonyl-ACP 
decarboxylase PksF 
 
Labrenzia alba CTQ66097.1 97/42 






ORF Annotation (RAST) BLAST homolog Origin accession number cover/identity 
% 
Lab13 mixed type I polyketide synthase - 
peptide synthetase 
 
mixed type I polyketide synthase - 
peptide synthetase  
Symbiont bacterium of 
Paederus fuscipes 
AAS47562.1 99/42 
 non-ribosomal peptide synthetase  Magnetovibrio blakemorei WP_069956861.1 98/36 





Symbiont bacterium of 
Paederus fuscipes 
AAS47561.1 94/73 
 flavin-containing monooxygenase 
PedG-like protein  
Candidatus Profftella armatura WP_020915400.1 98/71 
 monooxygenase  Labrenzia alba WP_055112032.1 97/62 
Lab15 mixed type I polyketide synthase - 
peptide synthetase 
 
mixed type I polyketide 
synthase/nonribosomal peptide 
synthetase  
Symbiont bacterium of 
Paederus fuscipes 
AAS47564.1 99/42 
 non-ribosomal peptide synthetase Methylobacter tundripaludum  WP_104425077.1 96/46 
 OnnI, partial  Symbiont bacterium of 
Theonella swinhoei 
 AAV97877.1 92/46 
Lab16 methyltransferase domain-containing 
protein 
 
OnnH  Symbiont bacterium of 
Theonella swinhoei 
 AAV97876.1 99/43 
 putative methyltransferase PedE Symbiont bacterium of 
Paederus fuscipes 
AAS47560.1 98/51 
 class I SAM-dependent 
methyltransferase  
Methylocucumis oryzae  WP_045777863.1 94/57 
Lab17 ATP-binding cassette domain-
containing protein 
hypothetical protein ETSY1_10275  Candidatus Entotheonella sp. 
TSY1 
 ETX00685.1 99/33 








ORF Annotation (RAST) BLAST homolog Origin accession number cover/identity 
% 
Lab18 cyclic peptide export ABC transporter 
 
cyclic peptide transporter  Oceanibaculum indicum WP_008944489.1 99/51 
 fused multidrug transport subunits of 





 WP_024079861.1 95/40 
 ABC transporter, ATP-








superfamily protein  
Methylobacter tundripaludum WP_104424065.1 97/42 
 4'-phosphopantetheinyl transferase  Candidatus Profftella armatura WP_020915412.1 82/31 










2.2. Hypothesis for the labrenzin biosynthetic pathway 
The core labrenzin molecule is constructed following an “assembly line” biosynthesis by the 
modular PKSs/NRPSs and further modified by the tailoring enzymes as proposed (Figure 16B). The 
structures of biosynthesis intermediates of labrenzin have been deducted from the specificity of 
enzymatic domains of each PKS/NRPS module. The domain analysis is based on the antiSMASH 
4.0 results and the described conserved motifs of the three PKS/NRPSs (El-Sayed et al., 2003).  
According to the modular structure predicted by antiSMASH v.4.0., the PKS (Lab4) from 
strain PHM005 consists of a “starter” module 0 with a GCN5-related N-acetyltransferase family 
(GNAT) domain that catalyzes the decarboxylation of malonyl-CoA to generate acetyl-CoA and its 
translocation to the ACP unit. After that, three elongating β-ketoacyl synthases (KSs) incorporate 
the three malonyl-CoA building units. Compared to PedI from P. fuscipes symbiont (Piel et al., 
2004), the first module of Lab4 contains an additional dehydratase (DH) domain, most probably 
inactive, since it lacks the typical conserved motif HXXXGXXXXP (El-Sayed et al., 2003). In 
addition, the presence of only one ECH domain in the third module does not appear to affect the 
structure of the first pyran ring of the labrenzin core structure. 
The domain architecture of the PKS/NRPS (Lab15) from strain PHM005 is almost identical 
to the architecture of PedF enzyme (Piel, 2002). The main singularity observed in Lab15 is the 
presence of a putative inactive DH domain attached to the first non-elongating KS0, while in PedF 
there is one putative inactive DH domain in the last module. 
According to antiSMASH predictions, the PKS/NRPS (Lab13) from strain PHM005, 
follows the domain order described in PedH, which is hypothesized by (Piel, 2002) to synthesize 
the chain containing the terminal arginine residue found in onnamide analogs (Matsunaga et al., 
1992). However, there are a few exceptions. Substrate predictions of Lab13 by pHHM and 
SANDPUMA indicate arginine and alanine, respectively, as candidate amino acids for the chain 
terminal of the putative onnamide-like molecule; therefore, it cannot be concluded with accuracy 
the last amino acid incorporation. Lab13 also possesses another putative inactive DH domain in the 
third module. The last non-elongating KS domain lacks the histidine conserved residue and the 




As presented in Figure 16B, it can be suspected that the genes encoding tailoring 
oxidoreductases and methyltransferases would be responsible for the hydroxylations and 
methylations of the polyketide core molecule, respectively. Since labrenzin intermediate containing 
the lateral chain has not been detected in the culture extracts, it can be assumed that some other 
enzyme, encoded in the lab cluster or elsewhere in the genome should hydrolyze the final 
polyketide product into two products: labrenzin and the cryptic moiety. Following the initial 
hypothesis set by Piel‟s research group over the years, it can be assumed that a yet unknown C-C 
bond cleavage mechanism is probably involved in the labrenzin biosynthesis. One possibility is to 
accept the premature cleavage of the polyketide intermediate at the end of the PKS/NRPS15, and 
the other possibility is to assume the hydrolysis of the final polyketide product after the biosynthesis 
on the PKS complex. The possible candidates for the hydrolytic cleavage of the molecule could be 







Figure 16. A) Map of the lab cluster comprising the genes for labrenzin production. B) Scheme predicting 
the pederin/onnamide modular biosynthesis in the free-living Alfaproteobacterium Labrenzia sp. PHM005. 
Specific domains have been identified and analyzed using antiSMASH. Domains (shown in circles) that are 
part of the same module are represented in the same color, less the putative non-functional domains in white. 
Module boundaries are defined according to recent improvements (Vander Wood and Keatinge-Clay, 2018). 
GNAT, GCN5-related N-acetyltransferase domain; ACP, acyl carrier protein domain; KS, ketosynthase 
domain; KS0, non-elongating ketosynthase domain; KR, ketoreductase domain; MT, methyltransferase 
domain; ECH, enoyl- CoA hydratase/isomerase domain; A, adenylation domain; AT, acyltransferase; C, 
condensation domain; DH, dehydratase domain; PS, pyran synthase; PCP, peptidyl carrier protein domain; 
TE, thioesterase domain; OR, oxidoreductase; MT, methyltransferase. Putative trans-AT docking site 
associated with its respective KS is indicated by arrows. Two pathways are indicated: the synthesis of the 
labrenzin and the onnamide A questioned to be the complete molecule of the proposed pathway. Putative 






2.3. Comparative analyses with homologous gene clusters 
2.3.1. Pederin family gene clusters 
Using as a reference the genes of the pederin cluster from the symbiont of P. fuscipes, the 
homologous genes and their protein identities of the corresponding genes of Labrenzia sp. PHM005 
are visualized in Figure 17. The first observed difference between the two almost identical 
biosynthetic systems is the gene distribution in their host genomes. In the symbiont bacterium of P. 
fuscipes, the pederin genes are clustered in three genomic islands flanked by IS elements and 
transposons (Piel et al., 2004d, 2005). However, the pederin biosynthetic genes of strain PHM005 
are clustered together, suggesting its horizontal gene transfer, a very common phenomenon in 
bacteria (Roth and Lawrence, 1996). 
The lab gene cluster of strain PHM005 comprises three putative ABC transporters, one 
cytochrome P450 and one 4‟-phosphopantetheinyl transferase, which have not been identified in P. 
fuscipes or T. swinhoei. On the other hand, there are three proteins in the P. fuscipes symbiont, that 
are absent in Labrenzia sp. PHM005, i.e., a putative PedQ esterase, a PedR regulator and a protein 
of unknown function named PedK in P. fuscipes or OnnE and OnnF in T. swinhoei (Piel et al., 
2004b). The tailoring enzymes in strain PHM005 showed protein identity <60%, with the exception 
of the hydroxymethylglutaryl-CoA synthase (HMGS) and the oxygenase (OXY) which have 61% 
and 73% identity, respectively. Among the tailoring enzymes in lab cluster, there is a presence of 
HMGS, stand-alone ACP, KS and ECH, two putative acetyl-transferases (AT) and one 
oxidoreductase (OR). Another difference regarding the ped cluster is the number of methyl-
transferases (MTs). Ped cluster described in the beetle symbiont comprises three MTs (PedA, PedE 





Figure 17. Comparative analysis of a pederin cluster from a symbiont bacterium of P. fuscipes and the free-
living alphaproteobacterium Labrenzia sp. PHM005. Modified scheme of the pederin cluster as described 
from a: A) bacterium symbiont of P. fuscipes (Piel et al., 2004c) (above) and the newly described labrenzin 
cluster from Labrenzia sp. PHM005 (below). Homologous genes between two clusters are indicated by lines. 
Protein identity is visualized using colored scale that matches the identity percentage of all the genes from 
the cluster, using as reference the symbiont bacterium of P. fuscipes genes. PKS and NRPS genes are shown 
in green and tailoring enzymes in orange and gray. ABC, transporter; ACP, acyl carrier protein; AT, 
acyltransferase; ECH, enoyl-CoA hydratase/isomerase domain; HMGS, hydroxymethylglutaryl-CoA 
synthase; KS, ketosynthase; MT, methyltransferase; OR, oxidoreductase; OXY, monooxygenase; P450, 
cytochrome hydroxylase; PPT, phosphopantetheinyl transferase. B) Graphical representation of the 








2.3.1.1. PKS and hybrid PKS/NRPS similarities with other homologs 
Apart from pederin and onnamide gene clusters mentioned above, other biosynthetic gene 
clusters of compounds from the pederin family, such as those described for the biosynthesis of 
diaphorin, psymberin, nosperin and cusperin were inspected for the PKS/NRPS domain architecture 
using the antiSMASH v.4.0 software (Figure 18A). The starting PKS responsible for the synthesis 
of the first pyran ring of labrenzin is conserved in all these clusters, except in the psymberin cluster 
where PKS lacks the second module resulting in the absence of three C atoms. There is also a 
difference in the number of the tandem ACP domains found in the third module of the starting PKS. 
In addition, the third module comprises two enoyl-CoA hydratase (ECH1 and ECH2) domains in 
OnnB, while the rest of the starting PKSs contain a single ECH domain based on antiSMASH 
analysis. The ECH domains can exist as separate enzymes, as a part of the HMGS-cassette, or as 
embedded domains in the PKSs, like ECH2 in curacin A (Gu et al., 2006). It is hypothesized that 
the ECH domains are responsible for the exomethylene group formation in the pederin pyran 
structure (Piel et al., 2004d). The amino acid sequence of the putative ECH1 domains in all 7 PKSs 
were aligned using as reference the characterized ECH1 functional domain (CurE) from the curacin 
A biosynthetic pathway (Gu et al., 2006) (Figure 18B). The OnnB, NspA, CusA, and PedI maintain 
the conserved amino acid motifs, while DipP, PsyA, and PKS4 have deleted the regions containing 
the conserved motifs of ECH1, suggesting that they might not be functional and that only one 
functional ECH domain is enough to generate the corresponding compounds. It is also possible that 





Figure 18. A) Modular scheme and domain comparison of PKS/NRPSs responsible for the biosynthesis of 
pederin family compounds isolated from organisms of different ecological niches: labrenzin, Labrenzia sp. 
PHM005; pederin, P. fuscipes symbiont; diaphorin, Candidatus Profftella armatura; onnamide A, T. 
swinhoei symbiont; psymberin, Psammocinia sp. symbiont; nosperin, Nostoc sp.; cusperin, Cuspidothrix 
issatschenkoi (top to bottom). Common core structure of the respective polyketides is colored red. B) 
Alignment (aa) of putative ECH1 domains from the first PKS in onnamide A, nosperin, cusperin, pederin, 





2.3.2. Sesbanimide gene cluster 
During this thesis, two additional marine bacterial genomes that contained a trans-AT 
polyketide cluster strikingly similar to lab cluster were sequenced. S. indica PHM037 was isolated 
from the sponge Pandaros acanthifolium collected in the Caribbean Sea (Martinique Island) in 
October 2003 and L. aggregata PHM038 was isolated from the sponge belonging to the genus of 
Plakortis in Nosy Be (Madagascar) in November 2017. Both strains were sequenced as explained in 
Material and Methods 3.1. To explore the secondary metabolite gene clusters contained in the 
genomes of PHM037 and PHM038 strains the online platform of antiSMASH 5.0 was used. 
Genome mining revealed one almost identical trans-AT PKS cluster in both strains. Since the 
strains were producers of novel glutaramide-type polyketides, denominated sesbanimides, the 
cluster was named as sbn gene cluster. 
The region of 64 kb encodes a modular PKS, a mixed type I PKS/non-ribosomal peptide 
synthetase (PKS/NRPS), 16 auxiliary enzymes with assigned functions and 5 hypothetical proteins, 
possibly involved in sesbanimide biosynthesis. Figure 19A shows the sbn cluster delimited by the 
marginal genes shared by PHM037 and PHM038 and named alphabetically sbnA-W. Interestingly, 
the cluster comprises 19 genes homologs to the lab genes, hypothetical included, which is more 
than 80% of the sbn cluster. The sbn ORFs and their homologous protein are shown in Table 19. 
Based on comparative analyses, computational predictions, and the elucidated chemical structures 
of sesbanimide intermediates it has been proposed the sesbanimide assembly on a multi-domain 
modular PKS and PKS/NRPS with the assistance of several trans-acting protein components of the 
enzymatic complex (Figure 19B) based on the gene structure of PHM037.  
 
Table 19. ORFs from the sbn cluster and their closest homologues in the RefSeq database. 
ORF Protein/ 
gene 
putativefunction/homologue Origin Cover/identity 
% 
Accession number 
of a protein 
homologue 
SbnA AT/AH acyltransferase domain-containing protein Stappia indica USBA 352 100/97.82 WP_067221761.1 
SbnB 4’-PPT 4'-phosphopantetheinyl transferase  Stappia indica USBA 352 99/98.17 WP_067221763.1 
SbnC EST metallophosphoesterase  Stappia indica USBA 352 100/97.22 WP_067221764.1 
SbnD MT FkbM family methyltransferase Stappia indica USBA 352 100/94.03 WP_083202408.1 
SbnE P450 cytochrome P450 Stappia indica USBA 352 100/97.61 WP_083206337.1 






putativefunction/homologue Origin Cover/identity 
% 
Accession number 
of a protein 
homologue 
SbnG ACP acyl carrier protein Stappia indica USBA 352 100/98.77 WP_067221771.1 
SbnH KS polyketide beta-ketoacyl:ACP synthase Stappia sp. ARW1T 100/91.85 WP_120269013.1 
SbnI ECH enoyl-CoA hydratase/isomerase Stappia indica USBA 352 100/94.94 WP_067339094.1 
SbnJ AMT asparagine synthase (glutamine-hydrolyzing)  Stappia indica USBA 352 100/93.87 WP_067221776.1 
SbnK ACP acyl carrier protein Stappia sp. ARW1T 100/96.34 WP_120269016.1 
 
SbnL ABC cyclic peptide export ABC transporter Stappia indica USBA 352 100/96.33 WP_083202407.1 
SbnM ABC cyclic peptide export ABC transporter Stappia indica USBA 352 100/97.27 WP_097175571.1 
SbnN AT ACP S-malonyltransferase Stappia indica USBA 352 100/94.66 WP_097175572.1 
SbnO PKS SDR family NAD(P)-dependent 
oxidoreductase  
Stappia sp. ARW1T 100/88.66 WP_120269020.1 
SbnP OXY NAD(P)-binding domain-containing protein; 
monooxygenase 
Stappia indica USBA 352 100/96.50 WP_097175574.1 
SbnQ PKS/NRPS non-ribosomal peptide synthetase Stappia indica USBA 352 100/86.90 WP_067221787.1 
SbnR HYP1 prohibitin family protein Stappia indica USBA 352 100/97.92 WP_067221789.1 
SbnS ABC ABC transporter substrate-binding protein  Stappia indica USBA 352 100/92.36 WP_067221790.1 
SbnT HYP2 hypothetical protein Stappia indica USBA 352 97/94.37 WP_067221792.1 
SbnU HYP3 DUF697 domain-containing protein Stappia sp.ARW1T 100/97.17 WP_120269026.1 
SbnV HYP4 DUF697 domain-containing protein Stappia sp. ARW1T 99/86.78 WP_147421864.1 
SbnW HYP5 ParA family protein Stappia indica USBA 352 100/99.08 WP_097175579.1 
 
In analogy to biochemically characterized glutaramide assembly in gladiofungin molecule 
(Niehs et al., 2020), the loading module composed of the amidotransferase SbnJ and the ACP SbnK 
should be responsible for transferring the amino group from amino acid substrate, likely glutamine, 
to activated malonate. The complete glutaramide starting unit is further generated with the aid of the 
first two modules in the PKS SbnO. The loading module together with the unusual KS-B-ACP 
module are present in PKSs of other glutaramides, such as cyclohexamide (Yin et al., 2014), 
migrastatin, iso-migrastatin, dorrigocin (Lim et al., 2009), 9-methylstreptimidone (Wang et al., 
2013), and lactimidomycin (Seo et al., 2014). The remaining portion of the sesbanimide A core 
structure is assembled on the downstream SbnO modules. The last module contains tandem ECH 
domains and tandem ACPs as known from other trans-AT PKS modules that generate 
exomethylene branches (Helfrich and Piel, 2016; Piel, 2002). Both ACPs possess a distinctive motif 
DSxxxxxW identified as important for β-branching (Kosol et al., 2018). The genes sbnF-I encoding 





Figure 19. Proposed biosynthetic pathway for the assembly of sesbanimide polyketides. A) Genes 
comprising the sbn gene cluster for sesbanimide production. The homolog genes from the lab cluster are 
colored in green. B) Assembly of the polyketide core structure by PKS and PKS/NRPS multimodular 
complexes and trans-acting components: the loading module comprising amidotranferase (AMT) and 
associated acyl-carrier protein (ACP); β-branching cassette comprising hydroxymethylglutaryl-CoA synthase 
(HMGS), stand-alone ACP, ketosynthase (KS), enoyl-CoA hydratase (ECH); Baeyer-Villiger 
monooxygenase (BVMO). Other PKS domains indicated are ketoreductase (KR), dehydratase (DH), 
branching domain (B), non-elongating ketosynthase (KS0), methyltransferase (MT), condensation domain 
(C), adenylation domain (A), peptidyl carrier protein (PCP), thioesterase domain (TE). Trans-acting proteins 








An unusual feature of the sbn PKS is the additional large protein SbnQ comprising four PKS 
and one NRPS module, which do not correspond to moieties of previously reported sesbanimides. 
However, the fortuitous discovery of sesbanimide F carrying an extended lipoid moiety provides a 
rationale for this feature. The internal ester moiety of this congener is collinear with a split module 
comprising the SbnOQ interface and the monooxygenase SbnP, a module type recently shown to 
insert oxygen by Baeyer-Villiger oxidation resulting in ester formation (Meoded et al., 2018). The 
lipid moiety of sesbanimide F matches well to the subsequent PKS modules, but the compound 
lacks the final incorporation of an amino acid suggested by the terminal NRPS module of SbnQ, 
hypothetically an arginine according to NRPS2 Predictor (Röttig et al., 2011). 
2.3.2.1. PKS and hybrid PKS/NRPS similarities with other homologs 
Surprisingly, a comparative analysis of the modular architecture of SbnO revealed that the 
N-terminal glutaramide-forming modules, alongside with the loading module, and the C-terminal 
modules have originated from different gene clusters from different bacterial phyla (Figure 20). The 
loading module composed of AMT and ACP proteins, denominated SbnJ and SbnK, respectively, 
and the first three modules of SbnO, are architecturally identical to previously identified 
glutaramide polyketide clusters of cyclohexamide (Yin et al., 2014), migrastatin, iso-migrastatin, 
dorrigocin (Lim et al., 2009), 9-methylstreptimidone (Wang et al., 2013) and lactimidomycin (Seo 
et al., 2014) as well as in glutaramide clusters of several actinomycetes and Burkholderia spp. 
genomes (Stulberg et al., 2016). On the other hand, the last two modules of SbnO, comprising 
distinctive tandem ECH and ACP domains, are absent in the glutaramide clusters from 
Streptomyces and Burkholderia genomes. Moreover, protein identity analysis of downstream SbnO 
domains revealed similarities with the pederin-family gene clusters of labrenzin, pederin (Piel, 
2002; Piel et al., 2004d), nosperin (Kampa et al., 2013), and cusperin (Kust et al., 2018), as well as 





Figure 20. Protein identity and functionality comparisons of SbnO modules. A) Genetic scheme showing 
AMT, ACP and PKS from sbn cluster and characterized homologs in Streptomyces species. Sesbanimide C 
molecular structure (right) is shown in two colors; each color marks the moiety assembled on the respective 
PKS modules (the same color). B) Neighbor-joining tree based on the partial SbnO protein sequences 
included in the study (shadowed in grey) and the alignment with other homologous genes. Identified 
polyketides and their respective producers are indicated in bold. PKS domains (right) in homolog protein 
sequences are identified using TransATor (http://transator.ethz.ch).The scale shows evolutionary distances. 
Bootstrap values are indicated for each node. 
The across-genomes screening for the SbnQ homologues showed their presence in distant 
PKS clusters producing structurally different polyketides lacking glutaramide moieties. To 
investigate the genome distribution of SbnQ, a Neighbor-joining (Saitou and Nei, 1987) a 
phylogenetic analysis of the closest homologues was performed (Figure 21). Assuming OnnJ as a 
common ancestor from the onnamide cluster of the symbiont bacterium of T. swinhoei, it was 
poosible to find a clade of pederin-family gene clusters producing different polyketides, i.e., 
diaphorin in a bacterium symbiont of the plant pathogen D. citri (Nakabachi et al., 2013), pederin in 
a bacterium symbiont of the beetle P. fuscipes (Piel et al., 2004b), and labrenzin in Labrenzia sp. 
PHM005, as well as other orphan clusters of Azospirillum brasilense and Methylobacter 




as downstream PKS/NRPS in those clusters, forming hybrid polyketide complexes with divergent 
upstream PKSs. 
 
Figure 21. Neighbor-joining tree of SbnQ (PKS/NRPS) gene sequences, responsible for the assembly of the 
lipoid moiety of sesbanimide D (blue), and homologues. The characterized gene clusters are indicated in 
bold and their respective polyketide structures are shown (right). The scale shows evolutionary distances. 
Bootstrap values are indicated for each node. 
Moreover, when the modular architecture of SbnQ was compated with Lab13 from the lab 
cluster (Figure 22), it was observed that the order of domains in the corresponding modules is 
nearly conserved in both PKS/NRPSs and matches the assembly of lipoid moiety of sesbanimide F 
in S. indica PHM037. The sole modular difference detected in Lab13 is the lack of the second KS-
DH-ACP module, when compared to SbnQ. Such difference implies that the polyketide moiety in 
the missing labrenzin analog might be shorter by one malonate building unit. In addition, the final 







Figure 22. Scheme of the domain organization in Lab13 and SbnQ (PKS/NRPS). 
 
 
3. Growth and transcriptional analysis 
3.1. Growth properties of Labrenzia sp. PHM005 
In order to get the insights into the growth and physiological characteristics of this marine 
strain, several growth media were compared. Our results showed that Labrenzia sp. PHM005 is able 
to grow in the rich medium Marine Broth (MB) and in the defined medium Marine Basal Medium 
(MBM) containing glucose as carbon source and supplemented with vitamins as described in 
Material and Methods (chapter 1.2.1.) (Figure 23A). Labrenzin was detected by mass spectrometry 
in both media within the first 24 h of growth (Figure 23B). Although labrenzin was detected in 






Figure 23. Growth curves of Labrenzia sp. PHM005 and extracted ion chromatograms of culture extracts. 
(A) Strain is grown in Marine Broth (MB) and modified Marine Basal Medium (MBM) supplemented with 
different vitamin mixtures as indicated in the legend. (B) MS chromatograms showing the labrenzin 
extracted from different media after 24 h of cultivation (from up to down): MB; MBM; MBM + VIT; MBM 
+ B + T; MBM + Biotin; MBM + Thyamine; standard. Results represent the means of three replicates. 
Additionally, it was tested the growth on different sources of carbon, as the sole carbon 
source, such as citrate, glutarate, benzoate and cyclohexane (Figure 24). The results showed that the 
strain PHM005 could only grow in citrate and glutarate, although it did not exceed an optical 
density of 1. 
 
Figure 24. Growth monitoring of Labrenzia sp. PHM005 up to 144 h in MBM+VIT medium with different 





The growth requirement of NaCl was tested as an important growth factor for marine 
bacteria, starting from 20 g/L, an amount similar to that contained in commercial MB (19.45 g/L of 
NaCl). MB was used since this marine bacterium was unable to grow in the conventional LB 
medium currently used for E. coli in the lab. To determine the minimal NaCl concentration the cells 
were cultivated in the presence of increasing concentration of NaCl. The NaCl effect on the growth 
of Labrenzia sp. PHM005 is shown in Figure 25. 
 
Figure 25. Growth of Labrenzia sp. PHM005 culture after 24 h in MBM+VIT medium supplemented with 
different concentrations of NaCl. Results represent the means of three replicates. 
To conlcude, the optimal medium chosen for the successive cultivations of Labrenzia sp. 
PHM005 wt strain and mutant strains was MBM+VIT medium modified to contain 20 g/L of NaCl 
and 0.2% of glucose as carbon source; and M2 medium as a modified MBM+VIT medium with 
only difference being 2.0% of glucose. 
3.2. Gene transcription analyses 
3.2.1. Transcriptomics and identification of transcription initiation sites 
The transcriptional activity of lab cluster genes was tested on MBM+VIT medium. Figure 
26 shows the expression levels of lab cluster genes and the housekeeping genes in the early 
exponential phase. All lab cluster genes are expressed suggesting that these genes are activated 
during the exponential phase of growth and none of them remain silent. Interestingly, some of the 
hypothetical proteins were upregulated under this growing condition, such as Hyp4, Hyp5 and 




function. Pfam analysis revealed three transmembrane motifs (45-71 aa; 92-113 aa; 119-140aa) and 
IUPred2A web interface appointed to two protein disorder motifs at N and C-terminal side of the 
protein. Disordered segments characterize flexible conformations whose properties depend on 
environmental changes, as redox potential, or binding of other proteins (Mészáros et al., 2018). 
Hyp5 is a 289 aa prohibitin-family protein with SPFH/Band-7 family domain and a transmembrane 
motif (20-41 aa) according to Pfam database. This protein is phylogenetically related to stomatin-
like integral membrane domain proteins (Tavernarakis et al., 1999). Another upregulated 
hypothetical peptide, Hyp6, is the smallest of only 65 aa and characterized with two transmembrane 
motifs (6-24 aa; 31-52 aa). In line with the domain analysis, these upregulated proteins might be 
involved in regulation of lab cluster or the polyketide transport. 
 
Figure 26. Lab cluster gene expression levels in early exponential phase cultured in MBM+VIT medium. 
The order of the bars follows the order of the genes (from left to right). The results represent the mean of 
three replicates. Blue bars represent housekeeping genes RpoD and ProC. 
In addition to transcriptomics analysis, the cappable-seq method was employed for the 
identification of transcription initiation sites (TSS), or +1 sites, with the aim to localize the 
promotor regions within the lab cluster and confirm which genes were organized in operons. Table 




predicted by online tool BPROM (www.softberry.com) and manually inspected RBS. Figure 27 
shows the scheme of the lab genes‟ transcription. Based on the TSS and genes localizations, the 
possible operons of the lab cluster would comprise: 1) Hyp2-Hyp3-Hyp4; 2) Hyp5-ABC1; 3) Hyp6-
HMGS; 4) OR5-MT6; 5) AT9-OR8-P450; 6) PKS13-KS12; 7) PKS15-OXY14; 8) ABC18-ABC17. 
 
Figure 27. Scheme representing the lab cluster and TSSs. Direction of the transcription is shown by the 
direction of the arrow. 
 
Table 20. Cappable-seq identification of transcription initiation sites (TSSs) and bioinformatics predictions 
of RNA polymerase binding sequences and ribosome binding sequences (RBS). 
Genes TSS Strand -10 box (score) -35 box 
(score) 
RBS (position) 
Hyp1 776,746 + ATGTTTAAT (44) TTGCCT (56) AGAACGGG (-4) 
Hyp2/ 
Hyp3 
777,937 + TTGTACTAT (57) TTGCTC (31) GAGAATCAGCAGAGCCAAGAA (-4) / 
AAAACGGGCGCTGAG (-4) 
Hyp4     AAAACAGGAGA (-6) 
Hyp5/ 
ABC1 
780,616 + TGTTATCCT (65) AAGCAA (12) GGACG (-4) /  
GGCGAAG (-1) 
ACP2 783,366 - TGCTTCAAT (34) CTGCCG (20) AAGAACAACCCCAGGGACGCAACA (-3) 
Hyp6/ 782,594 + AGACAAACT (34) TCGAAA (23) AAAGGAGA (-8) 
HMGS3     AGGGAGAGTG (-7) 
PKS4 784,686 + GGATATCAG (23) TTGCCG (55) AGAGCAAAAGAGCCGGG (-10) 
OR5-
MT6 





804,336 - CCTTACAGT (35) TTCAAA (40) GGAC (-8) /  
GAGGCGG (-5) /  
GGGAGCGCAA (-5) 
AT10 804,396 + CGCTATCAT (66) GTGAGT (5) AGGTTCGAG (-1) 
ECH11 806,354 - ATTTAATCT (50) GTGCCT (23) AGGG (-1) 
PKS13/ 
KS12 
825,420 - CAGGATGAT (24) TTGTCG (47) GAAAGCCCAGG (-1) ; GGGAGATG (-5) ; 
GAAGCCGAG (-4) * / AACAACAG (-4) 
PKS15/ 
OXY14 
851,097 - GGCCAGGAT (26) TTGCTC (31) GGAAAG (-7) /  
GGGAGGGCGTTGAGG (-2) 
MT16 852,103 - TGTTAGGAT (60) TTGCCA (61) AAGGAAAAGA (-4) 




Genes TSS Strand -10 box (score) -35 box 
(score) 
RBS (position) 
ABC17   AGCTATAAA (45) ATGATG (22) GAAGGAAGGGACATGAAAA (-1) 
PPT19   CGGTACTAT (60) TTCTAA (27) GGAT (-8) 
*alternative RBSs 
3.2.2. Activity of the Pn (lab4) promoter in the presence of chemical elicitors 
Among different approaches for inducing the silent gene cluster, sub-inhibitory 
concentrations of antibiotics showed positive effect on various metabolic phenomena, such as 
transcription activation, activation of the quorum sensing regulators, biofilm production or 
activation of the biosynthesis of the cryptic natural products (Zarins-Tutt et al., 2016). During this 
work it was established a screening method in Labrenzia sp. PHM005 for the effectors of the 
promoter activity. For the proof of concept, the promoter P14g from pSEVA227M_p14g (kind gift 
from Gonzalo Durante) was replaced with a native promoter (Pn4) from the lab cluster (lab4), 
situated between lab3 and lab4 gene (see Figure 27), to construct a pSEVA227M_Pn4.  
Plasmid pSEVA227M_p14g has a few convenient updates for the screening process (Figure 
28). The strong promoter P14g is a derivative of PLac promoter engineered to be unaffected by LacI 
represor. AG-rich bicistronic RBS was designed to ensure improved translation of GFP. Finally, the 
monomeric super folder Green Fluorescent Protein (msfgfp) was especially engineered to be able to 
assemble correctly in adverse conditions. All three factors contribute to emitting stronger 
fluorescence.  
 
Figure 28. Scheme showing DNA extraction from the pSEVA227M_p14g zooming the promoter P14g, 
bicistronic linker and partial sequence of the GFP (left to right). 
As previously shown (Figure 26), the transcription level of lab4 gene encoding the first PKS 
responsible for the intiation of labrenzin biosynthesis was relatively low under cultivation in 
MBM+VIT (0.2% glucose) medium. The fluorescence of the GFP expressed from Pn and P14g 
promoters (Figure 28) was even visible at the white light from the pellets of transforrmed Labrenzia 




29B). Purple light, as a part of visible light, does not have damaging effect on the cells, therefore is 
a great tool for manual screening directly from the plates or the culture pellets. 
 
Figure 29. GFP expression in Labrenzia sp. PHM005 (pSEVA227M_Pn4) (under Pn promoter) (2) and 
Labrenzia sp. PHM005 (pSEVA227M_p14g) (under P14g promoter) (3). Labrenzia sp. PHM005 (1) was used 
as a control. A) white light; B) blue light. 
Some toxic compounds added in sub-inhibitory concentrations do not inhibit the growth of 
bacteria but might increase the levels of gene expression as an indirect consequence of intervening 
in the other metabolic pathways (Goh et al., 2002). As a proof of concept, different antibiotics such 
as trimethoprim, piperacillin, tylosin tartrate, and cephaloridine, were used. The cultivation of 
Labrenzia sp. PHM005 (pSEVA227M_Pn4) strain in 10 mL of M2 medium was monitored every 
24 h during 4 days. The expression difference between the different conditions faded as the 
bacterium entered the stationary growth phase somewhere between 48 h and 72 h of cultivation 
(Figure 30A). All compounds tested significantly increased the transcriptional activity of the Pn4 
promoter (p<0.05) at 24 h of cultivation, i.e., in the exponential growth phase, with trimethoprim 





Figure 30. The transcriptional activity of the Pn4 promoter expressed as relative fluorescence in the presence 
of trimethoprim, piperacillin, tylosin tartrate and cephaloridine during the cultivation of Labrenzia sp. 
PHM005 (pSEVA227M_Pn4) in M2 medium. A) GFP expression during 96 h of cultivation. B) GFP 
expression at 24 h. Significant data is considered for *p<0.05 and **p<0.005. Data represents the means of 
three replicates. 
 
These results not only show the modifications of the transcriptional activity of Pn4 promoter 
in the presence of the elicitors but also reveal that this promoter has the highest activity during the 
exponential growth phase. 
The next step was to measure the labrenzin production in the wt upon the addition of the 
elicitors in order to investigate the correlation between the gene transcription and the polyketide 
production. Figure 31 shows that the production of labrenzin was not significantly increased in the 






Figure 31. Production of labrenzin in Labrenzia sp. PHM005 after 72 h of cultivation in M2 medium 
expressed as the peak area obtained from MS. The means of three replicates are shown. 
4. Functional genetic study of the lab cluster 
A putative gene cluster responsible for the synthesis of labrenzin, the lab cluster, has been 
identified and characterized in silico (see Results chapter 2), showing that it encodes a trans-AT 
mixed type PKS/NRPS biosynthetic pathway that is almost identical to gene clusters responsible for 
the synthesis of pederin-family compounds. The cluster consists of a 79-kb region comprising three 
genes encoding multidomain hybrid polyketide synthase/non-ribosomal peptide synthetase 
(PKS/NRPS) proteins (Lab4, Lab13, and Lab15), and 16 auxiliary enzymes (Table 18). Since this is 
the first time a pederin gene cluster is identified in a cultivable bacterium, one of the main 
objectives of this doctoral thesis was to functionally characterize the lab cluster genes. 
4.1. Assembly of the polyketide backbone 
Firstly, it can be important to understand the polyketide backbone synthesis and to 
determine the key biosynthetic enzymes. Moreover, it was interesting to find the final product of the 




4.1.1. Functional assignation to lab gene cluster 
To investigate the association between the described gene cluster and the production of 
labrenzin a gene knockout was perfomed by homologous recombination where the sequence 
comprising the putative promoter region of the gene encoding PKS Lab4 and the region encoding 
the GNAT domain of the first module of Lab4 was deleted to generate a non-producing mutant 
Δlab4. This strain can be also used as a negative control strain for future experiments. 
The analyses of the culture extracts of the wt and mutant strain are shown in Figure 32A–C. 
As expected, the mutant strain was unable to produce labrenzin. The gene expression analysis 
performed with the mutant strain suggested that the deletion produces a polar effect on the 
expression of the genes encoding the putative oxidoreductase (Lab5) and the methyltransferase 
(Lab6) that are located downstream of the lab4 gene encoding a PKS, suggesting that the three 





Figure 32. Extracted ion chromatograms of the supernatant extracts obtained after 72 h of cultivation of 
Labrenzia sp. PHM005 in MBM+VIT medium: A) labrenzin standard; B) wt; C) Δlab4 mutant. D) RT-PCR 
analysis of the mRNA expression of lab gene cluster in the Δlab4 mutant cultured in MBM+VIT medium. 








In the early attempts to clone the entire lab cluster for its heterologous expression in other 
model microorganism a 16 kb fragment of the cluster comprising operon lab4-lab5-lab6 has been 
amplified by PCR and cloned into pSEVA338 plasmid (see Material and Methods section 7.2.1). 
The resulting plasmid was named pSEVA338_lab4-lab5-lab6. This 16-kb construct can be used to 
complement the non-producing Δlab4 mutant strain and evaluate the expression and production of 
such a complex protein in a plasmid. For that purpose, an additional modification of the plasmid 
was made by switching the original Pm promotor of pSEVA338 plasmid for the native lab4 Pn4 
promoter. The resulting plasmid was named pSEVA338_Pn_lab4-lab5-lab6. 
The experiment was set up considering two different physical conditions, i.e., temperature 
and shaking. The three PHM005 strains used in this experiment were: 1) wt; 2) Δlab4 
(pSEVA338_Pn_lab4-lab5-lab6); 3) Δlab4 (pSEVA338_lab4-lab5-lab6). Strains were cultured in 
MBM+VIT medium as described in Material and Methods 1.3. The strain Δlab4 (pSEVA338_lab4-
lab5-lab6) was cultivated with or without the addition of inducer 3-methyl-benzoate (0.2 mM) at 
the exponential phase. 
Figure 33 shows the relative abundance of labrenzin in different conditions. The results 
indicate that the production of labrenzin is somewhat better in the strains where lab4-lab5-lab6 
operon is expressed from the native Pn4 promoter. Nonetheless, the expression in the complemented 
strains did not reach the labrenzin levels produced in the wt strain. The results observed under 
higher temperature and shacking showed a very low labrenzin production in all complemented 
strains when compared to the production of wt. It is worth to mention that the labrenzin production 
by wt was higher under higher temperature and shacking (1.15E5 peak intensity) compared to the 






Figure 33. Production of labrenzin expressed as a relative abundance of MS extracted m/z = 512 ion peak 
intensity in different conditions. A) 72 h cultivation of strains in MBM+VIT with rotation set to 2.5 (New 
Brunswick Scientific Co. Gyrotory Water Bath Shaker Model G76) and 19 °C. B) 72 h cultivation of strains 
in MBM+VIT with shaking at 200 rpm (New Brunswick Innova® 44/44R) at 30 °C. Labrenzin production 
by: wt Labrenzia sp. PHM005 (blue), mutant Δlab4 (pSEVA338_Pn_lab4-lab5-lab6) (green), mutant Δlab4 
(pSEVA338_Pm_lab4-lab5-lab6) not induced (red), mutant Δlab4 (pSEVA338_lab4-lab5-lab6) induced 
(black). 
After sequencing and analyzing the the cloned region, one-point mutation was observed in 
PKS Lab4 coding gene resulting in the change of a threonine (codon ACC) by an isoleucine (codon 
ATC), but as this residue is not part of any conserved domain of the PKS Lab4, it should not be 
considered significant. 
4.1.2. Trans-acyltransferases 
The functional PKS type I modules consist of catalytic domains that are essential for the 
assembly and elongation of the polyketide, like KS, ACP and AT (see Introduction chapter 2.1.1). 
In trans-AT PKS, though, ATs are individual enzymes that interact with the modular ACP domains 
by selecting and loading the appropriate acyl-unit in trans. The lab cluster consists of two trans-





4.1.2.1. Trans-AT/hydrolase Lab9 mutation 
Lab9 is a trans-AT enzyme annotated as an acyltransferase domain-containing protein. Its 
homology with PedC suggested that it might play the same role as PedC as a broad substrate-editing 
enzyme in labrenzin biosynthesis. On the other hand, Lab10, an ACP-S-malonyltransferase, was 
hypothetized to be a malonate-unit loader. In order to test that hypotesis in labrenzin biosynthesis, 
the lab9 gene was inactived and complemented in trans. 
The lab9 gene was deleted by homologous recombination generating the mutant strain 
Δlab9 to test whether the coding trans-AT was essential for the labrenzin biosynthesis. The 
labrenzin production was reduced about one order of magnitude in the mutant strain (Figure 34A). 
Surprisingly, the complementation in trans of the mutant strain Δlab9 with plasmid 
pSEVA227M_lab9 did not restore the labrenzin levels of wt (Figure 34B).  
 
Figure 34. Labrenzin production in PHM005 wt, and mutant strains Δlab9 and Δlab9 (pSEVA227M_lab9). 
A) MS ion extraction (m/z =512) showing the relative abundance of labrenzin produced by the strains after 
72 h of cultivation in M2 medium. B) Abundance of labrenzin expressed as peak area obtained from the MS 




4.1.2.2. Simultaneous overexpression of Lab9 and Lab10 in the wt strain 
In order to improve labrenzin yields, both ATs (Lab9 and Lab10) from the lab cluster were 
cloned in a promoter-less middle-copy plasmid pSEVA331 yielding plasmid pSEVA331_AT9-10 
that was subsequently transferred to the wt strain. The region (2382 bp) comprising the lab9 and 
lab10, that are transcribed in opposed directions, containing their respective promoter regions was 
amplified by PCR and cloned in plasmid pSEVA331 to create plasmid pSEVA331_lab9_lab10. 
The culture supernatants were collected after 72 h of cultivation in M2 medium followed by the 
extraction and HPLC/MS analysis for the production of the polyketides. The results are shown in 
the (Figure 35). The recombinant strain wt (pSEVA331_lab9-10) did not show any significant 
increase in the production of labrenzin 1 and labrenzin analogs 2 and 3, as identified previously by 
PharmaMar (personal communication) when compared to the wt, but was somewhat higher when 





Figure 35. Production of labrenzin analogs in PHM005 strains wt, wt (pSEVA331_lab9-10) and wt 
(pSEVA331). A) MS chromatograms showing extracted ions in the range of m/z = 468-512 and 
intermediates 1 (m/z = 468), 2 (m/z = 498) and 3 (m/z = 512) of labrenzin biosynthesis obtained from the 
culture extracts after 72 h of cultivation in the M2 medium. The area of each peak is indicated above. B) 
Abundance of labrenzin analogs expressed as peak area obtained from the MS spectra. Results represent 
means of three replicates. 
4.1.3. Cryptic polyketide moiety synthesis 
The lab cluster contains one PKS, Lab4, and two hybrid PKS/NRPSs, Lab13 and Lab15. 
While Lab 4 and Lab15 are responsible for the biosynthesis of the labrenzin structural core, the 
polyketide moiety expected to be synthetized by Lab13, has remained cryptic until now. 
Interestingly, the Lab13 homologs are conserved in numerous orphan gene clusters distributed 




in sesbanimide F produced by S. indica PHM037 during this doctoral thesis and according to the 
conserved domain architecture between Lab13 and SbnQ (Figure 22), it should be identified some 
labrenzin analog intermediates in Labrenzia sp. PHM005 cultures similar to onnamide or similar to 
sesbanimide F. 
4.1.3.1. Identification of labrenzin in the cytosol 
Since it is only possible to predict the molecular structure of the unidentified labrenzin 
intermediate (onnamide- or sesbanimide F-like intermediates) by computation, without knowing the 
exact molecular mass and fragmentation pattern, its ion extraction in total MS scans is unreliable. 
Assuming that the final molecule (onamide-like) is completely synthetized by PKS, released and 
later processed by hydrolysis into at least two molecules, labrenzin and a residual moiety, several 
possible scenarios can be proposed. 
One scenario is that the whole molecule was fragmented in two parts during its 
transportation outside the cells as a result of transport cleavage. The residual moiety could remain 
bound to the cell membrane, which can explain the absence of the residual moiety in the culture 
extracts. In that scenario, labrenzin would only be detectable in the culture supernatant, but not in 
the internal cytosol. 
A second scenario can be that whole molecule is processed inside the cells and thus, 
labrenzin should be detectable in the cytosol. 
In order to test these hypotheses, the previously constructed non-producing mutant Δlab4 
was used as a control together with wt strain to analyze the presence of labrenzin in the cytosol by 
HPLC/MS. A purified labrenzin was also added to the Δlab4 cultures to check if labrenzin can be 
uptaken by the cells. The extraction of intracellular metabolome was performed after cell rupture by 
applying high-pressure as described in Materials and Methods 12.1. Figure 36 shows that labrenzin 
can be detected in the wt cytosol indicating that the large polyketide product is likely hydrolyzed 
intracellularly. The absence of labrenzin in the cytosol of Δlab4 when it was added to the culture 
medium suggests that labrenzin cannot be uptaked by the cells. Thus, the possibility that the 






Figure 36. MS ion extraction m/z = 512 of different intracellular extracts obtained after 72 h of cultivation in 
MBM+VIT medium of wt, Δlab4 mutant and Δlab4 mutant supplemented with pure labrenzin 
(Δlab4+labrenzin). 
4.1.3.2. Functional analysis of lab13 gene 
It has been hypothesized that the complete onamide-like product has to be synthetized and 
released from the enzymatic complex, to be further processed into labrenzin and the other residual 
moiety. However, another possibility could be that labrenzin could be released from the enzymatic 
complex before the whole molecule is synthesized as the result of a translocation fail of the 
intermediate between Lab15 and Lab13 PKS/NRPs units. If this was the case perhaps, the final 
Lab13 PKS/NRPs unit could not be necessary to produce labrenzin. Even more, the absence of 
Lab13 unit could favor such fail and further increase the production of labrenzin. 
In order to test this hypothesis, a mutant strain Δlab13 was constructed carrying a complete 
deletion of lab13 gene. The culture supernatants were collected after 72 h of cultivation in M2 
medium followed by the extraction and HPLC/MS analysis for the production of the polyketides. 
Figure 37 shows that Δlab13 mutant lacking the third PKS/NRPS unit does not produce labrenzin 
nor the other two labrenzin analogs identified previously by PharmaMar (personal communication). 
This result demonstrate that Lab13 is required for the synthesis of labrenzin, but in addition it 






Figure 37. MS chromatograms showing extracted ions in the range of m/z = 468-512 with intermediates 1 
(m/z = 468), 2 (m/z = 498) and 3 (m/z = 512) of labrenzin biosynthesis obtained from the wt and Δlab13 
mutant culture extracts after 72 h of cultivation in M2 medium. 
4.1.3.3. Cryptic labrenzin intermediate screening 
Labrenzin absorption at any of the tested wavelengths (210 nm, 215 nm, 254 nm, 260 nm, 
300 nm and 350 nm) is very low. This is the reason why labrenzin and other intermediates can be 
only monitored using mass spectrometry. On the other hand, molecules with higher content of 
double bonds like onnamide-like polyketides (Matsunaga et al., 1992) generally present acceptable 
adsorption levels at wavelengths of 260-350 nm. In order to find onnamide-like molecules the UV 
chromatograms of wt and Δlab13 culture extracts were compared (Figure 38 and Figure 40). 
A new different peak was detected at 260 nm at 41 min in the wt extract, as compared to 
Δlab13 extract, indicating a more hydrophobic molecule than the known labrenzin intermediates 
(Figure 39). Interestingly, the peak was not visible in the extract of Δlab13 mutant strongly 
indicating it could be related to labrenzin biosynthesis. However, there is no difference between the 






Figure 38. UV chromatograms at 210 nm of wt and Δlab13 mutant culture extracts obtained after 72 h of 
cultivation in M2 medium. 
 
Figure 39. UV chromatograms at 260 nm of wt and Δlab13 mutant culture extracts obtained after 72 h of 






Figure 40. UV chromatograms at 350 nm of wt and Δlab13 mutant culture extracts obtained after 72 h of 
cultivation in M2 medium. 
MS spectrum showed in Figure 41 revealed a peak at the same retention time with a 
dominant ion m/z = 840 and a less intensive ion m/z = 389. The chemical structure of the unknown 
molecule that would correspond to a molecular mass (in addition with Na
+
) of 840, is proposed 






Figure 41. HPLC/MS analysis of the wt culture extracts obtained after 72 h of cultivation in M2 medium. A) 
UV chromatogram at 260 nm and MS extraction of ion m/z = 840. B) Ion fragmentation of the extracted 
peak and the possible chemical structure of the molecule. 
4.1.3.4. Functional analysis of the thioesterase domain (TE) 
Although previous results indicated the third PKS/NRPS Lab13 was essential for the 
production of labrenzin, bearing in mind that almost the complete gene was eliminated (≈16 kb), it 
casted doubt on a correct enzymatic complex assembly due to the absence of the last unit. This is, 
the Lab13 deletion might had prevented or altered the correct formation of the partial 
multienzymatic complex bewteen the PKS Lab4 and PKS/NRPS Lab15 units. 
To ensure the correct conformation of the entire multi-enzymatic complex, the activity of 
the thioesterase (TE), the last domain of the last module of Lab13, responsible for the polyketide 
release, was specifically eliminated by performing a minimal genetic modification. The serine of 
the catalytic center composed by the Ser-Asp-His triad, well known in the esterase family proteins 
(Schneider and Marahiel, 1998), was changed by a less reactive alanine resulting in the construction 
of the lab13TES>A mutant. The Ser to Ala change is known to to disrupt the catalytic activity in 




1991). Using the SWISS-MODEL Server (https://swissmodel.expasy.org/) the model of the Lab13 
TE domain was obtained and identified the Ser67-Asp94-His217 triad (Figure 42). 
 
Figure 42. SWISS-MODEL of the Lab13 TE three-dimensional conformation. A) Spacefill model of TE 
with QMEAN color scheme showing the catalytic pocket from the side-left and right and indicating the 
active serine site. B) Cartoon model of TE in white color and zoom in of the amino acid triad Ser-Asp-His. 




The construction of the lab13TES>A mutant would allow to determine if labrenzin is 
produced only after the final onnamide-like product is relased from the multi-enzymatic complex or 
labrenzin can be produced before this release. The culture supernatants were collected after 72 h of 
cultivation in M2 medium followed by the extraction and HPLC/MS analysis for the production of 
the polyketides. The HPLC/MS analysis of the lab13TES>A culture extracts, as opposed to wt, 
showed a drastic reduction in production of labrenzin and the analog intermediates most probably 
due to the strong reduction of TE activity (Figure 43). Interestingly, although the labrenzin and 
other intermediates were present in the extracts, the 840 ion was not detectable in the lab13TES>A 
culture extract (not showed in the figure). On the other hand, the presence of different peaks 
indicates the possibility of the premature release of stalled intermediates. All these results suggest 
that the synthesis and release of the complete onnamide-like molecule is critical for the maximum 
yield of labrenzin and that the ester hydrolysis happens after the release from the PKS/NRPS 
complex. 
 
Figure 43. MS chromatograms showing extracted ions in the range of m/z = 468-512 with intermediates 1 
(m/z = 512), 2 (m/z = 498) and 3 (m/z = 468) of labrenzin biosynthesis obtained from the wt and 
lab13TES>A culture extracts after 72 h of cultivation in M2 medium. The abundance of the lab13TES>A 




4.2. Analysis of the polyketide modifications by tailoring enzymes 
Tailoring in polyketide biosynthesis consists in the additional reactions catalyzed by 
independent enzymes that modify the core polyketide intermediate synthetized by PKS and 
therefore contributes to the structural and functional versatility of the natural products. Different 
tailoring processes can be observed, but according to the modifying enzymes, they can be classified 
in two general categories. On-line tailoring enzymes are trans-acting enzymes that engage with the 
multi-enzymatic PKS/NRPS complex and perform modifications during the core intermediate 
synthesis, like β-branching enzymes in trans-AT PKSs (Calderone, 2008) or amino acid 
heterocyclizations in NRPSs (Sundaram and Hertweck, 2016), while the other tailoring enzymes 
allow the post-PKS modifications such as hydroxylations and methylations (Han et al., 2018; 
Mohammad et al., 2018). In line with the objectives of this thesis, several functional genetic 
analyses were perfomed to determine the chemical role of the tailoring enzymes and the essentiality 
for the synthesis of the products. Additionally, a wide spectrum of new labrenzin analogues have 
been prepared as potential new candidates for future drug developments. 
4.2.1. HCS cassette β-branching enzymes 
The most common feature of trans-AT PKS systems is the presence of single AT enzymes 
that incorporate α-carbon branches, such as methylmalonyl, into a growing polyketide chain. 
However, trans-AT PKS clusters often encode other freestanding enzymes that can introduce 
unusual β-branches. Those enzymes form the so-called β-branching cassette, usually composed of 
stand-alone hydroxymethylglutaryl-CoA synthase (HMGS), non-elongating ketosynthase (KS
0
), 
acyl carrier peptide (ACP) and one or two enoyl-CoA hydratases (ECH). The first evidence of the 
β-branching mechanism in a polyketide biosynthesis was demonstrated biochemically in the 
bacillaene cluster (Calderone et al., 2006). Since then, there were numerous reports of examples of 
HCS cassettes, contributing to the polyketide diversity like in myxovirescin (methoxymethyl and 
ethyl branches), pederin/onnamide (exomethylene group), bryostatin (acrylic ester), curacin 
(cyclopropyl group), mupirocin (methyl), leinamycin (1,3-dioxo-1,2-dithiolane moiety) and 




The key role in these processes holds HMGS since it is in charge of performing a complex 
aldol addition and the substrate selection. To explore the functional role of HMGS, it was generated 
a deletion mutant Δlab3 expecting to produce a different labrenzin intermediate. Surprisingly, the 
Δlab3 strain did not produce labrenzin suggesting an essential role of HMGS in labrenzin assembly, 
and a clear interaction with the PKS domains (Figure 44). 
 
Figure 44. MS chromatograms show extracted ion m/z = 512 (labrenzin) of the supernatant extracts obtained 
after 72 h of Δlab3 cultures cultivation in M2 medium. 
 
Next, a double deletion mutant Δlab11-Δlab12 with both ECH (lab11) and KS (lab12) 
inactivated was constructed to investigate their implication in labrezin β-branching. The engineered 
strain was unable to synthetize labrenzin (Figure 45). The deletion was complemented by co-
expressing both enzymes and by expressing each one separately. The labrenzin production was 
recovered after complementation with both functional enzymes, as expected, and with Lab11 alone. 
A complementation only with Lab12 was unsuccessful. This experiment suggests a crucial role of 
lab11 gene in labrenzin assembly, but not for lab12. These results indicated the possible 
redundancy of the ketosynthase. Alternatively, it might be involved in downstream processing of 





Figure 45. MS chromatograms showing extracted ion m/z = 512 (labrenzin) of the supernatant extracts 
obtained after 72 h of culturing the indicated strains in M2 medium. 
According to the results obtained from Δlab3 and Δlab11-Δlab12 mutants, it can be 
concluded that at least HMGS and ECH play essential roles in the early assembly of labrenzin. 
4.2.2. Methylations 
The early studies on pederin gene cluster proposed a position-specific methylation for each 
methyltransferase encoded in the pederin (ped) gene cluster (Piel, 2002; Zimmermann et al., 2009). 
Ped cluster comprises three MTs (PedA, PedE and PedO) while lab cluster has only two MTs (Lab6 
and Lab16). In comparison with pederin that has four methoxy groups, labrenzin has only three 
methoxy groups, lacking the 18-O-methylation (Figure 46). Since the pederin structure has four O-
methylations and the gene cluster only contained three MTs, it was assumed that one of them might 
have a double function. In vitro experimental analysis established that PedO was responsible for the 
methylation of the C18-OH group in pederin and it was hypothesized that PedA or PedE could have 
a dual function (Zimmermann et al., 2009). A protein homology comparison between MTs from 
labrenzin, pederin and diaphorin showed that Lab16 shares 51% identity with PedE, while Lab6 
shares 47% identity to PedA. Diaphorin, on the other hand, has only one O-methyl group that is 




orthologs (Nakabachi et al., 2013). In this sense, the identity between DipM and PedE is 60%. 
According to these sequence comparisons, Lab6 and Lab16 seem to be the functional analogs of 
PedA and PedE, respectively. 
It is important to notice that the wt PHM005 strain mainly accumulates two methylated 
intermediates in the supernatant, i.e., labrenzin (1) with two methylation on C6 and C17 and an 
analog (2) missing the O-methyl group on C17, as identified by PharmaMar (Figure 46). Curiosly, 
the analog with only one methyl group was barely detectable in the total MS scans. Therefore, it can 
be assumed that the methylations are produced sequentially, firstly and very quickly on both C6 and 
C10 and after that, the last methylation occurs on C17. However, this assumption does not inform 
about which one was the first methylation and which is the enzyme reposible for a dual methylation 
since several combinations are possible (see below). 
 
Figure 46. Chemical structure of pederin family polyketides. 
By overexpressing each one or both MTs in the wt PHM005 strain it would be possible to 
not only get an indication of the specific functions of each MT, but also test if it would be possible 
to improve the methylation of the final product and thus increase the labrenzin production. One 
would expect to notice a reduction in the 17-O-demethylated analog (2) when the specific 
methylase for C17 was overproduced. The recombinant culture supernatants were collected after 72 
h of cultivation in M2 medium followed by the extraction and HPLC/MS analysis for the 




encoding the MTs in the PHM005 wt strain. Surprinsingly, when compared to wt, the ratio of 1 and 
2 analogs did not change significantly when lab6 and/or lab16 genes were overexpressed. These 
experiments might suggest that the MT activities in wt strain are naturally saturated, but it cannot be 
discarded that the overexpressed MTs were not functional. 
 
Figure 47. Overexpression of MTs encoded by lab6 and lab16 genes in the PHM005 wt strain. MS 
chromatograms showing extracted ions m/z = 512 (1) (labrenzin) and m/z = 498 (2) (17-O-demethyl 
labrenzin analog) of the supernatant extracts obtained after 72 h of culture in M2 medium.  
In order to clarify these results, the deletion of each one or both MTs should provide a better 
information about their functions. In addition, by creating the mutants lacking the MTs it will be 
possible to test the functionality of the lab6 and lab16 genes by complementation. Moreover, it 
would be possible to create new demethylated labrenzin analogs, that will allow also to confirm if 






4.2.2.1. Function of Lab6 MT 
To determine the role of Lab6, the deletion mutant ∆lab6 was generated. The HPLC/MS 
analysis of the culture extracts of wt and ∆lab6 mutant revealed the accumulation of a new 
labrenzin intermediate (4) (Figure 48). The fragmentation pattern (m/z = 484; 394; 412) of this 
compound is characteristic of two previously identified compounds m/z = 498 and m/z = 512 (m/z 
= 498; 394; 412 and m/z = 512; 408; 426, respectively) and the molecular mass corresponds to 
labrenzin missing two –CH3 groups. In addition, the retention time of the intermediate is lower than 
the other two intermediates previously identified, (1) and (2), indicating that the new one is a more 
polar compound (see Material and Methods section 12.3), which perfectly aligns with a 
demethylated compound, i.e., having free –OH residues. Interestinlgy, this new intermediate has 
been already described as diaphorin, a natural product isolated from the symbiont of citrus pest D. 
citri (Nakabachi et al., 2013). Remarkably, this is the first time that diaphorin has been produced in 
a free-living bacterium using genetic engineering techniques.  
 
Figure 48. MS chromatograms of the supernatant extracts obtained after 72 h of ∆lab6 mutant and wt 
cultures in M2 medium showing extracted ions in the range m/z = 484-512. Intermediates 1 (m/z = 512), 2 




The lab6 mutation was complemented with plasmid pSEVA338_lab6 encoding a copy of 
Lab6. Figure 47 shows that both current labrenzin intermediates (1 and 2) are only partially 
recovered after complementation, suggesting that Lab6 is not fully functional when expressed in 
trans and explain the poor results observed in Figure 46. 
According to these results, it can be proposed that Lab 6 plays a dual function by 
methylating both C10 and C17 positions (Figure 49). Moreover, taking into account that the 
intermediate 2 is demethylated at C17 position, it can be proposed that methylation at C17 is 
produced only after methylation of C10. In addition, since a diaphorin peak is not currently 
abundant in wt strain, it can be assumed that methylation at C10 is very efficient. 
 
Figure 49. Proposed enzymatic reactions catalyzed by Lab6 MT based on the products found in ∆lab6 
mutant strain. 
4.2.2.2. Function of Lab16 MT 
Once ascribed a dual function for Lab6, it could be deduced the role of Lab16 as the Mt 
responsible of C6 methylation. Nevertheless, a deleted mutant strain ∆lab16 was created to confirm 
this hypothesis. In addition, this will allow to determine if methylations occur strictly sequentially, 
i.e., if the methylations of C10 and C17 positions occur only after the first methylation takes place 




Remarkably, Figure 49 shows that the ∆lab16 mutant strain was able to accumulate several 
new compounds methylated by Lab6, which were undetectable in the wt strain. Interestingly, 
chromatograms showed an unexpected chiral separation of peaks after HPLC/MS analysis (Figure 
50). Enantiomers 5a and 5b have a molecular mass m/z = 484 that corresponds to methylation at 
C10 position conserving the typical fragmentation for methylated compounds (m/z = 484; 394; 
412). Isomers 6a and 6b have a molecular mass m/z = 498 with the characteristic ion fragmentation 
pattern (m/z = 498, 408; 426) for a labrenzin analog missing one methyl group at C6. Enantiomer 
6a overlaps with enantiomer 5b, which can complicate the isolation of both compounds in case they 
will be required for physiological activity assays. 
The complementation of the ∆lab16 mutant strain with the pSEVA338-lab16 plasmid 
carrying a copy of MT Lab16 was only partial. As occured with Lab6 MT the expression of Lab16 
MT in trans does not seem to be efficient. 
The chemical reactions catalyzed by Lab6 in the ∆lab16 mutant strain and the intermediates 







Figure 50. MS chromatograms of the supernatant extracts obtained after 72 h of mutant ∆lab16 and wt 
culture cultivation in M2 medium showing extracted ions in the range m/z = 484-512. Intermediates 1 (m/z = 
512) and 2 (m/z = 498) produced by wt are shown. New intermediates 5a and 5b (m/z = 484), 6a and 6b (m/z 







Figure 51. Enzymatic reactions catalyzed by Lab6 MT in ∆lab16 mutant strain. 
These experiments suggest that the methylations at C10 and C17 positions can be produced 
by Lab6 independently of the existance of a previous methylation at C6 position by Lab16. 
Nevertheless, these results do not exclude a preferred methylation order that could be ascribed to 
the different catalytic parameters for the different intermediate substrates according to their 
dissimilar accomadation in the catalytic centers of both MTs. 
 
4.2.2.3. Construction of a double ∆lab6∆lab16 mutant 
To generate a completely demethylated labrenzin analog and to expand the list of possible 
drug candidates for the future applications, double ∆lab6∆lab16 mutant strain, where both MT 
coding genes have been deleted, was contructed. Figure 52 shows that this mutant is able to produce 
a completely demethylated labrenzin analog 7 with m/z = 470 following the familiar fragmentation 
pattern (m/z = 470; 394; 412) of labrenzin intermediates. As expeted, since this new compound is 
more polar compared to the other methylated derivatives, it is detected at a lower retention time. 
Interestingly, the relative abundance of the demethylated labrenzin analog, expressed as the ion 
intensity, was one order of magnitude below the intensity of labrenzin, produced by wt (1.98E4 vs. 
2.59E5). 
The recovery of the methylated analogs by complementation of ∆lab6∆lab16 mutant strain 





Figure 52. MS chromatograms of the supernatant extracts obtained after 72 h of mutant ∆lab6∆lab16 and wt 
culture cultivation in M2 medium showing extracted ions in the range m/z = 470-512. Intermediates 1 (m/z = 
512), 2 (m/z = 498) and 7 (m/z = 470) are indicated. 
The molecular structure of the intermediate derived from the disrupted tailoring reactions is 






Figure 53. Scheme showing the disrupted enzymatic reactions due to of lab6 and lab16 gene inactivation in 
∆lab6∆lab16 mutant strain. 
 
4.2.3. Tailoring hydroxylations 
Other tailoring reactions involved in labrenzin biosynthesis, beside methylations, are 
hydroxylations. In the lab cluster there are two putative FMN-dependent oxidoreductases (ORs), 
named Lab5 and Lab8, and a putative cytochrome P450, named Lab7, that are likely to be involved 
in the hydroxylations of C7 and C10 (Figure 46). The hydroxylation of C6 is generated by the PKS 
unit. A possible hypothesis was that at least one of the oxidoreductases would be responsible for at 
least one of the tailoring modifications. Also, the cytochrome P450 (Lab7) and OR (Lab8) form an 
operon and their ORFs overlap suggesting a functional dependence. 
In order to determine the specific function of each putative hydroxylating genes, several 






4.2.3.1. Tandem knockout of Lab7 and Lab8 
To investigate the functional role of cytochrome P450 Lab 7 and OR Lab8, both genes were 
deleted, the mutant were screened for the accumulating intermediates and the mutations were 
complemented by expressing both genes together or independently. Figure 54 shows that when 
compared to wt, the ∆lab7-lab8 mutant strain accumulates two intermediates with molecular masses 
454 (8) and 468 (3), while labrenzin (1) and its 17-O-demethylated analog (2) were absent (Figure 
54A). Considering the molecular masses of the newly accumulated compounds, it can be deducted 
the loss of two -CH3 groups (-28) and one oxygen (-16) for the m/z = 468 compound and one 
additional loss of one -CH3 group (-14) for the m/z = 454 compound which would correspond to the 
molecular structures showed in Figure 54B. Besides, the chemical structure of the 468 peak was 
previously identified and characterized by NMR by PharmaMar in the wt cultures which 
additionally supports the MS results obtained from the ∆lab7-lab8 culture extracts (personal 
communication, data not shown). 
Figure 54C shows the results of the complementation experiments of ∆lab7-∆lab8 mutant 
strain with pSEVA338_lab7-lab8, pSEVA338_lab8 and pSEVA338_lab7 plasmids. Interestingly, 
labrenzin production was observed only when the mutant was complemented by pSEVA338_lab7-
lab8. When the lab7 and lab8 genes were used to complement the mutant separately, labrenzin was 
not detected in the culture extracts, suggesting that both enzymes might be required for the 





Figure 54. Functional role of Lab7 and Lab8. A) MS chromatograms of extracts obtained after 72 h of 
∆lab7-∆lab8 mutant and wt cultures in M2 medium showing extracted ions in the range m/z = 454-512. The 
black and white dots indicate peaks m/z = 498 and m/z = 512, respectively. Accumulated polyketide 
intermediates in the ∆lab7-∆lab8 mutant are marked with numbers. B) The scheme showing the interrupted 
pathway of tailoring enzymatic reactions. C) The gene complementation experiment: a) wt used as a positive 
control; b) ∆lab7-lab8 used as a negative control; c) ∆lab7-∆lab8 (pSEVA338_lab7-lab8); d) ∆lab7-∆lab8 






4.2.3.2. Knockout of Lab5 
Once it has been established the tailoring role of the cytochrome P450 Lab7 and OR Lab8, it 
appears more clear the possible role of the OR Lab5, that could be most likely responsible for the 
hydroxylation at C7 position. The lab5 gene was deleted not only to confirm the tailoring role of 
OR Lab5, but also to test if the hydroxylation reactions happen in a specific order, i.e., if they are 
substrate specific. The culture extracts were screened for the new intermediates by HPLC/MS. 
Figure 55A shows new methylated intermediates without the C7-OH group, as expected, to 
confirm the function of Lab5. Three different peaks where observed in the MS spectra. The 
associated chemical structure are shown in the Figure 55B. Compound 9 with molecular mass 452 
corresponds to labrenzin (m/z = 512) without two -CH3 groups (-14) and two oxygens (-16). Two 
possible enantiomers 10a and 10b with molecular masses 482 correspond to a molecule 9 with the 
addition of one -CH3 group (+14) and oxygen (+16), i.e., 452 + 30 = 482. A fully methylated 
compound 11, on the other hand, presented with the m/z = 496, fits the compound 10 with the 
additional methyl group (482+14 = 496). 
Figure 55B shows the proposed alternative tailoring pathway once the lab5 gene was 
inactivated and the C7-hydroxylation is blocked. The ∆lab5 mutant strain accumulated compounds 
9, 10 and 11, but corresponding intermediate between 9 and 10 or 11 was not detected, probably 





Figure 55. Functional role of OR Lab5. A) MS chromatograms of the supernatant extracts obtained after 72 h 
of ∆lab5 mutant and wt cultures in M2 medium showing extracted ions in the range m/z = 452-512. 
Accumulated polyketide intermediates in are marked with numbers: 1 (m/z = 512), 2 (m/z = 498), 3 (m/z = 
468), 8a,b (m/z = 454), 9 (m/z = 452), 10a,b (m/z = 482), 11 (m/z = 496). B) Scheme showing the interrupted 
hydroxylation reaction and an alternative pathway for tailoring enzymatic reactions. 
 
4.2.3.3. Tandem knockout of Lab5-Lab6 
A further step was to eliminate both the OR Lab5 and the MT Lab6, which are organized in 
an operon, to generate a ∆lab5-lab6 mutant strain. The idea was to expand the repertoire of 
labrenzin analogs for future applications. Figure 56 shows the MS analysis of the mutant and wt 
culture extracts. As expected, the compound 9 (m/z = 452) was accumulated together with a small 




Lab6 was blocked, compounds 10 and 11 were not detected (Figure 56A). The updated alternative 
tailoring pathway is shown in Figure 56B. 
 
Figure 56. Generation of new labrenzin intermediates by deleting the OR Lab5 and MT Lab6. A) MS 
chromatograms of the supernatant extracts obtained after 72 h of ∆lab5-∆lab6 mutant and wt cultures in M2 
medium showing extracted ions in the range m/z = 452-512. The molecular masses of each labrenzin 
intermediate in wt are shown above the respective peak. Accumulated polyketide intermediates in ∆lab5-
∆lab6 mutant are marked with numbers. B) Scheme showing the interrupted hydroxylation and methylation 





4.2.4. Tailoring by heterologous expression PedO 
4.2.4.1. Production of pederin in PHM005 wt strain 
The difference between pederin and labrenzin is the methylation of C18-OH, that is absent 
in labrenzin. This was also predictable assuming that the lab cluster contains only two MTs, Lab6 
and Lab16, characterized in the previous sections, when compared to ped cluster, which contains 
three MTs. The biochemical in vitro experiments conducted with mycalamide as substrate, a 
pederin family compound with free C18-OH group, demonstrated that PedO is the only MT of ped 
cluster capable of methylating at C18 position (Zimmermann et al., 2009). 
In order to synthetize pederin for the first time in Labrenzia sp. PHM005, a synthetic pedO 
gene was heterologously expressed in this strain. The culture extracts were further analyzed by 
HPLC/MS. Figure 57A shows that a new intermediate, more hydrophobic than the previous analogs 
1 and 2 observed in wt strain. The MS spectrum revealed a new peak 13 at RT = 40.4 min and with 
ion fragmentation m/z = 526; 440; 422 matching with an additional methyl group, suggesting that it 
is pederin (Figure 57B). 
It is worth to mention that this result allows proposing that the hydrolysis of the onnamide-
like polyketide that should originate labrenzin must take place inside the cells. The methylation of 
C18 of labrenzin by PedO can only take place inside the cells. Thus, if the OH-C18 group is not 
generated inside the cells it will be imposible to obtain pederin. This observation cannot be deduced 
from the activities of the other tailoring genes since in those cases it cannot be discarded that the 
tailoring reactions could be perfomed during the synthesis of the polyketide or even previously to 





Figure 57. Pederin biosynthesis in Labrenzia sp. PHM005 wt (pSEVA338_PedO). A) MS chromatograms of 
the supernatant extracts obtained after 72 h of cultivation of wt cultures in M2 medium presenting extracted 
ions in the range m/z = 498-526. Intermediates 1 (m/z = 512), 2 (m/z = 498) and 13 (m/z = 13) are indicated. 
B) MS ion fragmentation of 13 (pederin). 
Although pederin was produced in Labrenzia sp. PHM005 wt (pSEVA338_PedO), it was 
not the most abundant intermediate in the extract. In order to optimize the expression of pedO and 
to obtain sufficient amount of pederin for its purification and structure elucidation, two new genetic 
approaches were carried out. 
Firstly, the relative pederin amount was increased by co-expressing pedO with lab6 and 
lab16 genes. Figure 58 shows MS chromatograms of culture extracts of strains harnessing different 
methyltransferase expression combinations. 17-O-demethylated labrenzin (2) was the the most 
abundant peak when pedO was expressed alone forming an operon with lab16 and when the three 
MT genes were co-expressed. On the other hand, pedO expressed together with lab6, appeared to be 




The second approach was to engineer the expression plasmid pSEVA338_pedO_lab6 with 
the constitutive strong P14g promoter, replacing the inducible Pm promoter. Nevertheless, the 
promoter switch did not seem to change the peak ratio as observed in the MS chromatograms. 
 
Figure 58. MS chromatograms of the culture extracts obtained after 72 h of cultivation of wt recombinant 
strains transformed with different plasmids in MBM+VIT medium. Extracted ions range is m/z = 498-526. 
Intermediates 1 (m/z = 512), 2 (m/z = 498) and 13 (m/z = 526) are indicated. 
However, when carbon rich media is used for the cultivation (M2 or 2MLA medium used in 
PharmaMar), the intermediates‟ ratio does not maintain. Moreover, pederin is about one order of 
magnitude less abundant than labrenzin in those cultures (data not shown). 
4.2.4.2. Production of novel pederin analogs in PHM005 mutant strains 
In addition to heterologously synthetized pederin in Labrenzia sp. PHM005 
(pSEVA338_PedO), the possibility of  à-la-carte production of novel pederin analogs for the future 
applications was explored taking into account that all previously generated mutants accumulated 




PedO can catalyze the methylation on other compounds with the available C18-OH group as well, 
independently of the tailoring of the substrate molecule. 
In order to generate new analogs, the pSEVA338_PedO plasmid was expressed in the 
∆lab6, ∆lab16 and ∆lab6∆lab16 mutant strains. 
The extract of ∆lab6 (pSEVA338_PedO) strain showed several new peaks in MS 
chromatograms (Figure 59). A part from the intermediate 4 lacking two methoxy groups (m/z = 
484) with RT = 29.4-30.0 min (see also Figure 48 and Figure 49), the strain also accumulated 3, 10-
demethoxy-labrenzin (m/z = 468) at RT = 28.0-28.6 min. This compound is also accumulated in the 
Δlab7-Δlab8 culture extracts (Figure 54). Therefore, it could be expected to detect the C18-OH 
methylated molecular counterparts. Summing one additional methyl group the expected products 
were detected in the total MS scan, as intermediates 14 (m/z = 498, 408; 426) and 16 (m/z = 482; 
428), respectively. Unexpectedly, the peaks 15a, 15b and 17 were detected in sufficient amount 
whose molecular mass and fragmentation pattern fit the previously identified labrenzin analogs. 
Intermediates 15a and 15b were isomers with ion fragmentation m/z = 468; 428 characteristic for 
the compounds 8a and 8b (m/z = 454; 414) produced by the Δlab7-Δlab8 mutant strain (Figure 54). 
Interestingly, demethylated counterpart did not accumulate in the culture extracts, suggesting that 
PedO might have higher affinity towards m/z = 454 intermediate as a substrate than Lab16. Under 
ideal conditions, compound 15 was expected to be completely transformed into compound 16, but 
according to the results presented in Figure 59, Lab16 methylation does not seem to be as efficient. 
The most unexpected result is the presence of the compound 17, whose molecular mass 
corresponds to two additional methylations (m/z = 496; 442), produced by methylation of 
compound 16. This result suggests that PedO might have a dual function that is able to replace the 
function of Lab6 and methylate another available -OH group. In addition, it can be observed that 
compound 14 is much less abundant than compounds 15, 16 or 17, suggesting that PedO prefers 
substrates lacking the C10-OH group under these conditions. To confirm the exact molecular 






Figure 59. MS chromatograms of the culture extracts obtained after 72 h of cultivation of ∆lab6 
(pSEVA338_PedO) strain in M2 medium. Extracted ions range is m/z = 468-498. Intermediates 3 (m/z = 
468), 4 (m/z = 484), 14 (m/z = 498), 15a,b (m/z = 468), 16 (m/z = 482), 17 (m/z = 498) are indicated. 
Molecular structures of hybrid intermediates are shown below. 
On the other hand, four new methylated analogs were detected in the extract of ∆lab16 
(pSEVA338_PedO) strain when it was compared to a control extract (Figure 60). As presented 
above, the ∆lab16 mutant generates two isomers lacking the C6-OH methylation: isomers 5a and 
5b at RT = 30.6 and 31.8, and isomers 6a and 6b at RT = 32.4 and 33.8 (see also Figure 50 and 
Figure 51). Besides these methylated intermediates, the mutant accumulated substantial amount of 
the two isomers 8a and 8b missing the C10-OH group with RT = 27.2-28.8 min (see also the Figure 
54). The ∆lab16 (pSEVA338_PedO) strain showed their molecular counterparts 18a and 18b (m/z 




additional methyl group. The unexpected result was again the appearance of the double methylated 
intermediate 21 with a fragmentation pattern m/z = 482; 442, typical for C10-dehydroxylated 
intermediate 8 of m/z = 454; 414 (Figure 54). Interestingly, the MS showed only one peak and it 
can be assumed either that compound 21 is produced from the quiral molecules 8a and 8b to a non-
quiral intermediate or that PedO methylation favors one configuration over the other. The 
substantial residual amounts of 1a and 1b indicate that the second methylation is less efficient under 
these conditions. 
 
Figure 60. MS chromatograms of the culture extract obtained after 72 h of cultivation of ∆lab16 
(pSEVA338_PedO) in M2 medium. Extracted ions range is m/z = 468-512. Intermediates 5 (m/z = 484), 6 
(m/z = 498), 8 (m/z = 454), 18 (m/z = 468), 19 (m/z = 498), 20 (m/z = 512), 21 (m/z = 482) are indicated. 




Finally, an intermediate 22 with only one methylation at C18-OH position was produced in 
the ∆lab6∆lab16 (pSEVA338_PedO) strain (Figure 61). Unfortunately, the abundances of 22 (m/z 
= 484; 426) and its precursor 7 in the ∆lab6∆lab16 mutant (m/z = 470; RT = 26.5) were barely 
detectable in the MS spectra. The strain also accumulated intermediates 18a, 18b and 21 as ∆lab16 
mutant from the previous section. 
 
Figure 61. MS chromatograms of the culture extract obtained after 72 h of cultivation of ∆lab6∆lab16 
(pSEVA338_PedO) strain in M2 medium. Extracted ions range is m/z = 468-484. Intermediates 7 (m/z = 
470), 8 (m/z = 454), 18 (m/z = 468), 21 (m/z = 482), 22 (m/z = 484) are indicated. Molecular structures of 








1. In silico characterization of the lab cluster
The potent and selective bioactivities of pederin family compounds have triggered their 
pharmaceutical interest during the last years mainly as drug candidates for cancer therapy (Wan et 
al., 2011), however, the production of pederin analogs had been ascribed to non-cultivable 
endosymbiont bacteria. Piel and collaborators hypothesized that pederin-like gene clusters first 
belonged to a free-living bacterium and later have been horizontally transferred among symbionts 
where they preferentially stayed with the premise that these compounds were more advantageous to 
the host organism than to the producer itself (Piel et al., 2004c). 
Until the recent discovery of a pederin analog produced by the free-living bacterium 
Labrenzia sp. PHM005 (Schleissner et al., 2017), pederin-related compounds were only obtained 
after extraction from insects or marine organisms (Helfrich and Piel, 2016), and by chemical 
synthesis through a multi-step process due to its complex structure (Wu et al., 2011). The structure 
of pederin and onnamide biosynthetic clusters have been reconstructed using partial sequences 
obtained from metagenomics analyses. Therefore, until now it has not been possible to fix precisely 
the boundaries of these clusters as well as to carry out functional or regulatory analyses. The 
discovery of the labrenzin produced by the cultivable strain Labrenzia sp. PHM005 has opened a 
new technical window not only to understand its biosynthesis and regulation, but also to apply 
biotechnological tools for industrial purposes and for developing large-scale production of these 
anti-cancer agents. 
Based on in silico genomic approaches the lab cluster was identified and described, a trans-
AT PKS/NRPS cluster that is responsible for the synthesis of labrenzin, a pederin analog in 
Labrenzia sp. PHM005. This allowed carrying out the comparative analyses between homologue 
gene clusters for the biosynthesis of psymberin, diaphorin, nosperin and cusperin to understand 
better the correlation between PKS domains and the chemical structure of growing polyketide. This 
lab cluster consists of three main PKSs/NPRSs genes that might be responsible not only for the 
synthesis of labrenzin but also for the synthesis of an onnamide-like analog. Interestingly, the 
partially published sequence of the homologous onnamide gene cluster (onn cluster) found in the 
metagenome of the sponge T. swinhoei contains all the PKS genes in a single region (Piel et al., 




analogs produced by the sponge might be generated by the same onn cluster by using alternative 
synthetic mechanisms (Piel et al., 2004c). 
Concerning to onnamide-like molecules, the assembly of sesbanimide analogs in S. indica 
PHM037, novel types of glutaramide-family polyketides was proposed in this work (Figure 19). 
More than 80% of the sbn biosynthetic genes are present in lab cluster, although those clusters are 
responsible for the production of structurally completely different molecules. Moreover, the 
structure of sesbanimide F revealed the cryptic polyketide moiety co-linear with the SbnQ domain 
organization. Strikingly, the modular architecture of downstream mixed type PKS/NRPS, SbnQ, 
shows a high similarity to PedH in pederin and Lab13 in labrenzin gene clusters. This insight 
provides a clue about the missing polyketide moiety in labrenzin biosynthesis. The unexpected 
presence of SbnQ homologs in unrelated polyketide gene clusters across phylogenetically distant 
bacteria raises intriguing questions about the evolutionary relationship between glutaramide-like 
and pederin-like pathways, as well as the functionality of their synthetic products. 
2. Bases of labrenzin production 
2.1. Trans-AT with proofreading role in labrenzin assembly 
In trans-AT PKS an external acyltransferase enzyme associates and dissociates with the 
PKS complex during the acyl transfer process from the activated acyl-CoA to the growing 
polyketide chain. The lab cluster encodes two trans-ATs, named Lab9 and Lab10. Interestingly, 
only a couple of PKS clusters have been described to contain more than one trans-AT, i.e., the 
PedC and PedD trans-ATs from the pederin cluster (Piel, 2002), and the BaeC and BaeD trans-ATs 
from the bacillaene gene cluster (Chen et al., 2006). Trans-AT Lab9 is homolog to PedC with 35% 
of amino acid identity and Lab10 is homolog to PedD with 51% of aa identity. In vitro experiments 
with PedC and PedD demonstrated their similar yet distinctive functional roles in pederin 
biosynthesis (Jensen et al., 2012). While PedD was responsible for loading malonyl units to ACPs, 
PedC showed proofreading activity hydrolyzing a whole variety of short-chain acyl-intermediates, 
suggesting that it is responsible for editing the incorrectly inserted acyl-units and thus, for 





In this work, it was showed the important role of Lab9 in the efficiency of the polyketide 
assembly, as its inactivation led to dramatic drop in labrenzin production (Figure 34). This result 
also supports the previous in vitro observation of the hydrolytic activity on its homologue PedC and 
the speculated the editing function (Jensen et al., 2012). Similar editing role can be find in stand-
alone type II TEs that hydrolyze residues attached to modular ACPs and can remove stalled 
intermediates, release the final product or control the substrate selection. In addition, alike Lab9 
knockout, there are several examples of TE type II removal causing significant decrease in the 
polyketide production up to 85-90% (tylosin), 40-60% (rifamycin B), 90% (candicidin), 84% 
(surfactin) (Kotowska and Pawlik, 2014). Unalike Lab9, these examples have reached the 
production in the wild type strain after its complementation. A possible explanation may be a Lab9 
misfolding and/or aggregation because of non-optimized overexpression or because the selection of 
an inadequate expression plasmid. 
Lab9 knockout also indicated that the trans-AT Lab10 alone is sufficient for the malonyl-
unit loading to the PKS and therefore the labrenzin biosynthesis. Overexpression of both trans-ATs, 
using the native promoters in a multicopy plasmid, did not lead to increased polyketide production 
under the conditions tested. Trans-ATs activity might also depend on the substrate availability and 
assembly efficiency on the global turnover of the PKS system, which may depend on many factors. 
In conclusion, the bottlenecks in polyketide biosynthesis might be based on something else and the 
increased production requires fine-tuning of several different variables. 
2.2. Transcriptional up-regulation 
Another approach to increase the labrenzin production was tested by using chemical elicitors 
to induce the transcription levels of lab genes. It has been shown that the sub-inhibitory 
concentrations of antibiotics have pleiotropic effect on multiple promoters across the genome, as 
they recruit the global transcription regulators that may activate the transcription of silent gene 
clusters (Goh et al., 2002; Zarins-Tutt et al., 2016). The main downside of this approach is the 
inability to determine the mechanism of gene activation since there are many factors involved and it 





It was showed that all the chemical substances used affected positively the promoter Pn4 
activity, especially using trimethoprim and piperacillin. They were also successfully applied in the 
first high-throughput elicitor screening resulted in de-silencing of two cryptic gene clusters in 
Burkholderia thailandensis and inducing at least five metabolic pathways (Seyedsayamdost, 2014). 
Although the lab4 transcription was upregulated, the production of labrenzin did not significantly 
increase as compared to wild type under the culture conditions tested. The obvious limitation of the 
method is the specific targeting of only one gene or one operon at a time. While in some cases the 
whole gene cluster is organized in one operon, like in didemnin B gene cluster from Tistrella 
mobilis (Xu et al., 2012), lab gene cluster has at least 15 identified TSS with the respective 
promoter regions (Figure 27). 
Alternatively, these results suggest that the gene transcription itself may not be the 
bottleneck in labrenzin production. Other factors should be taken into account in order to improve 
the labrenzin yields, such as engineering strong RBS sequences to improve the translation or 
ensuring excess of substrates and necessary cofactors. It is also possible that the presence of the 
chemicals interferes with other pathways or changes intracellular physical conditions that 
negatively affects the overall polyketide biosynthesis. 
In this thesis, a new tool to improve elicitors screening using GFP as a reporter in Labrenzia 
sp. PHM005 has been developed. Various high-throughput screening methods based on 
translational fusions of LacZ, XylE or GFP as reporters have been developed until now (Tomm et 
al., 2019). In this work, the monomeric super folder GFP was used as reporter gene and its 
production was enhanced using a bicistronic design element resulting in the green fluorescence 
visible to the naked eye. This property allows to screening many colonies at once on a simple petri 
dish and may be applied in random mutagenesis screenings in future studies. 
3. Essential enzymes for labrenzin biosynthesis 
In this work, several gene deletion mutant strains have been produced. The mutations have 
completely abolished the production of labrenzin, showing that the deleted genes play an essential 
role in labrenzin biosynthesis. This is the case of lab3, lab4, lab11 and lab13 genes encoding the 




3.1. Operon lab4-lab5-lab6 
The first and most straightforward mutation was performed by the inactivation of lab4 gene 
encoding the first PKS generating Δlab4 strain. This mutation was useful for demonstrating that the 
lab gene cluster was certainly the labrenzin biosynthetic cluster. In fact, this was the first time that a 
genetic engineering tool was applied to study a pederin-family gene cluster, since the ped gene 
cluster identified in 2002 could not be manipulated. At the same time, the mutagenesis of lab4 was 
designed to disrupt also the Pn4 promoter and ensure the generation of a non-producing labrenzin 
strain, to be used as a negative control in future studies. Not surprisingly, the mutation caused a 
polar effect on the expression of the following two genes, i.e., lab5 and lab6, demonstrating that 
these genes formed an operon. 
Restoring the labrenzin production in the Δlab4 (pSEVA338_lab4_lab5_lab6) mutant strain 
by complementation seemed a good opportunity to test the possibility of producing a large gene 
transcript using a multi-copy plasmid. PKSs are large multi-enzymatic proteins whose 
overproduction could be rather challenging. As expeted, labrenzin was detected in the completented 
strain but its production was below the level of wild type. The attempts to increase the production 
by changing the temperature and shaking were not sucsessful. Several reasons might explain the 
low production yield in the complemented strain such as protein aggregation caused by 
overexpression of the protein. Moreover, multi-copy plasmid replication and unregulated protein 
expression might act as a metabolic burden (Wu et al., 2016). Nevertheless, the reasons should be 
studied more carefully. 
3.2. β-branching enzymes 
There have been described many types of β-branching enzymes assisting the polyketide 
biosynthesis and contributing to their functional and chemical variety (Walker et al., 2020). HMGS 
cassette (or HCS cassettes) that introduces alkyl side-chains into β-position usually comprise 
individual HMGS, ACP, ECH and KS. However, there is only limited evidence of their function 
(Buchholz et al., 2010; Calderone et al., 2006; Haines et al., 2013; Simunovic and Müller, 2007). 
Among the tailoring enzymes in lab cluster, there are free-standing ACP, HMGS, ECH and KS as 




In this work, the essentiality of HMGS and ECH was shown, but suprisingly the knockout of 
the stand-alone KS
0
, that it expressed in the same operon with ECH, did not have an effect on the 
labrenzin production. One possible explanation for this finding is an enzyme redundancy, i.e., other 
enzyme from elsewhere in the genome could complement the decarboxylation function of KS
0
. 
On the other hand, the HCS cassette could interact in trans with the modular KS, more 
probable due to the high specificity of the lab genes and the fact that HCS cassette already interacts 
with the PKS modules. In agreement with this possibility, the third module of Lab4 PKS comprises 
an ECH domain and tandem ACP domains, conserving motif flags for β-branching specificity 
(Haines et al., 2013), immediately followed by a KS domain that could assist the HCS cassette. 
Then, it was surprising that the cluster could need a redundant KS
0
. On reason can be that 
the additional KS could improve the turnover of the branching enzymatic complex and use it to 
regulate the assembly rate. Another reason could be that stand-alone KS
0
 is engaged in the 
downstream polyketide tailoring. 
According to the results obtained from the knockout and complementation studies on 
HMGS, ECH, KS and backed up with data from other studies, it can be assumed that at least 
HMGS and ECH from HCS cassete are crucial for labrenzin biosynthesis, probably interacting with 
the Lab4 PKS module 3 to form the exo-methylene branch in labrenzin. Without this in trans 
activity the biosynthesis of the polyketide is impaired. The same outcome was reported in 
myxovirescin biosynthesis where the HMGS TaC knockout completely abolished the production 
(Simunovic and Müller, 2007) or in the mupirocin production after deleting HCS cassete genes 
(Hothersall et al., 2007). Considering this result, it would be interesting to manipulate these genes in 
order to increase the turnover of PKS and to improve the efficiency of the assembly flow in future 
works. 
ACP encoded by lab2 gene remains to be studied, although it likely forms a complex with 
HMGS as described (Walker et al., 2020). 
In conclusion, the proposed biochemical mechanism of exo-methylene β-branching in 
labrenzin biosynthesis would include the association of HMGS-ACP complex with the interaction 




mutagenesis (Haines et al., 2013), followed by successive dehydration and decarboxylation steps 
catalyzed by modular ECH and in trans acting ECH, as it was demonstrated in curacin A 
biosynthesis (Gu et al., 2006). 
4. Assembly of the large cryptic labrezin intermediate 
4.1. Comparative analysis with sesbanimide biosynthesis 
Chemical elucidation of the intermediates of sesbanimide biosynthetic pathway and 
sequencing of the genome of two marine producers opened the window to understand better the 
assembly patterns of sesbanimide and other similar polyketides. Strikingly, sbn cluster shared 80% 
of genes with lab cluster. The most interesting result of these analyses was the determination of 
sesbanimide F structure, revealing for the first time a clue to anticipate the structure of the large 
cryptic polyketide fragment (Figure 19) that should be synthezided by SbnQ, the Lab13 homolog. 
The structure of lipoid moiety of sesbanimide F reflects the architecture of SbnQ almost perfectly, 
with the exception of the terminal amino acid that is missing. Thus, sesbanimide F structure 
provides some clues for the whole polyketide assembly of lab cluster. 
An initial hypothesis was that the monooxygenase inserted between the two PKSs in ped 
cluster, PedG, would have a hydrolyzing function (Piel, 2002). Interestingly, its SbnP homologue, 
also located between two hybrid PKSs, could be a Baeyer-Villiger monooxygenases (BVMOs). 
These enzymes convert ketones and cyclic ketones into their corresponding esters and lactones, 
respectively (Leisch et al., 2011). The first demonstration of its role in a polyketide biosynthesis 
was an in vitro biochemical assay of individually expressed cis-monooxygenase from the FR901464 
pathway (Tang et al., 2013). Later, the expression of OocK, a BVMO from oocydin biosynthesis, 
showed that the enzyme could also produce an oxygen insertion into synthetic substrates. Thus, it 
was speculated that it is involved in the ester-like polyketide oocydin B synthesis, followed by ester 
hydrolysis into oocydin A (Meoded et al., 2018). Taking into account these observations, it has 
been suggested that SbnP is responsible for the oxygen insertion into the growing polyketide chain 
of sesbanimides that generates the long-chain intermediate sesbanimide F. Moroever, taking into 
account the high similarity of SbnQ and Lab13 and the BVMO homology with Lab14, it can be 




To explain the structure of the lipid moiety of sesbanimide F, it is worth to mention that the 
two first modules of SbnQ (also found in Lab13) should contain an enoyl reductase domain, but 
they are not present in the protein. This means that this function should be carried out by a trans-
enoyl reductase. In addition, taking into account the non-canonical distribution of the three 
dehydratase and two ketoreductase domains in the four PKS modules of SbnQ, these domains 
should act trans-modularly coordinated to generate the double bounds present in sesbanimide F. 
The presence of different sesbanimide congeners suggests that the final polyketide product 
might be processed into a longer intermediate sesbanimide F and shorter sesbanimides A, C, D and 
E, most probably by hydrolytic esterases or amidases encoded by additional tailoring genes. If 
amide cleavage was very efficient, it would explain why the fully elongated congener is not 
detected in the cultures. 
4.2. Mutations in downstream PKS/NRPS (Lab13) 
Lab13 is a hybrid PKS/NRPS involved in the downstream biosynthesis of the cryptic 
polyketide moiety that was first associated to onnamide-type molecules (Piel, 2002). Thus, it would 
be expected to detect in the labrenzin extracts at least a sesbanimide F-like molecule, as identified 
from the S. indica PHM037 culture extracts. One major aim of this thesis was the identification of 
the large onnamide-like labrenzin intermediate or at least a sebanimide F-like intermediate that can 
explain the labrenzin origin. The dilemma was to determine weather it was necessary to synthetize 
the whole polyketide intermediate in order to hydrolyze it later. Perhaps, labrenzin was produced in 
another way, for instance by a trans-acting enzyme, encoded within the cluster or elsewhere in the 
genome, that could release labrenzin from the PKS complex just at the moment it is synthetized. In 
this way, labrenzin could be produced before the onnamide-like polyketide could be synthesized. 
Should that be the case, there must be compelling reasons to justify the conservation of such a 
hughe lab13 gene. One reson could be that Lab13 is required to maintain the structure of the whole 
enzymatic complex. However, it could not explain why all key catalytic sites are still conserved in 
Lab13. If the only reason to maintain Lab13 was to support the complex structure, one should 
expect that the enzymatic activity of Lab13 might have disappeared by evolution. On the other 




two homologues of Lab13, are not identical, the idea that Lab13 migh have lost a domain and it 
could not be functional cannot be discarded. 
 The absence of labrenzin in the Δlab13 mutant strain confirmed that the Lab13 protein is 
required for the synthesis of labrenzin. However, this result does not mean that a whole polyketide 
has to be synthetized in order to produce labrenzin or that Lab13 is functional since, as mentioned 
above, Lab13 could be only needed to keep the structure of the enzymatic complex. 
To address the question of the enzymatic role in the polyketide elongation by Lab13, a point 
mutation was perfomed in the last thioesterase domain. This domain is required to release the 
polyketide from the enzymtaic complex. In this way, the 3D structure of Lab13 is not altered and it 
is possible to confirm is Lab13 is only required to keep the structure of the complex or it is fully 
functional. To this aim, the serine of the catalytic site was replaced by alanine in order to strongly 
reduce or even to abolish the thioesterase activity (Witkowski et al., 1994). The lab13TES>A 
mutant only produces a residual amount of labrenzin (Figure 43) suggesting that, as expected, the 
thiosterase activity was strongly reduced (Pazirandeh et al., 1991), that Lab13 is functional and that 
the synthesis of the whole onnamide-like polyketide should be a true intermediate in the sysnthesi 
of labrenzin. Therefore, the residual amount of labrenzin detected in the lab13TES>A mutant 
provides a more solid clue about the role of Lab13, suggesting that is it not only required as a 
structural support. In this case, since the mutation only impairs the release of the onnamide-like 
polyketide, it suggests that labrenzin is generated by hydrolysis of the onnamide-like polyketide 
once it was released from the complex. If labrenzin could be released before the large polyketide 
could be synthesized the lab13TES>A mutant should be able to produce labrenzin in high amounts 
as the wild type. 
On the other hand, the Δlab13 mutant allowed to compair the UV and MS chromatographs 
of crude extracts with those obtained from the wild type strain extracts. In this way, it can be 
observed that in extract from the wt strain there was a significantly abundant ion [M+Na]
+
 m/z = 
840 that was not present in the extracts of Δlab13 mutant. The molecular mass of this compound 
would correspond to the onnamide-like molecule containing the chain with the terminal amino acid 
arginine. Although this compound was not purified and the chemical structure was not elucidated 




the molecule. The compound strongly absorbs under UV light at 260 nm, that is compatible with the 
existence of double bonds in the molecule as expected (Matsunaga et al., 1992; Paul et al., 2002). 
5. Post-PKS tailoring modifications of labrenzin 
5.1. O-Methylation 
Since the first discovery of the ped cluster in the beetle P. fuscipes metagenome almost two 
decades ago (Piel, 2002), there have been identified five more homologous gene clusters in the 
genomes of symbionts responsible for the biosynthesis of structurally highly similar compounds 
such as, psymberin (Fisch et al., 2009), diaphorin (Nakabachi et al., 2013), nosperin (Kampa et al., 
2013), cusperin (Kust et al., 2018) and mycalamide A (Rust et al., 2020). In spite of the fact that O-
methylation plays an important role in the diversity of these compounds, there was only one 
experimental study to study the O-methylation in pederin-family polyketides (Zimmermann et al., 
2009). The in vitro biochemical assays reported that the methyltransferase PedO methylated the 
available 18C-OH group in mycalamide A. 
In this thesis, it has been confirmed the role of PedO since its expression allowed to generate 
pederin in the wild type strain PHM005 providing the labrenzin with an additional methylation on 
C18-OH. On the other hand, PedO also allowed generating two new dimethylated biosynthetic 
analogs in the Δlab6 and Δlab16 mutant strains suggesting a double function for this methylase. 
Interestingly, the double function of PedO was only noticeable upon the intermediates lacking the 
C10-OH group suggesting that PedO can only perform the second methylation if the C10 position 
remains non hydroxylated. A similar finding was observed when PedO was unable to methylate the 
C18-OH group of the mycalamide A intermediate when the neighboring -OH was methylated, i.e. 
C18 O-methylation appeared only possible when the C17-OH was non methylated (Zimmermann et 
al., 2009). 
The Δlab6 and Δlab16 mutant strains expressing PedO showed dominant MS peaks that 
corresponded to methylated hybrids of C10-dehydroxylated intermediates also indicating a 
possibility of substrate preference. In this work, PedO was expressed in the MTs mutants but it 
would be interesting to express it in mutants lacking the hydroxylation functions and test the 




intermediates based only on the MS results, they did indicate some level of sequentiality in the 
decoration process including both hydroxylations and methylations. 
Another example suggesting the substrate preference of MTs would be the poor pederin 
accumulation in the culture extracts obtained from the wt strain with PedO expressed in the 
conditions of high labrenzin production established by PharmaMar. If the premise that the C18 O-
methylation only occurs when the neighboring C17 OH remains demethylated is true (Zimmermann 
et al., 2009), it may explain the low abundance of pederin compared to labrenzin in the culture 
extract. On the contrary, in the MBM+vit medium the same expression system yielded dominant 
pederin versus labrenzin intermediate. One possibility for controlled ratio of labrenzin and pederin 
could be the fine-tuning of the Lab6 and PedO expression. 
As already mentioned, pederin has four O-methylations, but only three MTs are present in 
the ped cluster. Knowing that PedO is responsible for the C18 O-methylation, it was considered that 
one of the other MTs, PedA or PedE, would have a double function (Zimmermann et al., 2009). 
Analogously to pederin, labrenzin is decorated by three O-methylations but lab cluster only has two 
MTs, Lab6 and Lab16, homologues of PedA and PedE, respectively (Figure 17). The functional 
genetic analysis conducted in this thesis revealed the dual function of Lab6, by methylating C10-
OH and C17-OH groups. The knockout of lab6 gene, also demonstrated the role of lab16 gene. 
Nonetheless, the lab16 deletion confirmed the roles of MTs and the elimination of both MTs 
excluded the possibility of methylation redundancy. In addition, the results obtained by MS analysis 
showed that the methylation do not occur strictly sequentially. MS analysis of the mutant strains 
involved in the reactions of hydroxylation showed that the methylations occur even when C7-OH or 
C10-OH groups are missing, indicating that these MTs accept different substrates. Unexpectedly, 
the C6-O-methylation performed by Lab16 stabilizes the chirality of the intermediates. To obtain a 
more precise information about the substrate preferences, additional biochemical assays should be 
performed. 
Finally, it was interesting to dicuss why lab and ped clusters differ in one MT, i.e., the PedO 
MT. According to the theory of the Selfish Operon model (Roth and Lawrence, 1996), horizontal 
transfer drives the genes to evolve by forming clusters with the aim that the functionally related 




of obligate symbiont and divided between two loci, contains only one MT. One possibility is that 
this polyketide gene cluster was gaining new functions as it was being transfered horizontally across 
different bacterial taxa, and that eventually led to the evolution of ped and lab gene clusters. It is 
obvious that the PedO function “competes” with the unprocessed complete product, which is 
expected to be similar to ester-like polyketide sesbanimide F produced by S. indica PHM037. 
Therefore, it is possible that the presence of PedO depends on the efficiency of the hydrolysis of the 
polyketide ester, considering it leaves the C18-OH group free for the methylation. As the hydrolysis 
was becoming more efficient, due to the development of the host metabolism, intracellular redox 
state or the presence of another esterase-like enzyme in the host genome, it was more likely for the 
cluster to acquire another function. Nervertheless, other options can be envisioned to explain the 
presence of different MTs in the perderin-like clusters. 
5.2. Hydroxylation 
The functional genetic analyses carried out upon oxidoreductases and cytochrome P450 
(CYP450) from the lab cluster revealed some interesting and unexpected insights into the 
hydroxylation of the labrenzin and its analogs. CYP450s are universally spread enzymes 
responsible for the most versatile reactions in nature in terms of substrate range and transformations 
diversity (Munro et al., 2013). So far, numerous CYP450s involved in polyketide biosynthesis have 
been characterized, catalyzing diverse reactions such as desaturation (Reddick et al., 2007), 
hydroxylation (Mo et al., 2019; Stassi et al., 1993) and epoxidation (Ogura et al., 2004). Until 2017 
around 200 CYP450s engaged in 14 different transformations, mostly hydroxylations, had been 
characterized only in Streptomyces (Rudolf et al., 2017). 
The lab cluster contains genes encoding putative oxidoreductases Lab5, Lab8 and CYP450 
(Lab7) that were considered good candidates for the tailoring hydroxylation reactions. In this work, 
the indispensable role of CYP450 and the associated reductase Lab8 in the C10-OH group 
formation was demonstrated. Initially, Lab7 or Lab8 would be involved in downstream decoration 
functions and Lab5 could have a dual function, as it was showed for MT Lab6. Instead, the 
knockout of both genes and the following complementation experiments revealed the involvement 
of Lab7 and Lab8 in C10 hydroxylation. One indication that those enzymes would act in a 




hand, most of the CYP450s interact with diverse redox partners (RPs) and accordingly distribute 
among up to 10 different classes of cytochrome systems (Li et al., 2020). Since Lab8 is annotated as 
a FMN-dependent oxidoreductase, this hydroxylating system could belong to Class III, which is a 
three-component system consisting on a ferredoxin reductase, FMN-containing flavodoxin (Fld) 
and P450. 
Lab5, on the other hand, is annotated as LLM class flavin-dependent oxidoreductase and 
according to Pfam, the closest homolog is luciferase-like monooxygenase (E-value 7.8e-41). 
Moreover, the experimental analysis demonstrated it is responsible for the introduction of the C7-
OH group. The CYP450 is not involved in this reaction because the lab7-lab8 knockout did not 
affect C7-hydroxylation. This indicated that Lab5 belong to a different class of reductases than 
Lab8 and most likely it is sufficient to generate the hydroxylation. A different mechanism of action 
is also envisioned by the particular atomic environment and electron distribution in a direct 
proximity of C7 and C10. Another possibility is that some other CYP450 from the Labrenzia sp. 
PHM005 genome might assist this reaction, although, as demonstrated throughout this work, 
labrenzin related genes are highly specific and show a great level of clustering organization, 
through operons and overlapping ORFs. 
Recollecting the results of all ten intermediates accumulated by different mutants generated 
during this work, it can be deducted the polyketide tailoring pathway, as it would occur in the wild 
type PHM005 and the alternative pathways that would lead to the accumulation of certain 
intermediates in the mutant strains (Figure 62). Lab5 knockout also showed that Lab6 is substrate-
tolerant because it is able to methylate different labrenzin analogs, as it revealed new methylated 
intermediates lacking C7-OH group. Tandem knockout of Lab5 and Lab6 confirmed the established 
tailoring pathway and expanded the repertoire of labrenzin analogs. 
Interestingly, the MS analysis of the peaks abundance in crude extracts of Δlab5 and Δlab5-
Δlab6 mutants, as well as in the extracts of Δlab6 and Δlab6-Δlab16 mutants indicated a bottleneck 





Figure 62. Pathway of labrenzin tailoring reactions in Labrenzia sp. PHM005. Continuous line represents the 
reactions flow in the wild type strain and the dashed line the secondary reactions in mutant strains. 
6. Deciphering the labrenzin assembly line and future prospects 
Finally, based on the results obtained in this thesis, it can be propose a correction in the 
initial biosynthesis hypothesis and present the current pathway of the full labrenzin assembly by 
PKS/NRPS complex including tailoring modifications (Figure 62). The significant change to the 
initial scheme is due to the oxygen insertion by Baeyer-Villiger monooxygenase (OXY or Lab14) 
when the polyketide elongation continues by the Lab13 PKS/NRPS. This enzyme should produce 
an ester-polyketide that is analog to sesbanimide F. OXY is most likely essential for the proper 
polyketide backbone elongation rather than producing the polyketide hydrolysis, as previously 




complex by the TE domain. The labrenzin is produced by an unknown hydrolytic mechanism in one 
or two consecutive steps. 
The HMGS and ECH are crucial for the labrenzin assembly and they are likely involved in 
the early biosynthesis stage by catalyzing β-branching of exo-methylene residue. According to the 
results of this work, the free-standing KS
0
 is redundant activity in β-branching or could be involved 
in downstream processing of the molecule. 
Tailoring enzymes involved in labrenzin decoration are MTs (Lab6 and Lab16) and 
oxidoreductases (Lab5, Lab7 and Lab8). Lab16 methylates the C6-OH and Lab6 has a dual function 
by successively methylating both C10-OH and C17-OH group. Additionaly, in some clusters there 
would be a third methyltransferase PedO, catalyzing the C18-OH methylation (not shown in the 
figure). While the C6-OH group is introduced by modular modifications, C7-OH group is generated 
by individual Lab5 oxidoreductase. The Lab8 and Lab7 are both needed for the hydroxylation of the 






Figure 62. A) Map of the lab cluster comprising genes for labrenzin production. B) Corrected scheme 
predicting the labrenzin modular biosynthesis in a free-living Alfaproteobacterium Labrenzia sp. PHM005. 
Specific domains have been identified and analyzed using antiSMASH. Domains (shown in circles) that are 
part of the same module are represented in the same color, less the putative non-functional domains in white. 
Module boundaries are defined according to recent improvements (Vander Wood and Keatinge-Clay, 2018). 
GNAT, GCN5-related N-acetyltransferase domain; ACP, acyl carrier protein domain; KS, ketosynthase 
domain; KS0, non-elongating ketosynthase domain; KR, ketoreductase domain; MT, methyltransferase 
domain; ECH, enoyl- CoA hydratase/isomerase domain; A, adenylation domain; AT, acyltransferase; C, 
condensation domain; DH, dehydratase domain; PS, pyran synthase; PCP, peptidyl carrier protein domain; 
TE, thioesterase domain; OR, oxidoreductase; MT, methyltransferase. Putative trans-AT docking site 
associated with its respective KS is indicated by arrows. Modifications by tailoring enzymes are colored in 






To conclude, the biosynthesis of secondary metabolites is influenced by a wide variety of 
environmental and physiological signals, presumably reflecting the range of conditions that trigger 
their production in nature. The genetic manipulation of Labrenzia sp. PHM005 has opened the 
possibility of studying the pathway at a molecular level, not only to unravel the biosynthetic 
mechanisms for the sysnthesis of pederin-like compounds, but also to generate new pederin family 
analogs for pharmaceutical purposes. There are remarkable challenges ahead in understanding the 
regulatory cascades that link environmental and developmental signals to pleiotropic and ultimately 
pathway-specific regulatory genes for secondary metabolism. The availability of the entire genome 
sequence of Labrenzia sp. PHM005 and the possibility to develop transcriptome analyses and site-







1. The genome of the marine alphaproteobacterium Labrenzia sp. PHM005, a producer of 
polyketide labrenzin, consists of a circular chromosome (6.1 Mb) and a plasmid p1BIR (19 
kb). Its closest related strain is L. alexandrii (strain DFL-11). 
 
2. The production of labrenzin is associated with a trans-AT PKS gene cluster, denominated 
lab cluster, expanding over 79-kb genome region and comprising three genes encoding 
PKSs, 16 auxiliary genes and 6 ORFs with still unassigned function. 
 
3. Homologs of lab gene cluster are widespread across phylogenetically distant bacterial 
phyla. Comparative genomics between clusters have contributed to decipher polyketide 
assembly pathways. 
 
4. A new screening method to find effectors for labrencin production was created by testing 
molecules that significantly increase the transcription from the Pn promoter of lab4 gene. 
 
5. The lab3, lab4, lab11 and lab13 genes encoding respectively HMGS, PKS, ECH and 
PKS/NRPS are essential for the biosynthesis of labrenzin polyketide backbone. 
 
6. The serine mutation of thioesterase catalytic site of Lab13 drastically decreases labrenzin 
production suggesting that the polyketide backbone has to be fully sinthetized and released 
from the PKS/NRPS complex for the further hydrolitic processing into labrenzin in the 
bacterial cytosol. 
 
7. Although the knockout of trans-AT Lab9 significantly decreases the yields of labrenzin 
and its intermediates, trans-AT Lab10 alone is sufficient for the polyketide assembly. 
 
8. Methyltransferases Lab6 and Lab16 are responsible for the tailoring reactions of O-
methylation of the labrenzin molecular core. Lab6 has double function and sequentially 
methylates the C10-OH and C17-OH. Lab16 methylates the C6-OH and its knockout 
causes the quirality of the generated intermediates. Both MTs are substrate specific and 





9. Oxidoreductase Lab5 is involved in the hydroxylation at C7, whereas Lab7 and Lab8 are 
necessary for the hydroxylation at C10. 
 
10. PedO encoded in the P. fuscipes symbiont can catalyse the methylation of C18-OH of 
labrenzin generating for the first time pederin in a cultivable bacterium. 
 
11. Knockout experiments in the Labrenzia sp. PHM005 have allowed to generate ten different 
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1. Annex I: DNA sequences used for manipulations 







*TATA BOX; TSS indicated in red 

























































2. Annex II: Preliminary and confirmation analyses 
 
Figure 63. Deletion mutants constructed as described in Material and Methods 7.1.1 and verified by PCR. 






Figure 64. Antibiotic sensitivity of Labrenzia sp. PHM005 in MB monitored during 7 days. The antibiotics 
used were chloramphenicol, tetracycline, ampicillin, gentamycin, spectinomycin, streptomycin, rifampicin 
and kanamycin. The concentrations of antibiotics are indicated in µg/mL. 
 
 





3. Annex III: Ion fragmentation of the compounds by ESIMS  
Methylations 
Specific function of methyltransferase Lab6 
 
Figure 66. ESIMS fragmentation pattern of compound 4 in Δlab6 mutant and the proposed molecular 











Specific function of methyltransferase Lab16 
 
Figure 67. ESIMS fragmentation pattern of compounds 5a and 5b in Δlab16 mutant and the proposed 





Figure 68. ESIMS fragmentation pattern of compounds 6a and 6b in Δlab16 mutant and the proposed 














Generation of de-methylated labrenzin producer 
 
Figure 69. ESIMS fragmentation pattern of compound 7 in Δlab6Δlab16 mutant and the proposed molecular 














Tanadem knockout of Lab7 and Lab8 
 
Figure 70. ESIMS fragmentation pattern of compounds 8a and 8b in Δlab7Δlab8 mutant and the proposed 






Figure 71. ESIMS fragmentation pattern of compound 3 in Δlab7Δlab8 mutant and the proposed molecular 














Knockout of Lab5 
 
Figure 72. ESIMS fragmentation pattern of compound 9 in Δlab5 mutant and the proposed molecular 






Figure 73. ESIMS fragmentation pattern of compounds 10a and 10b in Δlab5 mutant and the proposed 






Figure 74. ESIMS fragmentation pattern of compound 11 in Δlab5 mutant and the proposed molecular 














Tanadem knockout of Lab5-6 
 
 
Figure 75. ESIMS fragmentation pattern of compound 12 in Δlab5-Δlab6 mutant and the proposed molecular 












Tailoring by heterologous expression of methyltransferase PedO 
Methyltransferase Lab6 mutant complemented with methyltransferase PedO 
 
Figure 76. ESIMS fragmentation patern of heterologously produced compound 14 in Δlab6 mutant and the 





Figure 77. ESIMS fragmentation patern of heterologously produced compound 15 in Δlab6 mutant and the 






Figure 78. ESIMS fragmentation patern of heterologously produced compound 16 in Δlab6 mutant and the 
proposed molecular structure. Ion masses include sodium ion. 
 
Figure 79. ESIMS fragmentation patern of heterologously produced compound 17 in Δlab6 mutant and the 





Methyltransferase Lab6 mutant complemented with methyltransferase PedO 
 
Figure 80. ESIMS fragmentation patern of heterologously produced compound 18 in Δlab16 mutant and the 





Figure 81. ESIMS fragmentation patern of heterologously produced compound 19 in Δlab16 mutant and the 
proposed molecular structure. Ion masses include sodium ion. 
 
Figure 82. ESIMS fragmentation patern of heterologously produced compound 20 in Δlab16 mutant and the 





Figure 83. ESIMS fragmentation patern of heterologously produced compound 21 in Δlab16 mutant and the 














Double methyltransferase mutant complemented with methyltransferase PedO 
 
Figure 84. ESIMS fragmentation patern of heterologously produced compound 22 in Δlab6Δlab16 mutant 





Figure 85. ESIMS fragmentation patern of heterologously produced compound 18 in Δlab6Δlab16 mutant 
and the proposed molecular structure. Ion masses include sodium ion. 
 
Figure 86. ESIMS fragmentation patern of heterologously produced compound 21 in Δlab6Δlab16 mutant 
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